Yaya tsawon lokacin da waɗannan alamun ke faruwa?
Kuma musamman ma a cikin mutanen da suka kai shekarunku, duk wani ciwon kirji da ya faru ya kamata a bi da shi ta wannan hanyar.
Kuma da wata zãfi.
Kuma ya kamata a duba yawan cholesterol da jini.
Kuma kana da zazzabi yanzu?
Kuma yanzu kana jin wannan ciwon a kirji?
Kuma idan kana da wahalar numfashi?
Kuma za ka iya gaya mini wasu daga cikin alamun da kake da su?
kuma yawan zafin jikinka
Kuma ina da tari.
Kuma ina da ɗan sanyi da tari
Kuma a yau ina da ciwon kirji sosai.
Kuma shin lokaci ne da ya dace da zafin jikinka?
Kuma yana haifar da ciwon kirji
Kuma ina ganin ina da kadan zazzabi
Kuma ina so ku nuna min inda ciwon kirji yake.
Kuma suna da wata zazzaɓi.
da kuma tarihin ciwon sukari.
Kuma ina so in gaya muku cewa kamar kirji na yana gab da karyewa.
Kuma ina so in gaya muku cewa mutane suna tari a kaina a koyaushe.
kuma kuna jin ciwon kirji
Kuma kun ce wannan shine matsin lamba a kirjin ku
Kowa a cikin iyalin yana da ciwon zuciya, cututtukan zuciya, bugun zuciya, babban cholesterol, hawan jini.
Shin akwai wasu alamomi ko matsaloli da kuka lura da su tare da ciwon tsoka?
Shin akwai wasu mutane a gidanku da suke da irin wannan ciwon?
Kana da wasu alamun cutar?
Kana da numfashi mai ƙarfi?
Har ila kana jin ciwon kirji?
Domin wannan lokacin mura ne
Amma ba za mu iya ware ciwon kirji ba, wanda yake da alaka da zuciya.
Amma wata matsala mai mahimmanci yanzu ita ce ciwon kirji.
Amma ina da wahalar numfashi.
Amma na san cewa mutane da yawa suna tari a kaina.
Amma muna bukatar mu ɗauki kowace cuta da ke tattare da ciwon kirji da muhimmanci.
Amma kana numfashi daidai yanzu, ko ba haka ba?
Na manta da shi gaba daya saboda ciwon kirji.
Kana jin kamar wani yana matsa maka a kirji?
Shin har yanzu kuna jin numfashi
Shin suna gunaguni cewa suna rashin lafiya da irin wannan alamun?
Kuna da wata matsala ta dindindin kamar hawan jini ko wani abu makamancin haka?
Kana da wasu cututtuka na kullum kamar ciwon sukari?
Kana da ciwon numfashi tare da ciwon kirji?
Kana da hawan jini?
Kana da wata matsala ta numfashi tare da shi?
Ka san abin da ya nuna?
Ka ga hoton?
Ka sha ruwa da yawa a yau
Duk da haka, ina yin gwajin ciwon sukari
"Kuma lalle ne, haƙĩƙa, ãyõyinsa kamar na ni suke.
Yaya zafin jikinka yake?
Yaya hawan jini naka yake?
Idan kana da zazzabi mai tsanani
Idan kana da zazzabi mai yawan digiri ɗari biyu ko sama da haka
Idan ka ga alamun cututtuka ko matsaloli na bukatar kulawa mafi kyau
Na yi zazzabi jiya.
Na kuma yi zazzabi kaɗan.
Na yi zazzabi jiya.
Ina da ciwon kirji a cikin kirji.
Ina kuma da matsalar numfashi.
Zan aiko muku da hoto.
Ina jin ciwon kirji a yau.
Ina da ciwon kai da zazzabi a yau.
Ina ganin wannan cutar mura ce.
Ina ganin wannan mura ce mai laushi.
Shin yana kama da wani mai nauyi yana zaune a kan kirjinka?
Ya fara da ciwon kai da zazzabi.
Wannan yana sa ni ciwo a tsakiyar kirji.
Wannan ciwo ne na kirji kamar matsi.
Yana cikin kirji na
Wannan shi ne a tsakiyar kirji na
Wannan shi ne tsakiyar kirji
Ina jin ciwo a kirji.
Ina matukar damuwa da ciwon kirji.
Ina so ku bayyana mini dalla-dalla game da wannan ciwon kirji.
kamar hawan jini ko ciwon sukari
kamar a tsakiyar kirji
Yanzu don zazzabi za ku iya shan wani mai zaki mai zaki
Yanzu Maryama, tsawon lokacin da kuka kasance da alamun cutar?
Yanzu kun ce kuna da ciwon kirji
Wani lokaci ina jin ciwon kirji mai sauƙi.
To, kuna da wasu alamun ban da ciwo?
Ko kuma kana jin kamar wani yana zaune a kan kirjinka?
Ya yi kama da zazzabi da tari da ciwon kai da ciwon tsoka.
daidai a tsakiyar kirji
Ku nuna mini wannan hoton inda kuke jin zafi.
Tun da kana da zazzabi
Shin kuna ganin wasu daga cikin waɗannan alamun suna da alaƙa da yin ciki?
Shin yaranku suna da irin wannan alamun?
Ka gaya mini game da ciwon kirji.
Ƙarfin jiki yana ƙaruwa da dare
Zazzabi da nake da shi a cikin kwanaki biyu da suka gabata
Wata rana, wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wataƙila wata.
Ni ne Dr. Porter a cibiyar kula da gaggawa.
Za ka iya gaya mini game da ciwon kirjinka?
Ina jin ciwo a gaban jikina a cikin kirji na a nan.
Ina jin ciwo mai tsanani a kirji.
Sa'ad da nake jin ciwon kirji
Wane irin ciwo ne kake da shi a kirji?
A wane lokaci ne wannan ciwon kirji ya soma?
Ina ciwon kirji?
A ina kuke jin wannan ciwon kirji?
Kuna jin ƙuƙwalwar kirji.
Ina so in gaya muku cewa ina da ciwon sukari da dai sauransu.
Ka ce kana da ciwon kirji.
Haɗuwa da cutar coronavirus (COVID-19) cikin sauri a cikin EU / EEA da United Kingdom, daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Yawan adadin cututtukan cutar coronavirus (COVID-19) yana nuna irin wannan yanayin a cikin ƙasashen EU/EUA da Ingila wanda ke tabbatar da cewa cutar COVID-19 tana ƙaruwa cikin sauri a duk ƙasashe, yana faruwa a matakai daban -daban dangane da ƙasar.
Dangane da gogewa daga Italiya, ƙasashe, asibitoci da raka'a masu kulawa mai tsanani dole ne su haɓaka shirye-shiryen su don saurin ƙaruwa cikin marasa lafiya na COVID-19 waɗanda za su buƙaci kulawar lafiya, musamman kulawa mai tsanani.
An bayar da rahoton rukunin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
A ranar 9 ga Janairun 2020, Cibiyar Kula da Cututtuka da Cututtuka, China ta ba da rahoton cewa an gano cutar coronavirus, wanda yanzu ake kira mai saurin kamuwa da cutar coronavirus 2 (SARS-CoV-2).
Tun daga wannan lokacin, cutar da kamuwa da cutar SARS-CoV-2 ta haifar an kira ta cutar coronavirus (COVID-19).
Shaidar da aka samu zuwa yau ita ce kashi 80% na mutanen da ke da COVID-19 suna da rashin lafiya mai laushi, wato, kamuwa da cutar numfashi tare da ko ba tare da cutar nimoniya ba kuma yawancin su sun warke.
A cikin kashi 14 cikin dari, COVID-19 ya ci gaba zuwa wani mummunan yanayin da ke buƙatar asibiti yayin da sauran kashi 6 cikin dari ke da mummunan yanayin da ke buƙatar kulawa mai tsanani.
Yawan mutuwar marasa lafiya da ke asibiti saboda COVID-19 ya kai kusan 4%.
A cikin wannan binciken, mun kimanta yanayin karuwar cutar COVID-19 a kowace ƙasa a cikin Tarayyar Turai / Yankin Tattalin Arzikin Turai (EU / EEA) da Ingila (UK) kuma mun kwatanta shi da lardin Hubei, China.
Mun kuma kwatanta adadin adadin COVID-19 na yanzu a cikin EU/EEA da UK da Italiya a lokacin Janairu 31 - Maris 15, 2020.
Yanayin COVID-19 a cikin EU/EEA da UK
Bayan China, COVID-19 ya kara fadada yanayin ƙasa kuma a halin yanzu, ayyukan cutar COVID-19 a sauran ƙasashen duniya sun wuce wannan ƙasar.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar EuroSurveillance ta 5 ga Maris, 2020, Spiteri et al. ya ba da rahoton farkon shari'ar COVID-19 da aka tabbatar a Turai kamar yadda WHO ta bayyana.
A cikin EU/EEA, Faransa ta ba da rahoton farkon lamuran uku da aka tabbatar a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, China a ranar 24 ga Janairu, 2020.
Zuwa 15 ga Maris, 2020, an samu shari'o'in COVID-19 a dukkan ƙasashen EU/EEA 30 da Ingila (UK), tare da 17,750 shari'o'i da mutuwar 1,441 daga Italiya kadai, tare da 39,768 shari'o'i da mutuwar 1,727 da aka ruwaito tsakanin 31 ga Disamba, 2019 da wannan kwanan wata.
Samun adadi mai yawa na shari'ar COVID-19 da kuma yaduwar tarawa
A Cibiyar Kula da Cututtuka ta Turai (ECDC), ana sabunta ƙididdigar shari'ar COVID-19 da aka ruwaito daga kowace ƙasa a duniya a kowace rana da ƙarfe 8:00 na safe daga tushen hukuma kawai kamar su Ma'aikatun Kiwon Lafiya na ƙasashe, Hukumomin Kiwon Lafiya na ƙasa da na yanki da WHO.
An yi amfani da wannan bayanan don tantance yanayin COVID-19 a cikin EU/EEA da UK da kuma kwatanta shi da cutar a Italiya.
A matsayin wakilin yaduwar shari'o'in COVID-19 masu aiki, mun lissafa taƙaitaccen yaduwar kwanaki 14 na shari'o'in COVID-19 yayin da muke la'akari da yanayin yanayin COVID-19 a kowace ƙasa ta EU/EEA da Burtaniya a lokacin Janairu 1 - 15 ga Maris 2020.
Mun kuma nuna adadin adadin adadin wadanda aka ruwaito a kowace kasa har zuwa karfe 8:00 na safiyar 15 ga Maris, 2020 a lokacin 31 ga Janairu zuwa 15 ga Maris, 2020 idan aka kwatanta da Italiya.
Yanayin COVID-19 a cikin EU/EEA da UK
Yanayin taƙaitaccen tarihin kwanaki 14 na yawan kamuwa da cutar COVID-19 a cikin ƙasashen EU/EEA da Burtaniya gabaɗaya yana bin lardin Hubei (China) (Figure 1).
A cikin EU/EEA da duk Burtaniya, yawan cutar COVID-19 ya fara ƙaruwa a kusa da 21 ga Fabrairu kuma ya karu sosai a kusa da 28 ga Fabrairu, 2020 (abun da ke ciki).
Wannan ya kasance ne saboda karuwar yawan adadin wadanda aka ruwaito daga Italiya, amma duk sauran kasashen EU/EEA da UK sun ga irin wannan karuwar karuwar cutar ta COVID-19.
Figure 2 ya nuna yawan adadin COVID-19 a cikin ƙasashen EU/EEA da UK idan aka kwatanta da Italiya a cikin lokacin Janairu 31 - Maris 15, 2020.
Wannan ya nuna musamman cewa a ranar 15 ga Maris da ƙarfe 8:00 na safe, sauran ƙasashe 15 na EU/EEA da UK sun riga sun ba da rahoton adadin adadin shari'o'in da za a iya kwatanta da na Italiya makonni 3 da suka gabata ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin rahotannin COVID-19 yana ƙaruwa cikin sauri a cikin EU/EEA da UK.
Yanayin da aka gani a cikin yawan cutar COVID-19 ya nuna cewa annobar tana ƙaruwa cikin sauri a duk ƙasashe.
Wannan duk da cewa kasashe suna cikin matakai daban-daban, bambance-bambance a cikin martani na lafiyar jama'a na ƙasa, da yiwuwar bambancin ma'anar shari'ar a cikin ƙasashe da kuma ladabi daban-daban don zaɓar marasa lafiya waɗanda ya kamata a gwada su don tabbatar da COVID-19, gami da kamawa da gwaji.
A farkon watan Maris na 2020, likitoci a yankunan da ke fama da cutar a Italiya sun ba da rahoton halin da ake ciki inda kashi 10% na marasa lafiyar COVID-19 ke buƙatar kulawa mai tsanani kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da raka'a masu kulawa mai tsanani a waɗannan yankuna sun riga sun kai iyakar ƙarfin su.
Bayanai game da asibiti da / ko asibiti na kula da kulawa mai tsanani na COVID-19 a halin yanzu ana samun su ne kawai a matakin EU/EEA don kashi 6% da 1% na shari'o'i, bi da bi (ba a nuna alkaluma ba).
Koyaya, yakamata a tattara su ta hanyar tsari don haɓaka bayanan sa ido na yanzu waɗanda ke mai da hankali kan adadin rahotannin da aka ruwaito da yawan mutuwar.
Wani bincike da aka yi a 2010-11 ya nuna cewa akwai bambanci sosai tsakanin yawan gadaje masu kula da marasa lafiya a Turai, daga 29.2 a Jamus zuwa 4.2 a Portugal a kan mutum 100,000.
Wannan yana nufin cewa ƙasashe na iya samun ƙarin ko ƙasa da albarkatu fiye da Italiya (gadoji 12.5 na kulawa mai tsanani da na tsaka - tsaka a cikin 100,000 na yawan jama'a a 2010-11).
Yada yawan asibitocin COVID-19 da ke cikin asibiti da ke da alaƙa da haɗarin 90% na ƙarfin gado mai mahimmanci tare da kimantawa ga kowace ƙasa ta EU/EEA da UK An ba da kwatancen yanayin da ya shafi yanayin ƙoshin lafiya tare da kimantawa ga kowace ƙasa ta EU/EEA da UK a cikin sabuntawa na shida na ECDC na Babban Hadarin Hadarin Hasara akan COVID-19.
Tunda har yanzu akwai lokuta da yawa a cikin ƙasashen EU/EEA da wasu yankuna na Burtaniya kuma asibitoci da raka'a masu kulawa da hankali suna ba da sabis ga yawan jama'ar yanki, ya kamata a samar da bayanai game da shari'o'i da gadajen kulawa da hankali a matakin farko a cikin Nomenclature of Territorial Unit for Statistics 2 (NUTS-2).
Kwarewar da aka samu daga Italiya da kuma yanayin da ake ciki a wasu ƙasashe ya nuna cewa annobar COVID-19 tana ƙaruwa cikin sauri a cikin EU/EEA da UK.
Kasashe, asibitoci da cibiyoyin kulawa da hankali ya kamata su shirya kansu don yanayin ci gaba da yaduwar al'umma na SARS-CoV-2 da karuwar yawan marasa lafiyar COVID-19 da ke buƙatar kiwon lafiya, musamman kulawa mai tsanani kamar yadda yake faruwa a yankunan da ke fama da cutar a Italiya.
Kamar yadda aka nuna a cikin sabon kimantawa na ECDC, tare da sauya ra'ayi daga iyakancewa zuwa ragewa, ana buƙatar saurin, mai saurin aiki da kuma cikakkiyar hanyar rage yaduwar SARS-CoV-2, saboda idan ba a aiwatar da shi a kan lokaci ba, yanke shawara mai sauri da ake tsammani a cikin adadin shari'o'in na iya ba da isasshen lokaci ga masu haɓaka da asibitoci don fahimta, karɓa da kuma daidaita amsar su daidai.
Har ila yau, kimantawa mai haɗari yana lissafin matakan kiwon lafiyar jama'a don magance tasirin cutar.
Kasashe suna da karancin damar kara kokarin sarrafa su da rage matsin lamba kan kiwon lafiya don rage yaduwar SARS-CoV-2.
Idan hakan ta gaza, akwai yiwuwar tsarin kiwon lafiya na sauran ƙasashen EU/EEA zai fuskanci karuwar marasa lafiya da ke buƙatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar coronavirus ta 2019 (COVID-19) da ke haifar da mummunan ciwon numfashi (SARS) coronavirus 2 (SARS-CoV-2) ya kashe mutane sama da 3,000 kuma ya kamu da mutane sama da 80,000 a China da sauran wurare a duniya, wanda hakan ya haifar da bala'i ga mutane.
Kamar kwayar cutar SARS-CoV, wacce ta haifar da SARS a cikin dubban mutane a 2003, SARS-CoV-2 na iya zama daga jemage kuma yana haifar da irin wannan alamun ta hanyar aiki iri ɗaya.
Ko da yake COVID-19 yana da ƙananan tsanani da mutuwar fiye da SARS, amma yana da saurin yaduwa kuma yana shafar tsofaffi fiye da matasa da maza fiye da mata.
A cikin martani ga yawan littattafan da ke fitowa a kan cututtuka masu tasowa, wannan labarin yana ƙoƙari ya ba da cikakken nazari game da wannan bincike mai tasowa.
Za mu hada da abubuwan asali kan ilimin annoba, ilimin kimiyyar cuta, ilimin kwayar cuta, ganewar asali, magani, hasashen da rigakafin cututtuka.
Duk da cewa har yanzu akwai tambayoyi da yawa da za a amsa, muna fatan wannan bita zai taimaka wajen fahimtar cutar da kuma kawar da ita.
Saboda barkewar cutar kwayar cutar, bikin bazara na ranar 25 ga Janairu, 2020 ya zama abin tunawa ga dukkan Sinawa, waɗanda aka nemi su zauna a gida duk hutun da kuma makonni da yawa bayan haka.
Kwayar cutar tana da kamanceceniya da kwayar cutar coronavirus (CoV) wacce ta haifar da barkewar cutar sankarar barbashi mai saurin kamuwa da cuta (SARS) a shekarar 2003; saboda haka, a ranar 11 ga Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta sake masa suna SARS-CoV-2 kuma ta sake masa suna cutar CoV Disease-19 (COVID-19).
Cutar ta fara ne a Wuhan, China kuma ta bazu cikin sauri zuwa duk ƙasar da kusan wasu ƙasashe 50 a duniya.
Ya zuwa 2 ga Maris, 2020, an sami karin mutane 80,000 da suka kamu da cutar COVID-19 tare da asibiti sama da 40,000 da mutuwar sama da 3,000.
WHO ta yi gargadin cewa COVID-19 shine makiyin jama'a na 1 kuma mai yiwuwa ya fi ta'addanci ƙarfi.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu bayan rahoton farko a ranar 7 ga Janairu, 2020, an buga labarai sama da 200 kan COVID-19, gami da ilimin kwayar cuta, ilimin annoba, ilimin kimiyya, bincike, da magani, wanda ya keɓance mutane da yawa daga marasa lafiya don tantance jerin ƙwayoyin cuta.
Wannan bita yana ƙoƙari ya ba da wani bayyani game da ci gaban bincike a kan sabon da kuma ci gaba mai sauri.
A duk lokacin da zai yiwu, za mu yi ƙoƙarin kwatanta COVID-19 da wata cuta da SARS da CoV ke haifarwa, Ciwon Numfashi na Gabas ta Tsakiya (MERS, barkewar 2012).
Za mu tattauna abin da muka koya har yanzu game da rigakafi da kuma tsinkayar cututtuka da kuma wasu tambayoyi masu mahimmanci.
CoVs galibi ana ɗaukar su marasa cutarwa ga mutane tare da haifar da kusan 15% na sanyi na yau da kullun 4.
Koyaya, sau biyu a wannan karni mun fuskanci manyan cututtukan mutum CoVs, watau, SARS-CoV da MERS-CoV, waɗanda suka haifar da barkewar barkewar cutar a cikin 2003 a China da 2012 a Saudi Arabiya bi da bi kuma nan da nan suka bazu zuwa wasu ƙasashe da yawa tare da mummunan rashin lafiya da mutuwar.
Don haka, COVID-19 na yanzu shine barkewar CoV na uku a tarihin da aka rubuta na mutane.
Kamar yadda aka nuna a hoto na 1.1, an fara sanar da kwararar cutar sankarar bargo daga Wuhan zuwa Hukumar Lafiya ta Kasa ta kasar Sin a ranar 31 ga Disamba, 2019.
Bayan kwana bakwai, an sake sakin jerin CoV.
An bayar da rahoton mummunan shari'ar farko daga Wuhan a ranar 15 ga Janairu, 2020.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe masu kusa.
A ranar 20 ga Janairu, an ba da rahoton kamuwa da cuta a tsakanin masu ba da kiwon lafiya, wanda ya nuna cewa yaduwar mutum zuwa mutum na iya yiwuwa.
A ranar 23 ga watan Janairu, an rufe birnin Wuhan tare da rufe duk zirga-zirgar jama'a.
A ranar 24 ga Janairu, binciken farko na asibiti kan cutar ya ba da rahoton cewa kawai 21 daga cikin marasa lafiya 41 da ke da tabbacin sun sami hulɗa kai tsaye da kasuwar abincin teku ta Wuhan, wanda ake tsammanin asalin cutar daga asalin da ba a sani ba.
A ranar 30 ga Janairu, WHO ta ayyana barkewar cutar a matsayin bala'in kiwon lafiya na duniya.
A lokacin wannan rahoton, cutar ta riga ta bazu ko'ina cikin China da wasu ƙasashe kusan 50 a duniya (Figure (Figure 2). 2).
Tunda yanayin yana kara saurin tashi, har yanzu ba a tantance iyakar yaduwar cutar da kuma tsananin cutar ba.
Nazarin cibiyar bincike da yawa na 8,866 da suka hada da 4,021 da aka tabbatar da cutar COVID-19 a ranar 11 ga Fabrairu, 2020 ya gabatar da sabon hoto game da cutar a cikin wannan hanyar (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Mutane masu shekaru daban -daban sun kamu da SARS -CoV-2, amma galibi suna tsakanin shekaru 30 zuwa 65.
Kusan rabin (47.7%) na mutanen da suka kamu da cutar sun haura shekaru 50, kaɗan kaɗan sun kasance ƙasa da shekaru 20, kuma mutane 14 ne kawai ke da cutar da shekarunsu ba su kai 10 ba.
Maza sun fi kamuwa da cutar SARS-CoV-2 fiye da mata (0.27/100,000) fiye da mata (0.31/100,000).
COVID-19 ya bazu ne a cikin garken da ke kusa da Hubei.
COVID-19 ya ɗauki kwanaki 5 (2-9) a matsakaita daga farawa zuwa ganewar asali.
Matsakaicin lokacin incubation ya kasance kwanaki 4. 8 (3. 0 - 7. 2).
Matsakaicin lokaci daga farawa zuwa mutuwa shine kwanaki 9. 5 (4. 8 - 13).
Adadin haifuwa na asali (R0) ya kasance 3. 77 (95% CI:3. 51 - 4. 05) kuma daidaitaccen R0 ya kasance 2. 23 - 4. 82.
Adadin mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairun 2020, wanda ya yi daidai da yawan zirga-zirgar ababen hawa a kasar Sin kafin bikin bazara.
Yawan mutuwar marasa lafiya tare da tabbatar da shari'o'in ya kasance 1.44% (95% CI: 1.10-1.86%) kuma daidaitaccen mutuwar dukkan marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Manyan abubuwan haɗari guda uku na COVID-19 sune jinsi (maza), shekaru (≥60), da ciwon huhu mai tsanani.
CoVs ƙananan ƙwayoyin cuta ne masu girma da ƙarancin ƙwayoyin cuta tare da RNA guda ɗaya.
Ana iya raba su zuwa ƙarni huɗu, watau, alpha, beta, gamma da delta daga cikinsu an san alpha da beta-CoVs suna kamuwa da mutane.
A cikin glycoprotein, SARS-CoV da MERS-CoV, ƙwayoyin halitta suna haɗuwa da masu karɓar kwayoyin halitta na Angiotensin - Converting Enzyme 2 (ACE2) da Dipeptidyl Peptidase 4 (DPP4), bi da bi, sannan kuma suna haɗuwa da membrane.
Kwayar RNA ta kwayar cuta ta saki a cikin kwayoyin halitta; bayan kwayar kwayar kwayar cuta ta kwayar cuta ta kwayar cuta ta sake yin kwayar cuta tare da glycoproteins da nucleocapsid proteins, wanda daga baya ya haɗu da membrane plasma don kawar da kwayar cuta.
An sanar da jerin kwayoyin halittar SARS-CoV-2 na farko a ranar 10 ga Janairun 2020.
SARS-CoV-2 an gano sabon nau'in beta-CoV wanda ya nuna kamanceceniya ta fiye da 99.98% a cikin samfuran 10 da aka tattara daga kasuwar abincin teku ta Hunan a Wuhan, asalin barkewar cutar.
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar nazarin lantarki na watsawa, an gano SARS-CoV-2 a cikin ƙananan sassan jikin mutum.
An gano mai karɓar mai karɓar mutum ACE2, SARS-CoV-2, da SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana haɗuwa da ACE2 na ɗan adam tare da rauni fiye da SARS-CoV wanda ya dace da gaskiyar cewa SARS-CoV-2, yana haifar da ƙananan cututtukan cututtuka a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2, yana iya samar da sabon ƙaramin furotin wanda orf3b ke ɓoyewa da furotin mai ɓoyewa wanda orf8 ke ɓoyewa.
SARS-CoV-2 na orf3b na iya taka rawa a cikin cututtukan kwayar cutar kuma yana iya toshe bayyanar IFNβ; kodayake orf8 ba shi da sanannen yanki ko yanayin aiki.
A ranar 18 ga Fabrairun 2020, Zhou, et al. sun ba da rahoton tsarin cryo-EM na cikakken tsawon ɗan adam ACE2 a ƙudurin 2.9 Å a cikin cakuda shi da amino acid transporter B0AT1.
Sun gano cewa cakuda, wanda ke da kyauta da rufewa, an tattara shi azaman dimer kuma cakuda ACE2-B0AT1 na iya haɗa sunadarai biyu na S waɗanda ke ba da shaida don ganowa da kamuwa da CoV.
B0AT1 na iya zama makasudin magani don binciken magunguna don hana kamuwa da cutar SARS-CoV-2.
Mahimman abinci da kuma matsakaici
An san cewa SARS-CoV da MERS-CoV duka sun samo asali ne daga barbashi kuma an watsa su ga mutane ta hanyar cats da raƙuma, bi da bi.
Ta hanyar kwatanta jinsin SARS-CoV-2 da sauran CoVs, an ɗauka cewa bat shine asalin SARS-CoV-2 saboda sabon kwayar cutar tana da kamanceceniya da kashi 96% da SARS-like CoVs biyu da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, ba a san wane matsakaiciyar abinci mai gina jiki ya taimaka wa kwayar cutar ta ƙetare shingen jinsin don cutar da mutane ba kuma har yanzu ba a bayyana hanyar watsawa ba.
Ji, et al., sun ba da shawarar maciji a matsayin mai ɗaukar kwayar cutar daga jemage zuwa ɗan adam wanda ya haɗa da sake haɗuwa da S protein.
A cewar wani bincike, masu bincike a Guangzhou, China sun nuna cewa pangolins - dogon bakin, dabbar dabba mai cin tururuwa da ake amfani da ita a maganin gargajiya na kasar Sin - na iya zama matsakaiciyar matsakaiciyar abinci ga SARS-CoV-2 da SARS-CoV-2 bisa ga kamanceceniya ta 99% tsakanin kwayoyin halitta da CoV da aka samu a pangolins.
Koyaya, yaduwar bambancin 1% a cikin dukkanin kwayoyin halittar biyu har yanzu babban bambanci ne; sabili da haka, ana jiran sakamako mai mahimmanci don tabbataccen shaida (Fig.
Abubuwan da ke tattare da SARS-CoV-2 ba a san su ba tukuna.
SARS-CoV da MERS-CoV na iya rayuwa har tsawon kwanaki 5 a cikin yanayin bushewar yanayi na wucin gadi na awanni 48 da ƙasa da 20 °C da zafi 40% -50%.
SARS-CoV-2 na iya samun irin wannan halaye.
An ba da rahoton cewa SARS-CoV-2, yana da ƙarancin ƙarancin haske na ultraviolet na minti 30 a 56 °C; ether, 75% ethanol, chlorinated disinfectants, parasitic acid, chloroform da sauran masu narkewar mai suna iya kashe kwayar cutar yadda ya kamata, amma ba chlorhexidine ba.
Yawan jama'ar ɗan adam gabaɗaya ba su da rigakafi ga SARS-CoV-2 kuma saboda haka suna da saukin kamuwa da cutar.
A halin yanzu babu wani cikakken binciken da aka ruwaito game da amsawar rigakafi ga SARS-CoV-2.
Don haka, zamu iya komawa ne kawai ga karatun da aka yi a baya akan sauran CoVs, musamman SARS-CoV da MERS-CoV (Figure (Figure 4).4).
A yadda aka saba, bayan kwayar cutar ta shiga cikin mai gina jiki, an fara gano ta ta hanyar tsarin rigakafin cutar ta hanyar mai gina jiki daga masu karɓar ganowa (PRR) gami da masu karɓar nau'in C-type lectin-like receptors, masu karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar kar
Ta hanyoyi daban -daban, kwayar cutar tana haifar da bayyanar abubuwan ƙonewa, balaga na ƙwayoyin dendritic da kuma kira don hada nau'ikan I Interferon (IFNs) wanda ke iyakance yaduwar kwayar cutar da kuma hanzarta phagocytosis na macrophage na ƙwayoyin cuta.
Koyaya, furotin N na SARS-CoV na iya taimaka wa kwayar cutar ta guje wa halayen rigakafi.
Ba da daɗewa ba, tsarin rigakafin da aka daidaita ya shiga cikin yaƙi da kwayar cutar.
Kwayoyin T lymphocytes, gami da CD4 + da CD8 + T cells suna taka muhimmiyar rawa wajen kariya.
Kwayoyin CD4+ T suna motsa kwayoyin B don samar da ƙwayoyin cuta na musamman na ƙwayoyin cuta kuma CD8+ T ƙwayoyin suna kashe ƙwayoyin cuta kai tsaye.
T-helper cells suna samar da cytokines masu taimakawa kumburi don taimakawa kwayoyin kariya.
Koyaya, CoVs na iya hana ayyukan T cell ta hanyar kashe T cells.
Hakanan rigakafin triiodothyronine, gami da kari da rigakafi kamar C3a da C5a, suna da mahimmanci don yaƙar kamuwa da cutar.
Misali, kwayoyin cuta da aka ware daga mai warkewa sun kashe MERS-CoV.
A gefe guda, yawan amsawar tsarin garkuwar jiki yana haifar da adadi mai yawa na ƙwayoyin halitta kyauta a cikin gida wanda zai iya haifar da mummunan lalacewar huhu da sauran gabobin, har ma da rashin aiki da yawa da mutuwa a cikin mafi munin yanayi.
Babban cutar SARS-CoV-2 da ke nuna farkon farawar garken yana iya shafar tsofaffi da mata masu juna biyu tare da rashin lafiyar.
Abu ne na yau da kullun cewa mutanen da suka kamu da ƙwayoyin cuta da yawa ko waɗanda ke da tsarin rigakafi mai haɗuwa suna iya kamuwa da cutar fiye da sauran.
Dangane da nazarin shari'o'in 425 na farko a Wuhan, an kiyasta matsakaicin lokacin incubation na SARS-CoV-2 kwanaki 1-14, mafi yawa kwanaki 3-7.
Koyaya, nazarin shari'o'i 1,099 ya nuna cewa tsawon lokacin incubation ya kasance kwanaki 3 a matsakaita kuma ya kasance daga 0 zuwa 24 days.
Kamar yadda aka ambata a sama, wani binciken da aka yi kwanan nan, wanda ya danganci alƙaluma na shari'o'i 8,866, ya nuna cewa lokacin incubation ya kasance kwanaki 4. 8 (3. 0-7. 2).
Daidaita lokacin keɓewar da ya dace dangane da mafi ƙarancin lokacin incubation kuma don haka hana kamuwa da cutar daga mutane marasa alamun cutar daga watsa kwayar cutar ga wasu mutane yana da mahimmanci ga hukumomin kiwon lafiya.
A matsayin al'ada, mutanen da suka kamu da cutar ko kuma suka kamu da cutar suna buƙatar keɓewa na kwanaki 14.
Shin ya kamata a kara wa'adin killacewa zuwa kwanaki 24?
Yawanci zazzabi shine babban alamun farko na COVID-19 wanda ba zai iya kasancewa tare da alamun bayyanar ba ko kuma ya haɗa da wasu alamun kamar bushewar tari, numfashi, ciwon tsoka, zafin rai, ciwon kai, ciwon makogwaro, numfashi, ciwon kirji, gudawa, tashin zuciya da amai.
Wasu marasa lafiya sun sami wahalar numfashi da / ko hypoxemia mako guda bayan fara cutar.
A cikin mawuyacin hali, marasa lafiya sun sami saurin haɓaka ciwon cututtukan numfashi mai saurin gaske, harin septic, acidity na rayuwa da kuma cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Ya kamata a bincika marasa lafiya da zazzabi da / ko alamun numfashi da kuma zazzabi mai tsanani ba tare da alamun bayyanar cutar huhu ba don ganewar asali.
A cikin binciken alƙaluma a ƙarshen Disamba 2019, kashi 98 na alamun cutar sun kasance zazzabi, kashi 76 na tari, kashi 55 na wahalar numfashi da kashi 3 na zawo; 8% na marasa lafiya suna buƙatar taimakon iska.
An ba da rahoton irin wannan binciken a cikin binciken biyu na kwanan nan na garken da ke haifar da watsawa ta hanyar iyali da kuma mutum mara alama.
A kwatankwacin haka, binciken alƙaluma na 2012 ya lura cewa marasa lafiya na MERS-CoV suma suna da zazzabi (98%), bushewar tari (47%) da wahalar numfashi (55%) a matsayin manyan alamun.
Koyaya, fiye da marasa lafiya na COVID-19, 80% daga cikinsu sun buƙaci taimakon iska kuma wannan ya yi daidai da mafi girman mutuwar MERS fiye da COVID-19.
Hakanan an lura da zawo (26%) da ciwon makogwaro (21%) a cikin marasa lafiya na MERS.
An lura cewa zazzabi (99%-100%), bushewar tari (29%-75%), wahalar numfashi (40%-42%), zawo (20-25%) da ciwon makogwaro (13-25%) sune manyan alamun a cikin marasa lafiyar SARS kuma kusan 14% -20% na marasa lafiya sun buƙaci taimakon iska.
Adadin mutuwar COVID-19 ya kasance 2% har zuwa 14 ga Fabrairu, lokacin da aka tabbatar da shari'o'in a duk duniya sun kai 66,576.
A kwatankwacin haka, mutuwar SARS ta kasance 10% na 8,096 da aka tabbatar da cutar a watan Nuwamba 2002.
Ga MERS, yawan mutuwar ya kai kashi 37 cikin dari na mutane 2,494 da aka tabbatar da su, bisa ga binciken alƙaluma na Yuni 2012.
Nazarin da ya gabata ya ba da rahoton cewa R0 na SARS-CoV-2 ya kasance 6.47 mafi girma tare da 95% confidence interval (CI) na 5.71-7.23 yayin da R0 na SARS-CoV ya kasance tsakanin 2 zuwa 4.
Kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da bayyanar cututtuka, yawan mutuwa da R0 an gabatar da su a cikin teburin 1.1.
Bayanan da aka ambata a sama sun nuna cewa SARS-CoV-2 yana da ƙarfin watsawa fiye da MERS-CoV da SARS-CoV, amma ba shi da haɗari kamar na biyun.
Saboda haka, sarrafa cutar ta SARS-CoV-2 ta fi ƙalubale fiye da MERS-CoV da SARS-CoV.
Sau da yawa garken yana farawa ne daga iyali ɗaya ko kuma mutane ko kuma motoci kamar jirgin ruwa.
Yawancin lokuta marasa lafiya suna da tarihin tafiya ko zama a Wuhan ko wasu yankuna masu fama da cutar a cikin makonni biyu da suka gabata, ko kuma sun kasance tare da mutane masu kamuwa da cutar ko marasa lafiya.
Koyaya, an ba da rahoton cewa mutane na iya ɗaukar kwayar cutar ba tare da alamomi ba sama da makonni biyu kuma marasa lafiya da aka sallama daga asibiti na iya sake ɗaukar kwayar cutar, wanda ke ba da gargaɗin tsawaita lokacin keɓewa.
A farkon matakin marasa lafiya suna da ƙarancin ƙwayoyin farin jini (musamman ƙwayoyin lymphocytes) ko ƙananan ƙwayoyin jini.
Misali, an gano lymphopenia da ƙaruwa da matakan aminotransferase na aspartate da ƙarancin cutar a cikin marasa lafiya 1,099 COVID-19 tare da ƙididdigar ƙwayoyin farin jini &lt; 1×109/L &lt; 4×109/L.
Wasu marasa lafiya sun sami ƙaruwa a cikin jini na ƙwayoyin enzyme na hanta da myoglobin kuma yawancin marasa lafiya suna da ƙaruwa a cikin jini na furotin mai amsawa da redness.
A cikin marasa lafiya masu fama da cutar, matakin D-dimer, wani samfurin lalacewar fibrin da ke cikin jini, ya karu kuma ƙididdigar ƙwayoyin lymphocyte ya ci gaba da raguwa.
Yawancin marasa lafiya na COVID-19 suna da ƙarancin ƙarancin ƙwayar cuta a cikin radiography na kirji kuma ana nuna su ta hanyar hotunan filastik na gefe biyu ko ɓoyayyen gilashin ƙasa a cikin huhu.
Yawancin lokaci marasa lafiya suna samun cutar nimoniya, lalacewar huhu mai tsanani da kuma ciwon numfashi mai tsanani (ARDS).
Lokacin da ARDS ta faru, musayar gas tana da matukar damuwa saboda kumburi mara kyau, tarin yawa da kuma ci gaba da fibrosis.
Yanayin cutar na nau'in I da na II na cutar ta Pneumocyte yana rage matakin mai kunnawa da kuma kara karfin jiki don haka rage karfin huhu da kuma kara hadarin ciwon huhu.
Saboda haka, mafi munin sakamakon radiography na kirji galibi yana daidai da mafi munin yanayin cutar.
Binciken farko na bincike kan COVID-19 a ranar 18 ga Fabrairun 2020 ya lura da ɓarkewar ƙwayoyin cuta a cikin huhu na wani mai haƙuri da ya mutu daga cutar, ƙirƙirar halayen membrane da ɓarkewar ƙwayoyin lymphocytes, da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta da ARDS kuma yayi kama da na marasa lafiya SARS da MERS.
Gano SARS-CoV-2 RNA ta hanyar juyawa-transcriptase polymerase chain reaction (RT-PCR) an yi amfani da shi azaman babban ma'auni don gano COVID-19.
Koyaya, saboda yawan kuskuren kuskuren da zai iya sa bala'in ya yi saurin yaduwa, an fara amfani da bayyanar cututtuka don ganewar asali a China a ranar 13 ga Fabrairu, 2020 (wanda ba ya dogara da RT-PCR kawai).
Haka ma cutar SARS ta faru.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwaje -gwajen dakin gwaje -gwaje da binciken radiological suna da mahimmanci kuma dole ne don yin ganewar asali mai tasiri.
A ranar 14 ga Fabrairun 2020, kungiyar Feng Zheng ta bayyana wata yarjejeniya ta amfani da fasahar CRISPR-based SHERLOCK don gano SARS-CoV-2, wanda ke gano ɓangarorin SARS-CoV-2 na wucin gadi a 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (10-100 kwafi a cikin microliter na shigarwa) ba tare da buƙatar kayan aiki mai zurfi ba, ta amfani da dipstick.
Idan an tabbatar da shi a cikin samfuran asibiti, ana fatan cewa sabuwar fasahar za ta iya haɓaka ƙwarewa da sauƙi sosai.
Saboda rashin gogewa tare da sabon CoV, likitoci na iya ba da kulawa ta tallafi ga marasa lafiya na COVID-19 tare da gwada magungunan daban-daban da aka yi amfani da su a baya ko aka ba da shawarar don magance wasu CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan hoto (Table (Table 2).2).
Wadannan magungunan sun hada da maganin riga -kafi, masu hana rigakafi, steroids, jini daga marasa lafiya, magungunan gargajiya da kuma yiwuwar magani tare da taimakon ilimin halayyar dan adam.
An kuma ba da shawarar amfani da jini daga marasa lafiya da suka warke.
Kamfanonin magunguna suna cikin gasa don samar da rigakafi da alluran rigakafi ga kwayar cutar.
SARS-CoV-2 da farko yana mamaye huhu da yiwuwar wasu gabobin da ke bayyana ACE2 kamar tsarin narkewa da koda.
Duk da haka, rashin ƙarfi da rashin ƙarfi na numfashi sun kasance babban haɗari ga marasa lafiya kuma sune manyan abubuwan da ke haifar da mutuwa.
Saboda haka, taimakon numfashi yana da mahimmanci don rage alamun cututtuka da ceton rai kuma ya haɗa da maganin oxygen na yau da kullun, oxygen mai gudana, iska mai shiga ciki da kuma iska mai shiga ciki dangane da tsananin cutar.
Marasa lafiya da ke da mummunan cututtukan numfashi suna buƙatar taimakon ECMO, fasahar ingantacciyar hanyar zuciya da huhu da ake amfani da ita don magance cututtukan zuciya ko rashin ƙarfi.
Hakanan, kiyaye daidaiton lantarki, rigakafin kamuwa da cuta ta biyu da magani da harin septic, da kare ayyukan gabobin jiki masu mahimmanci suna da mahimmanci ga marasa lafiya SARS-CoV-2.
An san cewa guguwar cytokine tana haifar da mummunan tsarin rigakafi a cikin marasa lafiya na SARS da MERS.
Cytokine Storm wani nau'i ne na tsarin mai saurin amsawa wanda ke nuna sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan cytokines suna motsa kwayoyin rigakafi don sakin adadi mai yawa na ƙwayoyin kyauta waɗanda ke haifar da ARDS da gazawar gabobin da yawa.
Maganin rigakafi yana da mahimmanci wajen magance guguwar cytokine, musamman a cikin marasa lafiya masu tsanani.
An yi amfani da corticosteroids da tosylisumab, mai hana IL6-monoclonal immunosuppressant, don magance guguwar cytokine.
Sauran magungunan rigakafi na rigakafi don guguwar cytokinin sun haɗa da canji a cikin amsar rigakafin T-cell; toshe IFN-γ, IL-1, da TNF; hana JAK; Blinatumumab; mai hana siginar cytokine 4; da kuma mai hana HDAC.
Ana amfani da steroid a matsayin mai hana rigakafi, don rage tsananin lalacewar kumburi a cikin maganin SARS.
Koyaya, manyan allurai na steroid ba su da amfani a cikin mummunan lalacewar huhu a cikin marasa lafiya na SARS da COVID-19.
Maimakon haka, suna iya haifar da mummunan sakamako masu illa, musamman osteoarthritis na waje, yana shafar cututtukan cututtukan.
Koyaya, ana ba da shawarar amfani da hankali a cikin marasa lafiya masu fama da cutar COVID-19 a cikin gajeren lokaci na corticosteroids a ƙananan zuwa matsakaiciyar allurai.
A lokacin rubuce-rubuce, ba a tabbatar da wani maganin rigakafin cutar ba.
Koyaya, an sami tasirin maganin remdesivir, analog na nucleotide a cikin jijiya a cikin wani mai haƙuri na Amurka na COVID-19.
Remdesivir wani sabon magani ne na rigakafin cutar da aka fara samarwa da Gilead don magance cututtukan da ƙwayoyin cuta na Ebola da Malberg ke haifarwa.
Daga baya, remdesivir ya kuma nuna yiwuwar hana sauran ƙwayoyin RNA masu haɗari, gami da ƙwayoyin MERS da SARS.
Dangane da waɗannan, Gilead ta samar da mahaɗan ga China don yin gwaje -gwaje biyu akan mutanen da ke da cutar SARS-CoV-2 kuma sakamakon yana da kyau.
Hakanan, an ba da shawarar baricitinib, interferon-α, iopinavir/ritonavir, da ribavirin a matsayin yiwuwar magani ga marasa lafiya da ke da cututtukan numfashi masu tsanani.
Bayan maganin hadewa tare da iopianavir / ritonavir, za a iya samun gudawa, tashin zuciya, amai, lalacewar hanta da sauran halayen da ba su dace ba.
Ya kamata a lura da hulɗar waɗannan magungunan tare da sauran magungunan da aka yi amfani da su a cikin marasa lafiya.
Samun jini da kuma rigakafi daga marasa lafiya da suka warke
Akwai dogon tarihi na tattara jini daga marasa lafiya da suka warke daga wata cuta mai saurin yaduwa don magance wasu marasa lafiya da ke fama da cutar guda ɗaya ko don hana lafiyayyun mutane kamuwa da cutar.
A zahiri, jinin marasa lafiya da suka warke suna da matakan rigakafi ga cutar.
Kwayoyin rigakafi da kwayoyin B ke samarwa don yaƙar ƙwayoyin cuta da sauran ƙwayoyin cuta sune immunoglobulin (Ig) kuma suna gano kwayoyin da ke cikin ƙwayoyin cuta kuma suna kashe su kai tsaye.
Dangane da wannan, an tattara jini daga jinin wani rukuni na marasa lafiya waɗanda suka warke daga COVID-19 kuma an sanya su cikin marasa lafiya 10 masu rauni.
Alamun su sun inganta cikin awanni 24 tare da rage kumburi da nauyin kwayar cuta da ingantaccen oxygenation a cikin jini.
Duk da haka, har sai an samar da magunguna na musamman, ana buƙatar tabbatarwa da bayani don ba da shawarar amfani da hanyar don amfani da yawa.
Hakanan, duk da tasirin warkewa, wasu lahani da suka shafi plasma dole ne a yi la'akari da su a hankali.
Misali, ƙwayoyin cuta na iya haifar da hawan jini da kuma haifar da cutar sankarar cytokine, wanda zai iya zama mai cutarwa.
Yawan adadin rigakafi a cikin jini yawanci yana da ƙarancin ƙarfi, kuma ana buƙatar ƙarin plasma don kula da marasa lafiya masu rauni.
Yana da wahala a bunkasa da kuma samar da takamaiman rigakafi cikin sauri don yaƙar cutar ta duniya.
Saboda haka, yana da mahimmanci kuma mai yiwuwa a ware ƙwayoyin B daga marasa lafiya da suka warke kuma a gano lambar kwayoyin da ke ɓoye ƙwayoyin cuta masu tasiri ko bincika ƙwayoyin cuta masu tasiri ga sunadarai masu mahimmanci na kwayar cutar.
Ta haka, za mu iya ƙara yawan samar da rigakafi.
An yi amfani da TCM don magance cututtuka da yawa a China tsawon dubban shekaru.
Koyaya, tasirinsa ya dogara ne akan haɗuwa da abubuwa daban -daban a cikin tsari daban -daban dangane da ganewar asali na cutar dangane da ka'idodin TCM.
Yawancin abubuwan da ke aiki har yanzu ba a san su ba ko kuma ba su da amfani saboda yana da wuya a cire da kuma tabbatar da irin waɗannan abubuwan ko kuma mafi kyawun haɗuwa.
A halin yanzu, saboda rashin ingantaccen magani da takamaiman magani don COVID-19, TCM ya zama ɗayan manyan magunguna masu madadin marasa lafiya tare da alamun bayyanar cututtuka masu sauƙi zuwa matsakaici ko waɗanda suka dawo daga mawuyacin yanayi.
Misali, an gano cewa Shu Feng Ji Do capsules da Lian Hua Qing Wen capsules suna da tasiri wajen magance COVID-19.
Yawancin larduna na kasar Sin sun ga mafi girman adadin warkewa a cikin maganin COVID-19 a cikin 87% na marasa lafiya da ke amfani da TCM, gami da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei inda kusan 30% na marasa lafiyar COVID-19 kawai suka yi amfani da TCM, ya kasance mafi ƙarancin adadin warkewa (13%).
Koyaya, wannan kwatancen yana da yawa saboda akwai wasu abubuwan tasiri da yawa, kamar yawan marasa lafiya da tsananin da ya kamata a haɗa su cikin kimantawa.
A ranar 18 ga Fabrairun 2020, Boly Zheng da abokan aiki sun buga binciken don kwatanta maganin maganin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Yamma Y Y Y Yamma Yamma Y Y Y Y Y Yamma Yamma Y Y Y Y
Sun gano cewa lokacin da ake buƙatar zafin jiki na jiki, bayyanar cututtuka da asibiti a cikin rukunin WM + TCM ya kasance ƙasa da ƙasa da na rukunin WM kawai.
Mafi mahimmanci, yawan alamun cutarwa (mai sauƙi zuwa mai tsanani) ya kasance ƙasa da ƙimar WM + TCM fiye da rukunin WM kawai (7.4% vs. 46.2%) kuma yawan mutuwar ya kasance ƙasa da rukunin WM + TCM fiye da rukunin WM kawai (8.8% vs. 39%).
Duk da haka, har yanzu ana jiran ƙarin gwaji mai kyau a cikin manyan cibiyoyi don tabbatar da inganci da amincin TCM.
Hakanan zai zama mai ban sha'awa don gano tsarin ayyukan kuma idan zai yiwu a bayyana ingantattun abubuwan haɗin magungunan TCM ko haɗuwa da su.
Marasa lafiya da ake zargi ko tabbatar da COVID-19 suna fuskantar tsananin tsoron cutar mai saurin yaduwa da cutar kuma waɗanda aka keɓe suna fuskantar rashin jin daɗi, kaɗaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, rashin isasshen iskar shaka da tari, da kuma mummunan tasirin magani kamar rashin bacci da corticosteroids ke haifarwa, na iya haifar da ƙarin damuwa da wahalar hankali.
A farkon lokacin barkewar SARS, an ba da rahoton cututtukan halayyar mutum da yawa, gami da ci gaba da damuwa, rashin kwanciyar hankali, tashin hankali, tashin hankali, alamun tunani, hauka, har ma da kashe kansa.
Neman tuntuɓar da ake buƙata da keɓaɓɓun hanyoyin magance cutar COVID-19 a matsayin ɓangare na amsoshin lafiyar jama'a; na iya sa mutane su ƙara damuwa da damuwa game da cutar, keɓewa da tasirin ƙazantawa ga danginsu da abokansu.
Don haka, ya kamata a samar da kulawar lafiyar kwakwalwa ga marasa lafiya, mutanen da ake zargi da cutar COVID-19, da kuma mutanen da suka yi hulɗa da su, da kuma jama'a.
Tallafin ilimin halayyar dan adam ya kamata ya hada da kafa kungiyoyin kiwon lafiyar kwakwalwa masu yawa, sadarwa mai kyau tare da ci gaba da ingantaccen sabuntawa game da barkewar SARS-CoV-2 da tsare -tsaren magani, da kuma amfani da na'urorin lantarki na ƙwararru da aikace -aikace don guje wa kusanci da juna.
Ana buƙatar alluran rigakafi masu tasiri don katse hanyar watsawa zuwa ƙwayoyin cuta masu ƙarancin ƙwayoyin cuta daga ƙwayoyin dabbobi da ƙwayoyin cuta masu cutarwa kuma galibi suna dacewa da maganin rigakafin cutar a cikin kula da annoba saboda ƙwayoyin cuta masu ƙaruwa.
An yi ƙoƙari don haɓaka alluran rigakafin S-protein don samar da rigakafi na dogon lokaci da ƙarfi da kuma kariya ga SARS-CoV.
An kimanta alluran rigakafin da aka yi amfani da su a cikin SARS a cikin kwayoyin halitta.
Koyaya, tasirin waɗannan alluran rigakafin a cikin tsofaffi da kuma ƙwayoyin cuta masu ƙalubale masu haɗari da kuma kariya daga kamuwa da cutar kwayar cutar zoonotic har yanzu ana buƙatar ƙaddara kafin fara kowane binciken asibiti.
Wannan wataƙila saboda SARS ya ƙare a hankali shekaru 17 da suka gabata kuma ba a ba da rahoton sabon shari'a ba tun daga wannan lokacin.
Akasin haka, lokuta da garken MERS suna ci gaba da faruwa a Gabas ta Tsakiya kuma suna yaduwa zuwa wasu yankuna saboda kasancewar tushen zoonotic a yankunan da annobar ta barke.
An haɓaka dabarun rigakafi don MERS ta amfani da ƙwayoyin cuta marasa aiki, plasmids na DNA, masu ɗaukar hoto, nanoparticles, ƙwayoyin cuta masu kama da ƙwayoyin cuta da ƙwayoyin ƙwayoyin cuta masu sake haɗawa kuma an kimanta wasu a cikin samfurin dabba.
Samar da ingantaccen allurar rigakafi mai lafiya da inganci ga mutane marasa rigakafi ga SARS-CoV-2 yana da matukar mahimmanci kuma yana da mahimmanci don sarrafa cutar da ke gudana.
Koyaya, saboda tsayin lokaci da ake buƙata (a matsakaita watanni 18) don haɓaka allurar rigakafi da wahalar shawo kanta saboda canjin yanayin CoVs.
A matsayin sabon cuta, COVID-19 kwanan nan ya fara bayyana cikakkiyar hanyar bincikensa a cikin dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya suna iya murmurewa a hankali ba tare da alamun wasu cututtuka ba.
Koyaya, kamar SARS da MERS, COVID-19 yana da alaƙa da yawan rashin lafiya da mutuwa a cikin marasa lafiya masu mawuyacin hali.
Saboda haka, yana da mahimmanci ga hukumomin kiwon lafiya suyi samfurin bincike don fifita ayyukan su, musamman a yankuna masu iyakance albarkatu.
Dangane da nazarin asibiti da aka ruwaito zuwa yanzu, abubuwan da ke gaba na iya tasiri ko alaƙa da ganewar asali na marasa lafiya na COVID-19 (Table (Table 33):
Shekaru: Shekaru sune mafi mahimmancin mahimmancin bincike don cutar SARS, kamar yadda yake ga COVID-19.
A cikin nazarin shari'o'i 8,866, COVID-19 ya faru ne a cikin shekaru 30-65, wanda 47.7% na marasa lafiya sun haura shekaru 50, kamar yadda aka bayyana a sama.
Marasa lafiya da ke buƙatar kulawa mai tsanani sun fi saurin samun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututut
Jima'i: Maza sun fi kamuwa da cutar SARS-CoV-2 fiye da mata (0.31/100,000 vs. 0.27/100,000), kamar yadda aka ambata a sama.
Abubuwan da ke faruwa da rikitarwa: Marasa lafiya na COVID-19 waɗanda ke buƙatar kulawa mai tsanani suna iya fuskantar mummunan rauni da rashin ƙarfi.
Abubuwan da ke faruwa na zuciya sune babban dalilin mutuwar marasa lafiya na SARS.
An ba da rahoton cewa SARS-CoV-2, na iya haɗuwa da collagenosites masu ACE2-positive waɗanda ke haifar da cututtukan hanta a cikin marasa lafiya COVID-19.
Yana da kyau a lura cewa shekaru da cututtukan da ke tattare da su suna da alaƙa sosai kuma suna iya tsoma baki tare da juna.
Binciken Lab mara kyau: Matsayin C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko lalacewar nama kuma an ba da shawarar shi azaman mai yiwuwa mai nuna alamun cutar, amsawa ga magani da ƙarshe murmurewa.
Hakanan an ba da shawarar alaƙar matakan CRP da tsananin cutar COVID-19 da kuma cutar.
Hakanan, haɓaka haɓakar lactate hydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT) da creatinine kinase (CK) na iya taimakawa wajen hango sakamakon.
Wadannan enzymes suna bayyana a cikin kwayoyin halitta da yawa, musamman a zuciya da hanta, kuma an saki su a lokacin lalacewar nama.
Don haka, sune alamun gargajiya na cututtukan zuciya ko hanta.
Manyan alamun cututtuka: Radiography na kirji tare da wasu matsaloli da ci gaban lokaci na alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Amfani da steroid: Kamar yadda aka ambata a sama, steroids masu hana rigakafi ne waɗanda aka saba amfani da su azaman maganin haɗin gwiwa a cikin cututtukan cututtuka don rage tsananin lalacewar mai ba da magani.
Tunda aka yi amfani da allurai masu yawa na corticosteroids a cikin marasa lafiya masu tsanani na SARS, yawancin waɗanda suka tsira sun sha wahala daga rashin ƙarfi na rayuwa tare da nakasa da ƙarancin rayuwa.
Don haka, idan an buƙata, ya kamata a yi amfani da steroid a cikin marasa lafiya na COVID-19 a cikin ƙananan allurai da gajeren lokaci.
Matsin lamba: Kamar yadda aka ambata a sama, marasa lafiya da yawa sun sha wahala daga matsanancin damuwa yayin barkewar COVID-19, saboda sau da yawa suna jimre wa tsawon lokacin keɓewa da matsanancin rashin tabbas da kuma shaida mutuwar dangin dangi da abokan aiki.
Bayar da shawarwari na tunani da tallafi na dogon lokaci yana da mahimmanci don taimakawa waɗannan mutane su fita daga damuwa da komawa cikin rayuwar yau da kullun.
Dangane da nazarin alƙaluma da aka yi har yanzu, COVID-19 yana nuna halaye na annoba daban da SARS.
Baya ga yin kwafi a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 na iya yin kwafi cikin ƙwarewa a cikin hanyoyin numfashi na sama kuma ba ya haifar da sauƙi ko babu alamun bayyanar cutar a farkon lokacin kamuwa da cutar kamar sauran CoVs da ke haifar da sanyi.
Saboda haka, marasa lafiya masu kamuwa da cutar na iya samar da kwayar cutar da yawa yayin ayyukan yau da kullun a farkon matakin ko lokacin incubation, tare da haifar da wahala sosai wajen sarrafa annobar.
Koyaya, ana tsammanin watsa SARS-CoV ya faru ne lokacin da marasa lafiya ke da rashin lafiya, yayin da yawancin watsawar ba su faru ba a lokacin farkon matakin.
Don haka, barkewar COVID-19 ta yanzu ta fi barkewar SARS tsanani da wahalar sarrafawa.
A halin yanzu akwai manyan ƙoƙari a China, gami da kulle-kulle a Wuhan da biranen da ke kewaye da shi da kuma keɓewar kusan dukkanin jama'a a cikin fatan rushe watsa SARS-CoV-2.
Duk da cewa waɗannan matakan suna lalata tattalin arziki da sauran sassan ƙasar, yawan sabbin marasa lafiya suna raguwa, wanda ke nuna alamar cutar.
Hasashen mafi kyawun hasashe shine cewa barkewar cutar za ta ƙare a ƙarshen Maris kuma lokacin saukarwa zai ɗauki watanni 3-4.
Duk da haka, wasu masana ba su da tabbaci.
Paul Hunter, et al., ya yi hasashen cewa COVID-19 wanda ya fi SARS kamuwa da cuta ba zai ƙare a 2020 ba.
Ira Longini, et al., sun kafa samfurin don hango sakamakon cutar kuma sun nuna cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Kungiyar ta Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin tsakiyar turbinate da kuma makogwaro na marasa lafiya da suka warke kuma suka bar asibiti makonni 2 da suka gabata wanda ke nuna cewa sabon kwayar cutar da aka gano na iya zama yanayin da ke faruwa kamar mura.
Koyaya, akwai alamun da ke nuna alkawura daga China dangane da raguwar sabbin lamura, wanda ke nuna cewa dabarun yanzu na iya aiki.
Da farko an yi hasashen cewa cutar Ebola za ta kai mutum miliyan daya, tare da mutuwar mutane miliyan daya.
Koyaya, ta hanyar keɓewa da keɓewa, cutar ta ƙarshe ta sami iko.
Zai yiwu cewa, kamar SARS-CoV, SARS-CoV-2 zai raunana cikin kamuwa da cuta kuma a ƙarshe ya ƙare ko ya zama ƙarancin cutar cuta da ke rayuwa tare da ɗan adam.
Kwatanta cutar COVID-19 da SARS da MERS an nuna su a ƙasa (Fig.
SARS-CoV-2 yana da saurin yaduwa ta hanyar tari ko hancinsa da kuma yiwuwar tuntuɓar kai tsaye da kayan da ke dauke da kwayar cutar.
An kuma gano kwayar cutar a cikin bargo, wanda hakan ya haifar da sabon yiwuwar yaduwar cutar daga baki zuwa bargo.
Wani binciken da aka yi kwanan nan na mutane 138 ya ba da rahoton cewa kashi 41% na masu cutar, ciki har da marasa lafiya 17 da ke da wasu cututtuka da kuma masu ba da kiwon lafiya 40, wataƙila sun kasance saboda kamuwa da cuta ta asibiti.
Don haka, dole ne a yi taka tsantsan don kare mutane, musamman masu ba da kiwon lafiya, ma'aikatan zamantakewa, membobin iyali, abokan aiki da waɗanda ke tsaye kusa da marasa lafiya ko waɗanda ke da cutar.
Layin farko na kariya wanda za'a iya amfani dashi don rage haɗarin kamuwa da cuta shine sanya abin rufe fuska; amfani da duka masks na tiyata da masks na N95 na numfashi (jerin # 1860s) suna taimakawa wajen sarrafa yaduwar kwayar cutar.
Masks na fuska na tiyata suna hana digo na ruwa daga yiwuwar kamuwa da cutar daga iska ko mannewa ga abubuwan da ke cikin abubuwa, daga inda zasu iya zuwa wasu.
Koyaya, kawai N95 (jerin # 1860s) masks ne kawai zasu iya hana ƙananan ƙwayoyin cuta kamar 10 zuwa 80 nm shiga cikin numfashi tare da kawai 5% na ƙwayoyin cuta da za a iya wucewa gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV a cikin girman kuma duka suna da kusan 85 nm.
Tunda ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙ
Tare da abin rufe fuska, masu ba da kiwon lafiya dole ne su sa rigunan keɓewa masu dacewa don rage haɗuwa da ƙwayoyin cuta.
Kwayar cutar na iya kamuwa da mutum ta hanyar idanu.
A ranar 22 ga Janairun 2020, wani likita ya kamu da SARS-CoV-2, duk da cewa yana sanye da abin rufe fuska na N95; ƙila kwayar cutar ta shiga cikin jikinsa ta hanyar idanunsa masu kumburi.
Don haka, masu ba da kiwon lafiya su sa rigar fuska ko tabarau yayin aiki tare da marasa lafiya.
Ana ba da shawarar sosai ga jama'a a yankunan da abin ya shafa ko kuma za su iya shafawa cewa kowa ya wanke hannayensa da sabulu mai kashe ƙwayoyin cuta sau da yawa fiye da yadda ya saba, yi ƙoƙarin kasancewa cikin gida don keɓe kai da iyakance hulɗa da mutanen da ke da cutar.
An dauki nisan kafa uku ya zama mai dacewa ga mutane su nisanta kansu da mai cutar.
Waɗannan ayyukan sune ingantattun matakan rage haɗarin kamuwa da cutar tare da hana yaduwar kwayar cutar.
Kodayake SARS-CoV-2 ya zo ne a matsayin sabon kwayar cuta ga ɗan adam, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, saboda kamanceceniya da SARS-CoV, zai iya zama da matukar damuwa ga China bisa ga zurfin ƙwaƙwalwar ajiyar barkewar SARS a 2003.
Koyaya, har zuwa 19 ga Janairun 2020, darektan Cibiyar Kula da Cututtuka ta Wuhan ya ta'azantar da 'yan ƙasa da cewa sabon kwayar cutar tana da ƙarancin kamuwa da cutar ɗan adam da iyakantaccen iyawar haifuwa kuma babu wata matsala a hanawa da iyakance cutar.
Wannan sakon ya ba da damar jin tsoron jama'a, musamman a lokacin da ƙasar ke shirin bikin bazara kuma lokacin ya yi don rage cutar zuwa ƙarami a Wuhan.
Hukumomin kula da cututtuka a kasar Sin na iya koyon darasi daga wannan kuma su yi gyare - gyare masu muhimmanci a nan gaba.
Misali, wadannan hukumomin dole ne su kasance masu taka tsantsan yayin (1) yin sanarwa ga jama'a saboda kowane kalma yana da mahimmanci ga 'yan ƙasa kuma yana iya canza halayensu da yanke shawara; (2) zama masu saukin kai da kuma amsawa ga bayanan da ba na yau da kullun ba daga wuraren shan magani maimakon jiran sanarwar da aka yi daga likitoci ko jami'ai; (3) zama masu taka tsantsan don iyakance yiwuwar cutar a farkon matakin maimakon ƙoƙarin ta'azantar da jama'a; da kuma (4) fitar da manufa da ingantattun ayyuka don wayar da kan jama'a game da cutar, kuma a kai a kai bincika da inganta tsarin amsawar al'umma.
Cutar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, ya yadu zuwa duk kasar Sin da wasu kasashe 50 a duniya a lokacin da nake rubuta wannan.
Tunda kwayar cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da COVID-19 da SARS, barkewar COVID-19 ya haifar da maimaita SARS.
Koyaya, akwai wasu bambance -bambance masu mahimmanci tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci don iyakance cutar da kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa da maza fiye da mata, kuma tsananin cutar da mutuwar tsofaffi ma ya fi na matasa.
Yawan mutuwar SARS ya fi na COVID-19 (10.91% da 1.44%).
Marasa lafiya na COVID-19 suna watsa kwayar cutar koda kuwa basu da alamomi yayin da marasa lafiya na SARS galibi suke yin hakan lokacin da suke cikin rashin lafiya, wanda ke haifar da wahala sosai wajen iyakance yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana wani ɓangare dalilin da yasa SARS-CoV-2 ke yaduwa cikin sauri da kuma yaduwa fiye da SARS-CoV.
Gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mara kyau a cikin wasu marasa lafiya na COVID-19.
A gefe guda kuma, marasa lafiya da suka warke suna iya sake yin kwayar cutar.
Wadannan binciken sun kara hadarin yaduwar kwayar cutar sosai.
Duk da irin wannan ci gaba mai sauri a cikin bincike kan COVID-19, akwai wasu mahimman batutuwa da ba a warware su ba, kamar haka:
Daga ina SARS-CoV-2 ya fito?
Kodayake an sami kamanceceniya ta kwayoyin halitta 96% tsakanin SARS-CoV-2 da SARS-like CoVs biyu na bat, har yanzu ba za mu iya yanke shawarar cewa SARS-CoV-2 ya fito ne daga bat ba.
Abincin asali, ka ce wane irin dabba ne ya kasance matsakaici a cikin watsa kwayar cutar daga jemage zuwa mutum?
Ba tare da gano amsar # 1 da 2 ba, ba za mu iya dakatar da yaduwar cutar ba kuma barkewar cutar na iya sake faruwa a kowane lokaci.
Kodayake gwajin kwayoyin halitta da gwajin sunadarai sun nuna cewa SARS-CoV-2, yana haɗuwa da ACE2, ta yaya kwayar cutar ke shiga cikin ƙwayoyin iska kuma daga baya ta canza cututtuka?
Shin kwayar cutar tana ɗaure ga ƙwayoyin ACE2-keɓaɓɓu a wasu gabobin jiki?
Ba tare da amsoshin waɗannan tambayoyin ba, ba za mu iya samun saurin ganewar asali da magani mai tasiri ba.
Har yaushe cutar za ta ci gaba?
Ta yaya kwayar cutar ke bunkasa ta hanyar kwayoyin halitta yayin watsawa ga mutane?
Shin zai zama annoba ta duniya, kamar SARS, ko kuma zai ci gaba da faruwa a kai a kai kamar mura?
Yana da muhimmanci, amma zai ɗauki lokaci kafin a sami amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Koyaya, duk farashin da za mu biya, ba mu da wani zaɓi sai dai mu dakatar da cutar da wuri-wuri kuma mu dawo da rayuwarmu ga al'ada.
Animalic asalin mutum coronaviruses
Juyin halitta da daidaitawa sun haifar da juyin halitta na coronaviruses (CoVs) da masu gina su (gami da mutane) a cikin dubunnan shekaru.
Kafin 2003, an san cewa akwai wasu kwayoyin cuta guda biyu na mutum (HCoVs) da ke haifar da rashin lafiya kamar sanyi.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Fitowar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake kawo CoVs cikin haske kuma ya ba mu mamaki da yawan kamuwa da cuta amma rage cututtukan cuta fiye da 'yar'uwarta SARS-CoV.
Cutar HCoV cuta ce ta dabbobi kuma fahimtar asalin HCoVs zai taimaka mana.
Yawancin HCoVs sun samo asali ne daga barbashi, wanda ba su da cutar.
Akwai kuma bayanai game da matsakaitan ƙwayoyin cuta na wasu HCoVs.
Gano abubuwan gina jiki na dabbobi yana da tasiri kai tsaye wajen hana cututtukan ɗan adam.
Binciken hulɗar CoV-nutrient a cikin dabbobi na iya ba da mahimman bayanai game da cutar ta CoV a cikin mutane.
A cikin wannan bita, mun gabatar da bayyani game da bayanan yanzu game da HCoVs bakwai, tare da mai da hankali kan tarihin ganowa da kuma asalin dabbobi da kuma watsawa tsakanin jinsuna.
Mahimmanci, muna kwatanta da bambance-bambance tsakanin HCoVs daban-daban daga yanayin ci gaban ƙwayoyin cuta da sake haɗuwa da kwayoyin halitta.
Ana tattauna cutar ta CoV ta yanzu ta 2019 (COVID-19) a cikin wannan hangen nesa.
Hakanan, an kuma nuna mahimmancin buƙatar maye gurbin abubuwan gina jiki cikin nasara da kuma tasirin ci gaban kwayar cutar a hankali kan tsananin cutar.
Coronaviruses (CoVs) suna cikin dangin Coronaviridae wanda ya ƙunshi ƙungiyoyin ƙwayoyin cuta masu ƙarancin ƙwayoyin cuta, masu ƙarancin ƙwayoyin RNA guda ɗaya.
Waɗannan ƙwayoyin cuta, waɗanda ke ɗaukar mafi girman ƙwayoyin cuta na 26 zuwa 32 kilobases a cikin ƙwayoyin cuta na RNA, an ba su suna CoVs saboda ƙirar su kamar kambi a ƙarƙashin microscope na lantarki.
A tsarin, CoVs suna da kwayoyin halittar da ba su da sashi wanda ke da tsari iri ɗaya.
Kimanin kashi biyu bisa uku na kwayoyin halitta suna da manyan sigogi guda biyu (ORF1a da ORF1b), waɗanda aka canza zuwa pp1a da pp1ab replicase polyproteins.
Ana sarrafa polyprotein don samar da furotin 16 marasa tsari da ake kira nsp1 ~ 16.
Sauran ɓangaren kwayoyin halitta suna da ORFs don gina jiki, ciki har da spike (S), envelope (E), membrane (M) da nucleoproteins (N).
Hakanan ana tsara furotin masu taimako da yawa na musamman na CoVs ta hanyar al'adun CoVs daban -daban.
Dangane da bambancin jerin sunayen sunadarai, an rarraba CoV zuwa ƙarni huɗu (alpha-CoV, beta-CoV, gamma-CoV, da delta-CoV), daga cikinsu beta-CoVs sune mafi yawan HCoVs kuma an raba su zuwa zuriya huɗu (A, B, C, da D).
Shaidar ethnographic ta nuna cewa dodanni da ƙudaje sune tushen kwayoyin halittar alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune manyan ƙwayoyin gamma-CoVs da delta-CoVs.
A cikin dubunnan shekaru, CoVs sun ci gaba da ƙetare shingen jinsuna kuma sun fito a matsayin wasu mahimman cututtukan ɗan adam.
Zuwa yau, an san mutane bakwai da ke dauke da kwayar cutar HCoV.
Daga cikinsu akwai HCoV-229E da HCoV-NL63 alpha-CoVs.
Sauran beta-CoVs guda biyar sun haɗa da HCoV-OC43, HCoV-HKU1, mummunan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan SARS-CoV-2).
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da alamun rashin lafiya kamar sanyi da / ko zawo.
Sabanin haka, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 da aka gano, suna da matukar cutarwa, suna haifar da mummunan cututtukan ƙananan iska a cikin marasa lafiya da yawa tare da yiwuwar ciwon bugun jini mai tsanani (ARDS) da bayyanar hypertensive.
An ware HCoV-229E na farko, B814, daga ɓarkewar hanci na marasa lafiya da sanyi a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an tattara ƙarin bayani ta hanyar nazarin dalla -dalla game da HCoV-229E da HCoV-OC43, dukansu suna haifar da alamun iyakancewa.
A zahiri, tun kafin barkewar SARS, an yarda da ra'ayin cewa kamuwa da HCoVs ba shi da lahani.
Cutar SARS ta 2003 ta kasance daya daga cikin bala'o'i masu yawa a tarihin yanzu, tare da kamuwa da mutane fiye da 8000 tare da mutuwar kusan kashi 10 cikin dari na marasa lafiya.
Shekaru goma bayan haka, barkewar cutar murar Gabas ta Tsakiya (MERS) ta haifar da wata annoba mai ci gaba a yankin Larabawa tare da yaduwar tartsatsi a wasu wurare a duniya.
2019 Novel HCoV (2019-nCoV), wanda aka sake masa suna SARS-CoV-2, shine mai haifar da annobar cutar coronavirus ta 2019 (COVID-19), wacce ta kashe mutane 3,120 kuma ta kamu da mutane sama da 91,000 har zuwa 3 ga Maris, 2020.
Ƙararrawar gargadi tana busawa kuma dole ne duniya ta shirya don cutar SARS-CoV-2 mai zuwa.
Dukkanin HCoVs bakwai suna da asalin dabbobi daga bargo, beraye ko dabbobin gida.
Yawancin shaidu suna tallafawa ci gaban gaba ɗaya daga duka HCoVs daga fararen fata, waɗanda ƙwayoyin cuta ke da kyau kuma ba su da cutarwa, amma suna nuna bambancin kwayoyin halitta.
Cutar ta COVID-19 ta gabatar da manyan kalubale na kiwon lafiya, kimiyya, zamantakewa da ɗabi'a ga China da duniya.
Gano asalin HCoVs yana ba da tsari don fahimtar tarihin halitta, motsawa da abubuwan da ke tattare da ƙetare jinsuna.
Zai iya jagorantar ko samar da damar gano kwayoyin halitta, tsaka-tsaki da haɓaka abubuwan abinci na SARS-CoV-2 tare da mahimmancin tasiri wajen hana yaduwar gaba.
A cikin wannan bita mun gabatar da bayyani game da asalin dabbobi, watsawa tsakanin jinsuna da kuma cutar HCoVs.
Musamman, muna haskakawa da tattauna batun gama gari cewa ƙwayoyin cuta na HCoVs ba su da cutar a cikin abubuwan da ke cikin su na halitta, amma sun zama masu cutar bayan watsawa cikin ƙwayoyin cuta zuwa sabon mai gina jiki.
Za mu kuma sake nazarin yanayin ci gaban HCoV a hankali wanda yawanci yakan haifar da karuwar kamuwa da cuta tare da raguwar cutar.
Hakanan ana tattauna sakamakon barkewar cutar SARS-CoV-2 a cikin wannan mahallin.
An san CoVs na dabbobi tun daga ƙarshen 1930s.
Kafin HCoV-229E jinsin da aka fara warewa daga jijiyoyin jini na marasa lafiya masu kamuwa da cutar sanyi, an ware CoVs daban -daban daga dabbobi da yawa da ke dauke da cutar, gami da turkey, beraye, shanu, aladu, kuliyoyi da karnuka.
An gano HCoVs bakwai a cikin shekarun da suka gabata.
A takaice dai, taƙaitaccen tarihin tarihin gano HCoV (Table 1) zai zama mai ba da bayani da kuma koyarwa.
An fara ware HCoV-229E a cikin shekara ta 1966 daga hanyoyin numfashi na marasa lafiya da ke fama da cutar cutar cutar sama, wanda daga baya ya dace da girma a cikin layin sel na WI-38 huhu.
A cikin marasa lafiya da ke dauke da HCoV-229E, alamun sanyi, gami da ciwon kai, atishawa, rashin jin daɗi da ciwon makogwaro, tare da zazzabi da tari, an lura da su a cikin kashi 10 ~ 20% na lokuta.
Daga baya a cikin 1967, an ware HCoV-OC43 daga hanyar tsari da kuma haɓaka sashi a cikin kwakwalwar berayen shan nono.
Halayen asibiti na kamuwa da cutar HCoV-OC43 suna kama da kamuwa da cutar da HCoV-229E ke haifarwa wanda ba za a iya rarrabe shi da kamuwa da cutar ba tare da wasu cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Dukansu HCoV-229E da HCoV-OC43 suna yaduwa a duk duniya kuma suna iya zama masu yaduwa a lokacin hunturu tare da yanayin zafi.
Yawancin lokaci, tsawon lokacin ci gaban gaba na waɗannan ƙwayoyin cuta biyu bai kai mako ɗaya ba, bayan haka akwai kusan makonni 2 na rashin lafiya.
A cewar wani binciken da aka yi da masu sa kai na ɗan adam, lafiyayyun mutane da ke dauke da HCoV-229E sun kamu da sanyi mai laushi.
A cikin ƙananan marasa lafiya marasa lafiya suna nuna cututtukan ƙananan ƙananan iska.
SARS wanda kuma aka sani da cutar sankarar bargo, shine farkon annobar da aka fara rubuta a tarihin ɗan adam wanda ya haifar da HCoV kuma wanda ya haifar da shi, HCoV na uku da aka gano, SARS-CoV.
Ana iya gano farkon cutar SARS a lardin Guangdong na kasar Sin a ƙarshen 2002.
A yayin da cutar ta SARS ta bazu zuwa kasashe da nahiyoyi da yawa, an samu mutane 8,096 da suka kamu da cutar tare da mutuwar mutane 774.
Baya ga masu yaduwa, an kiyasta cewa kusan kashi biyu na biyu na iya ƙaruwa saboda kowane lamari tare da tsawon lokaci na ci gaba na kwanaki 4 zuwa 7 da kuma bayyanar mafi girman tasirin kwayar cutar a ranar 10 na cutar.
Marasa lafiya da ke dauke da SARS-CoV suna fara nuna alamun musculoskeletal, ciwon kai, zazzabi, rashin jin daɗi da sanyi, sannan wahalar numfashi, tari da matsalar numfashi suna zuwa a matsayin alamun bayyanar.
Lymphopenia, rashin aikin hanta da haɓaka creatinine kinase sune abubuwan da suka shafi asibiti na SARS.
Hakanan ana ganin lalacewar ƙwayoyin iska, yaduwar ƙwayoyin epithelial da haɓaka macrophages a cikin marasa lafiya na SARS.
Kimanin kashi 20-30% na marasa lafiya suna buƙatar kulawa mai tsanani da iska mai ƙarfi daga baya.
Baya ga ƙananan hanyoyin numfashi, gabobin ciki da hanta da kodan, galibi tare da guguwar cytokine, na iya kamuwa da cututtuka a cikin waɗannan mawuyacin yanayi, wanda zai iya zama haɗari musamman ga marasa lafiya marasa lafiya.
An fara ware kwayar cutar ne daga wani dangi na mai cutar mai cutarwa ta hanyar yin alurar riga kafi a cikin huhu wanda ya yi tafiya daga Guangzhou zuwa Hong Kong.
Tun daga wannan lokacin, an yi ƙoƙari sosai wajen bincika HCoV.
An ware HCoV-NL63 daga jariri mai wata 7 a ƙarshen 2004 a Netherlands.
An fara gano cewa an yaduwa ne tsakanin yara kanana, tsofaffi da marasa lafiya da ke da rashin lafiyar jiki da cututtukan numfashi.
Cutar da HCoV-NL63 ke haifarwa ta zama ruwan sanyi, conjunctivitis, zazzabi, da kuma cutar sankarar bargo.
A wani binciken na biyu mai zaman kansa, an bayyana yadda aka ware kwayar cutar daga hancin wani yaro mai wata takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi ne a Netherlands, amma a zahiri ya bazu ko'ina cikin duniya.
An kiyasta cewa HCoV-NL63 yana haifar da kusan kashi 4.7 cikin ɗari na cututtukan numfashi na yau da kullun kuma yana da mafi girman faruwar lokacin bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da cutar murhun murhun murhun, wanda kuma ake kira croup.
A wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 da haihuwa wanda aka kwantar da shi a asibiti a Hong Kong tare da cutar huhu da kuma cutar sankarar bargo.
Baya ga cutar nimoniya da kuma cutar sankarar bargo da aka samu a cikin al'umma, an kuma ba da rahoton cewa HCoV-HKU1 yana da alaƙa da mummunan cutar asma.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an gano HCoV-HKU1 a duk faɗin duniya, yana haifar da cututtukan numfashi masu sauƙi.
Dukkanin HCoVs da aka samo daga al'ummomin huɗu sun dace da mutane kuma ba su da wata ma'ana ta canzawa don haifar da cututtuka masu saurin kamuwa da cuta, kodayake akwai haɗari saboda dalilan da ba a sani ba kamar yadda ya faru a cikin wani lamari mai wuya na HCoV-NL63, wanda ya haifar da mummunan cututtukan ƙananan iska a cikin China kwanan nan.
Yawancin lokaci, waɗannan HCoVs ma suna zama marasa guba ko cututtuka lokacin da suka sami ikon watsawa yadda ya kamata da kuma ci gaba da kasancewa cikin mutane.
An fara gano MERS-CoV a cikin 2012 daga huhu na wani mai shekaru 60 a Saudi Arabiya wanda ya kamu da cutar huhu da ciwon koda.
Duk da yake yawancin magungunan da aka tabbatar da su a cikin dakin gwaje -gwaje sun samo asali ne daga Gabas ta Tsakiya, an ba da rahoton wasu ƙasashen Turai da Tunisia da ke da alaƙa da alaƙa da alaƙa da alaƙa da alaƙa.
Wani barkewar cutar ta biyu ya faru ne a Koriya ta Kudu a shekarar 2015 tare da tabbatar da shari'o'i 186.
Bayyanar asibiti na MERS, wanda ke nuna ci gaba mai tsanani na cutar huhu, yayi kama da SARS.
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da MERS suma suna samun ciwon koda mai tsanani, wanda har yanzu ana ganin MERS ne kawai a cikin cututtukan da ke haifar da HCoV.
Fiye da 30% na marasa lafiya suna nuna alamun gastrointestinal kamar zawo da amai.
Zuwa 14 ga Fabrairun 2020, an ba da rahoton fiye da shari'o'in tabbatar da gwaji 2500 tare da yawan mutuwar 34.4%, wanda ya sa MERS-CoV ya zama ɗayan ƙwayoyin cuta masu cutarwa da aka sani ga mutane.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano garken marasa lafiyar cutar nimoniya da ke da alaƙa da kamuwa da cutar SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana barkewar cutar cututtukan ƙananan iska ta hanyar SARS-CoV-2 a matsayin gaggawa ta lafiyar jama'a na damuwa ta duniya kuma ta ba da sunan cutar COVID-19.
Har zuwa 3 ga Maris, 2020, an tabbatar da shari'o'i 90,053 a duk duniya tare da mutuwar marasa lafiya na 3.4%.
Abin lura, yawan mace - macen da ke cikin Hubei China ya kai kashi 4.2%, yayin da a waje da shi ya kai kashi 1.2%.
SARS-CoV-2 yana haifar da mummunan kamuwa da cuta na numfashi kamar SARS-CoV da MERS-CoV, wanda ke nuna zazzabi, tari da wahalar numfashi.
Wasu marasa lafiya ma suna fama da zazzabi.
Ciwon huhu yana daya daga cikin manyan alamun cutar kuma yana iya ci gaba da zama ciwo mai tsanani na numfashi.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda babban kamanceceniya na 82% na jerin nucleotides, sun kasance cikin rassan rassan.
SARS-CoV-2 a bayyane yake ba shi da cutarwa sosai, amma yana da saurin yaduwa fiye da SARS-CoV da MERS-CoV.
An bayar da rahoton marasa lafiya marasa alamun da ke dauke da SARS-CoV-2 kuma suna iya taimakawa wajen saurin yaduwar ta a duk duniya.
Kwatanta SARS-CoV-2 da sauran HCoVs shida da kuma lura da bambancinsa ya nuna kamanceceniya da bambance-bambance masu ban sha'awa.
Na farko, tsawon lokacin kamuwa da cutar HCoV da kuma tsarin aikinsa suna kama da juna.
A wannan batun, SARS-CoV-2 yana bin al'adar sauran HCoVs guda shida.
Na biyu, tsananin alamun COVID-19 yayi kama da SARS-CoV da HCoVs guda huɗu da aka samo daga al'umma (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna halaye waɗanda galibi ana gani yayin kamuwa da HCoVs da aka samu daga al'umma, gami da marasa ƙarancin, masu laushi ko marasa alamomi.
A gefe guda, ana iya ganin ƙaramin ƙaramin ƙananan shari'o'in COVID-19, kamar yadda yake a cikin yanayin kamuwa da SARS-CoV, kodayake rabo ya ɗan ragu.
Na uku, ana kuma ganin nau'ikan HCoVs da SARS-CoVs da aka samo daga al'umma a cikin watsa SARS-CoV-2.
A gefe guda, kamuwa da cutar SARS-CoV-2 ya fi na HCoVs da aka samo daga al'umma.
A gefe guda, har yanzu ba a tabbatar da ko kamuwa da cutar SARS-CoV-2 ya ragu ba bayan ya ci gaba da zama mutum kamar yadda yake a cikin shari'ar SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfuran stool.
Ko watsawar SARS-CoV-2 ta hanyar mahaifa yana taka muhimmiyar rawa a cikin aƙalla wasu yanayi kamar SARS-CoV, binciken nan gaba ya rage ya bayyana.
Hakanan yana da ban sha'awa sosai ganin ko SARS-CoV-2 na iya yin yanayi kamar yadda ake yi da HCoVs da aka samo daga al'umma.
Koyaya, halaye na SARS-CoV-2, gami da kamuwa da cuta, cututtuka da ci gaba da yaduwa bayan sun shiga cikin mutane, zasu yi tasiri kan ƙarshen barkewar cutar COVID-19.
HCoVs da aka samo daga dukkan al'ummomi huɗu waɗanda ke haifar da alamun rashin lafiya sun dace da mutane.
Daga wani hangen nesa, yana iya zama gaskiya cewa mutane sun daidaita da kyau ga waɗannan HCoVs huɗu.
A wasu kalmomin, duka HCoVs na iya tsira daga annoba ta farko.
An kawar da HCoVs da ke haifar da cututtuka masu tsanani a cikin mutane da waɗanda ke haifar da cututtukan HCoV masu tsanani a cikin mutane.
Don wannan ya faru, tarin maye gurbi wanda ke hana abubuwan hana abinci mai gina jiki dole ne ya haifar da HCoVs a cikin mutane a cikin isasshen iyaka.
A wannan ma'anar, tsawon lokacin da barkewar SARS-CoV-2 ke ci gaba da kamuwa da mutane da yawa, to hakanan zai iya zama cikakke ga mutane.
Idan ya daidaita sosai, zai yi wuya a hana watsa shi ga mutane ta hanyar keɓewa ko wasu matakan kula da kamuwa da cuta.
Shekaru da yawa, CoVs da aka samo daga al'ummomi huɗu suna yaduwa cikin yawan mutane, suna haifar da sanyi a cikin marasa lafiya marasa lafiya.
Wadannan ƙwayoyin cuta ba sa buƙatar dabbobi.
Akasin haka, SARS-CoV da MERS-CoV masu cutarwa ba su dace da mutane ba kuma ba za a iya ci gaba da watsa su ga mutane ba.
Suna buƙatar ci gaba da yaduwa a cikin ƙwayoyin su na dabbobi kuma suna iya samun damar watsawa zuwa maƙasudin ɗan adam ta hanyar ɗaya ko fiye da matsakaici da haɓaka masu gina jiki.
Halaye na SARS-CoV-2 iri ɗaya ne da na SARS-CoV/MERS-CoV da HCoVs da aka samo daga al'ummomi huɗu.
Aƙalla a halin yanzu yana da saurin yaduwa kamar HCoVs da aka samo daga al'umma.
Koyaya, ya fi cutar HCoVs da aka samo daga al'umma kuma ba shi da cutar SARS-CoV ko MERS-CoV.
Ya rage a gani idan zai dace da mutane sosai kuma ya wuce zuwa mutane ba tare da wata kwayar halitta ko matsakaiciyar dabba ba.
Kafin tattauna asalin dabbobi na HCoVs, zai taimaka mana sosai mu tattauna ma'anoni da halaye na ci gaban HCoVs, na halitta, na halitta, na tsaka-tsaki da haɓaka abubuwan gina jiki.
Wani dabba shine mai haɓaka ci gaba na HCoV idan yana da babban makoma tare da rabon babban kamanni a matakin jerin nucleotide.
Kwayar cutar ta asali tana da kyau sosai kuma ba ta da cutarwa a cikin wannan abincin.
Hakanan, kwayoyin cuta suna ba da HCoVs ci gaba da dogon lokaci.
A cikin duka yanayi biyu, kwayoyin halitta suna kamuwa da cutar kuma suna da ƙwayoyin halitta na HCoV ko kuma asalinsa.
Akasin haka, idan HCoV ya shiga cikin wani sabon matsakaiciyar abinci mai gina jiki kafin ko kusa da shi kafin shiga cikin mutane, ba ya daidaita da sabon abincin kuma galibi yana haifar da cututtuka.
Wannan matsakaiciyar sinadarin na iya zama tushen tushen kamuwa da cutar ta mutum kuma yana iya zama mai haɓaka ta hanyar barin kwayar cutar ta ninka na ɗan lokaci sannan kuma ta hanyar watsa shi zuwa ga ɗan adam don haɓaka ƙimar kamuwa da cutar.
HCoV na iya shiga cikin kamuwa da cuta idan ba zai iya ci gaba da watsawa a cikin matsakaiciyar mai gina jiki ba.
A gefe guda, HCoVs na iya dacewa da matsakaiciyar abinci mai gina jiki kuma suna iya kasancewa cikin gida na dogon lokaci.
A wannan yanayin, matsakaiciyar abinci mai gina jiki ta zama abinci mai gina jiki na halitta.
Bayanai na annoba sun nuna a baya cewa yanayin SARS mai nuna alama shine tarihin hulɗa da dabbobi masu wasa.
Binciken da aka yi a baya ya nuna cewa masu sayar da dabbobi sun fi yawan masu cutar SARS-CoV IgG fiye da sauran jama'a.
An gano cewa dabbobi masu shayarwa masu shayarwa (Paguma larvata) da karnukan raccoon a kasuwannin dabbobi masu rai suna dauke da ƙwayoyin cuta irin na SARS-CoV waɗanda suka yi kama da SARS-CoV.
Wannan ya kasance yana da goyan baya ta hanyar cewa ba a sake samun rahoton SARS ba bayan an kashe dukkan kayan kasuwa.
Koyaya, an ba da rahoton cewa yawancin masks na dabbobi masu shayarwa waɗanda ba su haɗu da kasuwannin dabbobi masu rai ba, da daji ko gonaki ba su da SARS-CoV, wanda ke nuna cewa masks na dabbobi masu shayarwa na iya zama masu tsanani ne kawai a matsayin matsakaiciyar haɓaka mai gina jiki ba a matsayin asalin SARS-CoV ba.
Abin lura, tunda kashi 80% na dabbobi daban-daban a kasuwannin Guangzhou suna da rigakafin SARS-CoV, ba za a iya musanta yiwuwar cewa yawancin ƙananan dabbobi masu shayarwa na iya zama matsakaitan masu haɓaka abinci mai gina jiki na SARS-CoV ba.
Duk waɗannan suna da alama sune magungunan ƙarshe na SARS-CoV.
Binciken bin diddigin kwayar halitta ta SARS-CoV ya bayyana wani kwayar cuta mai kama da SARS mai suna SARS-related rhinolephus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda aka samo a cikin barayen da ke da doki na kasar Sin.
Wadannan kwari suna da kyau ga rigakafin SARS-CoV da kuma tsarin kwayoyin SARSr-Rh-BatCoV HKU3.
Waɗannan da sauran CoVs na bat suna da kamanceceniya da jerin nucleotide 88-92% tare da SARS-CoV.
Wadannan binciken sun kafa tushen sabon ra'ayi cewa jemage suna ciyar da cututtukan ɗan adam da ke fitowa.
An kuma gano wasu SARS kamar CoVs (SL-CoVs) a cikin jemage amma babu wanda aka ware a matsayin kwayar cuta mai rai ban da WIV1.
An san enzyme mai canzawa na Angiotensin na mutum 2 (ACE2) a matsayin mai karɓar SARS-CoV.
WIV1 da aka cire daga samfuran ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin
Abin sha'awa, ƙwayar SARS da ke warkewa ta iya kashe WIV1.
Ya zuwa yanzu, WIV1 shine mafi kusa magajin SARS-CoV a cikin jemage, yana raba kamanceceniya na 95% na jerin nucleotide.
Duk da kamanceceniya tsakanin waɗannan ƙwayoyin cuta biyu, ana ɗaukar cewa WIV1 ba ita ce mafi kusa da ƙwayar cuta ta SARS-CoV ba kuma bargo ba shine mafi kusa da ƙwayar cuta ta SARS-CoV ba.
Binciken kwayar halitta ya sanya MERS-CoV cikin rukuni ɗaya kamar na CoV-HKU4 na Batman da CoV-HKU5 na Batman.
Bat CoV-HKU4 da MERS-CoV suna amfani da mai karɓar abinci iri ɗaya, diphptidyl peptidase 4 (DPP4) don shiga cikin ƙwayoyin cuta.
Tsarin RNA-wanda aka tsara RNA polymerase na MERS-CoV yana da kusanci da kwayar halitta ga kwayar cutar beta-CoV da aka gano a Turai da Afirka.
Har zuwa yanzu, ba a sami wani MERS-CoV mai rai a cikin fararen fata ba.
MERS-CoV da mafi kusa da shi CoV-HKU25 suna da kamanceceniya da jerin nucleotide kawai na 87%.
Don haka, bazawa ba za su iya zama mafi kusa da MERS-CoV ba.
A gefe guda, nazarin Gabas ta Tsakiya ya nuna cewa raƙuma masu ƙwanƙwasa kamar raƙuman Gabas ta Tsakiya a ƙasashen Afirka da yawa suna da ƙwayar cuta ga ƙwayoyin cuta na MERS-CoV.
An ware MERS-CoV mai rai, mai kama da kwayar cutar da aka samu a cikin mutane, daga hancin hanci na raƙuma masu ƙwanƙwasa, wanda ke nuna cewa raƙuma masu ƙarancin ƙwayar cuta ne na MERS-CoV.
Hakanan yana da mahimmanci cewa an lura da fitar da kwayar cutar mai yawa a cikin raƙuman da aka kamu da su a cikin gwaji tare da MERS-CoV, waɗanda galibi suna da alamun rashin bayyanar cututtuka amma suna da ƙananan alamun cutar.
Abin lura, raƙuman da suka kamu da cutar ba wai kawai suna fitar da ƙwayoyin cuta ta hanyar hanyar numfashi ba har ma ta hanyar hanyar wucewa ta hanyar wucewa, wanda shine babban hanyar fitar da ƙwayoyin cuta daga barbashi.
Koyaya, tambayoyi har yanzu suna nan tunda babu tarihin hulɗa da rakuma kafin bayyanar cututtukan da aka tabbatar da MERS, mai yiwuwa saboda yaduwar mutum zuwa mutum ko wasu hanyoyin watsawa da ba a sani ba waɗanda suka haɗa da nau'in dabbobi da ke ba da MERS-CoV.
SARS-CoV-2 yana da kamanceceniya da nucleotide 96.2% daga CoV RaTG13 daga jemage wanda aka ware daga batsa na jinsin Rhinolephus.
Kamar yadda yake a cikin shari'ar SARS-CoV da MERS-CoV, bambancin tsari tsakanin SARS-CoV-2 da RaTG13 ya isa ya ƙayyade alaƙar mahaifa.
Wato, ba za a iya samun kwari mafi kusa da SARS-CoV-2 ba, har sai an sami CoVs masu kama da kwari a nan gaba.
Wataƙila, matsakaicin abincin dabbobi na SARS-CoV-2 ya kasance daga cikin nau'ikan dabbobin da aka sayar da su a cikin kasuwar sayar da abincin teku ta Hunan wanda aka haɗa da alamun alamun cutar COVID-19 da yawa na farko.
Yawancin karatun da aka yi kwanan nan dangane da jerin abubuwan da ke tattare da kwayoyin halitta sun ba da shawarar cewa rukunin ƙananan dabbobi masu shayarwa masu haɗari da aka sani da pangolins (Jawa na mutum) na iya ɗaukar nauyin asalin beta-CoVs da ke da alaƙa da SARS-CoV-2.
Waɗannan sabbin kwayoyin halittar pangolin CoV suna da kamanceceniya da 85-92% na jerin nucleotide tare da SARS-CoV-2.
Koyaya, suna da alaƙa da RaTG13 daidai da kusan 90% kama a matakin jerin nucleotide.
Suna cikin ƙananan ƙwayoyin cuta guda biyu na ƙwayoyin cuta masu kama da SARS-CoV-2 a cikin asalin asali wanda ɗayan ke da kamanceceniya da 97.4% amino acid jerin kama da SARS-CoV-2 tare da yanki mai kama da mai karɓar mai karɓa (RBD).
Akasin haka, RBD na SARS-CoV-2 da RaTG13 sun bambanta sosai duk da kamanceceniyar tsari a cikin kwayoyin halitta.
Wani binciken da aka yi a baya na pangolin mara lafiya ya kuma ba da rahoton gano tarin kwayar cutar ta kwayar cutar daga samfurori na huhu, wanda ya yi kama da SARS-CoV-2.
Wannan binciken ya ɗauki hanyoyi daban -daban da kuma kulawar hannu don samar da jerin kwayoyin halittar ɗan adam tare da cikakken ginshiƙan kwayar cutar da ke da cikakkiyar tsawon 86.3%.
Ba za mu iya musanta yiwuwar cewa pangolin yana ɗaya daga cikin matsakaitan abincin dabbobi na SARS-CoV-2 ba.
Koyaya, a halin yanzu babu wata hujja da ke tallafawa asalin SARS-CoV-2 kai tsaye ta hanyar pangolin saboda bambancin tsari tsakanin SARS-CoV-2 da pangolin SARS-CoV-2-da ke da alaƙa da beta-CoVs.
Hakanan, tazara tsakanin SARS-CoV-2 da RaTG13 ta fi ƙasa da ta SARS-CoV-2 da pangolin SARS-CoV-2 da ke da alaƙa da beta-CoVs.
Har yanzu ba a kafa hanyar ci gaban SARS-CoV-2 a cikin jemage, pangolins da sauran dabbobi masu shayarwa ba.
Inda aka sami mafi girman kamanceceniya a cikin jerin jerin RBDs tsakanin SARS-CoV-2 da pangolin, SARS-CoV-2-da ke da alaƙa da beta-CoVs, SARS-CoV-2 da RaTG13 suna da mafi girman kamanceceniya a cikin jerin kwayoyin halitta.
Yana da matukar zato cewa babban kamanceceniya tsakanin pangolin SARS-CoV-2-da ke da alaƙa da beta-CoVs da RBDs na SARS-CoV-2 saboda haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar
Wani tsari na daban yana ba da shawarar sake haɗuwa tsakanin beta-CoV da RaTG13 da ke da alaƙa da pangolin SARS-CoV-2 a cikin nau'in namun daji na uku.
A matsayin mai motsawa na ci gaba na gaba, sake haɗuwa yana da yawa a cikin beta-CoVs.
Har yanzu ba a san asalin asalin SARS-CoV-2 ba.
Baya ga HCoVs masu cutarwa sosai, an kuma yi nazarin asalin HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar ilimin halittu ta nuna cewa duka HCoV-NL63 da HCoV-229E na iya samo asali ne daga CoVs na bat, yayin da aka gano asalin kwayar cutar HCoV-OC43 da HCoV-HKU1 a cikin ƙwayoyin cuta.
An ba da rahoton cewa an gano CoV na Batman mai suna ARCoV.2 (Applachain Ridge CoV) wanda aka samo a cikin ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun
A gefe guda, HCoV-229E yana da alaƙa da wata kwayar cuta mai suna Hipposideros/GhanaKwam/19/2008, wanda aka samo a Ghana, kodayake camellids ma sun kasance masu samar da abinci mai mahimmanci.
Don tsabta, an taƙaita bayanin yanzu game da asalin dabbobi na HCoVs da aka sani a cikin Hoto 1 da Tebur 2.
Binciken kwayar halitta ya ba da hujja game da abubuwan da suka faru na watsa HCoVs a cikin tarihi.
Lokacin da HCoV-OC43 ya ƙetare jinsuna don cutar da mutane daga dabbobin gida a kusa da 1890, an lura da annobar kamuwa da cuta ta numfashi.
Tarihin watsawar HCoV-229E tsakanin jinsuna ba shi da bayyane.
An gano alpha-CoVs na bat a kusa da HCoV-229E.
A tsakanin su akwai alpaca alpha-CoV.
Akwai shaidu da yawa da ke tallafawa watsa kwayar cutar kai tsaye daga jemage zuwa mutane.
Da farko, mutane ba alpacas ba ne suka fara hulɗa da baramin a cikin yanayin muhalli.
Maimakon haka, mutane suna da dangantaka da alpacas.
Na biyu, HCoV-229E-da ke da alaƙa da bat Alpha-CoV ya bambanta kuma ba shi da cutar a cikin bat, yayin da alpaca Alpha-CoV ya haifar da barkewar cutar numfashi a cikin dabbobin da ke fama da cutar.
A ƙarshe, ba a sami alpaca alpha-CoV a cikin dabbobin daji ba.
Don haka, ba za a iya musanta yiwuwar cewa alpacas suna samun HCoV-229E-da ke da alaƙa da alpha-CoV daga mutane ba.
A zahiri, ƙwayoyin cuta na rabies, Ebola, Nipah da Hendra sune tushen tushen cututtukan ɗan adam.
Saboda haka ba abin mamaki bane cewa jemage na iya watsa HCoV-229E kai tsaye ga mutane.
A madadin haka, inda ƙuda-ƙuda alpha-CoVs sune ƙwayoyin halittar HCoV-229E, alpacas da raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙ
MERS-CoV misali ne mai kyau na yaduwar jinsin daga bargo zuwa raƙumi mai ƙwanƙwasa da raƙumi mai ƙwanƙwasawa zuwa ɗan adam.
An san ci gaban MERS-CoV daga fararen fata a farkon gano shi kuma an ƙarfafa shi ta hanyar binciken da aka yi.
A bayyane yake cewa dodanni suna ba da wadatattun nau'ikan ƙwayoyin cuta don musayar ƙwayoyin halittar jini da watsawa tsakanin jinsuna.
Tsawon rai, mazauna masu yawa, hulɗar zamantakewar kusa da ƙwarewar tashi duk yanayi ne masu dacewa don fararen fata su zama masu watsa kwayar cutar.
A gefe guda, MERS-CoV ya shiga cikin raƙuman da ke da ƙwanƙwasawa shekaru da yawa.
Ya zama mai dacewa sosai a cikin waɗannan raƙuman waɗanda suka canza daga matsakaiciyar abinci mai gina jiki zuwa mai gina jiki mai ɗorewa da ɗorewa.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙananan ƙimar maye gurbi a cikin waɗannan dabbobin.
Yana da haɗarin watsawa a cikin mutane kuma mutane sun kasance masu ciyar da MERS-CoV na ƙarshe saboda ba za a iya ci gaba da watsa shi ba.
Sabanin rawar da rakuma ke takawa wajen watsa MERS-CoV, rawar da pangolins ke takawa wajen watsa SARS-CoV-2, idan akwai, ta bambanta.
Musamman, pangolin beta-CoVs suna da cutarwa sosai a cikin pangolin.
Suna iya zama masu ciyar da beta-CoVs masu alaƙa da SARS-CoV-2, kamar yadda suke a cikin yanayin SARS-CoV.
Yawancin yiwuwar watsa SARS-CoV-2 daga dabbobi zuwa mutane ana iya yarda da su ko kuma a musanta su a cikin karatun gaba.
Na farko, barbashi na iya zama masu ciyar da kwayar cutar SARS-CoV-2 mai alaƙa da SARS-CoV-2, kusan kamar SARS-CoV-2.
Mutane na iya raba mazaunin muhalli tare da barbashi ta hanyar kashe ko hakar ma'adinai.
Na biyu, pangolins na iya zama ɗayan matsakaitan haɓaka abubuwan gina jiki waɗanda ƙwayoyin cuta masu alaƙa da SARS-CoV-2 suka shigo.
Mutane suna kamuwa da cutar ta hanyar kashewa da cin naman wasa.
Yana yiwuwa cewa dabbobi masu shayarwa da yawa, gami da dabbobin gida, na iya zama masu karɓar SARS-CoV-2.
Ana buƙatar binciken rigakafi a cikin dabbobi na gida da na daji.
Na uku, kamar yadda aka ambata a sama, SARS-CoV-2 na iya sake haɗuwa da daidaitawa a cikin nau'in na uku wanda ke da alaƙa da duka bat da pangolin.
Har yanzu ana binciken asalin SARS-CoV-2 a cikin dabbobi.
Baya ga nau'ikan nau'ikan dabbobi, manyan abubuwa guda uku dangane da kwayar cutar suna da mahimmanci don sauƙaƙe ƙetare shingen jinsin CoV.
Na farko, yawan canjin da suke samu a cikin kwafin RNA.
Idan aka kwatanta da sauran ƙwayoyin RNA guda ɗaya, ana iya ɗaukar ƙimar maye gurbin CoV mai matsakaici zuwa mafi girma tare da matsakaicin maye gurbin ~ 10-4 maye gurbin a kowace shekara a kowane wuri 2 dangane da matakin daidaitawar CoV a cikin sabbin kwayoyin halitta.
CoVs suna da Exoribonucleases masu karantawa, wanda kawar da su na iya haifar da ƙarancin canji da lalacewa ko rage rayuwa.
Abin sha'awa, ana tsammanin analog ɗin nucleotide remdesivir, yana hana kwafin CoV ta wannan exoribonuclease da RNA-tushen RNA polymerase.
Remdesivir yana daya daga cikin mafi kyawun wakilai masu cutar SARS-CoV-2 da aka bincika a cikin gwaji na asibiti.
Duk da haka, yawan canjin halittar CoVs ya ninka na kwayoyin halittar su sau miliyan.
Hakanan, yawan canjin halitta yakan kasance mafi girma lokacin da CoVs basu dace da abinci mai gina jiki ba.
Idan aka kwatanta da SARS-CoV tare da yawan canjin yanayi, yawan canjin SARS-CoV-2 ya yi ƙasa da ƙasa, wanda ke nuna babban matakin daidaitawa a cikin mutane.
Wataƙila, ya riga ya daidaita da sauran abubuwan gina jiki kusa da mutane.
Kamar SARS-CoV-2, wannan ma ya shafi MERS-CoV wanda ya dace da raƙuma masu ƙwanƙwasa.
A ka'ida, ba zai yiwu ba cewa kwayar halittar zata iya hana alluran rigakafi da maganin rigakafi da SARS-CoV-2 da sauri.
Na biyu, babban RNA a cikin CoV yana sanya ƙarin filastik akan canjin kwayar halitta don maye gurbin kwayar halitta da sake haɗawa, yana haɓaka yiwuwar ci gaban haɗin gwiwar cikin gida, wanda ke da fa'ida ga fitowar sabon CoVs idan yanayi ya dace.
Wannan yana da goyan bayan tsarin buɗewa na musamman da kuma aikin furotin da aka tsara a ƙarshen genome na 3.
Na uku, CoVs suna canza samfuran bazuwar sau da yawa yayin kwafin RNA ta hanyar hanyar zaɓi na kwafin kwafi.
A cikin abubuwan gina jiki da ke aiki a matsayin mahaɗin, sauye - sauyen fiber galibi suna faruwa yayin kwafin CoV RNA.
RNA mai cikakken tsayi da kuma subgenomic RNA, wanda yayi kama da juna, zai iya sake haɗuwa don samar da sababbin CoVs.
An sami shaidar kwayar halitta ta sake haɗuwa ta halitta a cikin duka HCoV-HKU1 da HCoV-OC43 da kuma CoVs na dabbobi kamar su SL-CoV na Batman da CoV-HKU9 na Batman.
Hadin gwiwar kwayar cuta da mai gina jiki dangane da watsawa
Baya ga abubuwan da aka ambata a sama, hulɗar kwayar cuta tare da mai karɓar abinci mai gina jiki wani muhimmin abu ne wanda ke shafar watsawar cikin gida.
A nan, ana ganin sake haɗuwa da SARS-CoV a matsayin misali na yau da kullun, wanda kuma ya nuna shaidar zaɓin tabbatacce yayin abubuwan da ke faruwa na watsawa tsakanin al'ummomi.
Dangane da nazarin kwatancen masu rarrabuwa tsakanin SARS-CoVs na mutum da na teku, SARS-CoVs tare da maye gurbi a kan RBD na furotin S musamman ana tsammanin za su iya daidaitawa cikin sauri zuwa nau'ikan abubuwan gina jiki daban -daban.
Yawancin lokaci, RBD a cikin furotin S na CoV yana hulɗa tare da mai karɓar ƙwayoyin cuta kuma ana zaɓar mai gina jiki ta hanyar amsawar rigakafi tare da ƙarfi.
A cikin SARS-CoV, RBD yana cikin amino acid na 318 zuwa 510 a sashin S1 wanda ke haɗuwa da ACE2 na ɗan adam da kuma masu karɓar sa don shiga kwayar.
SARS-CoV na RBD yana iya gane masu karɓar ACE2 na dabbobi daban -daban, gami da bargo, seabass, beraye da karnukan rakun, wanda ke haifar da yaduwar ƙwayoyin cuta tsakanin jinsuna.
A zahiri, ragowar amino acid 6 ne kawai aka lura dasu a cikin RBD daban da na mutum da na kwayar cutar ta Ceta kuma 4 daga cikinsu suna cikin tushen tushen mai karɓar mai karɓar ACE2 don hulɗa da mai karɓar.
RBD na Cvet SARS-CoV yana dauke da K479N da S487T maye gurbi wanda zai iya kara jan hankalin protein spike don hulɗa tare da mai karɓar ACE2 na ɗan adam.
A wasu kalmomin, waɗannan amino acid biyu masu maye gurbin na iya zama masu mahimmanci a cikin haɓakar kwayar cutar a cikin mutane.
Yana da mahimmanci cewa SARS-CoV-2, yana raba mai karɓar kwayar halitta iri ɗaya da SARS-CoV.
Bambanci 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S1 na furotin yana nuna cewa haɗin haɗin S na furotin tare da ACE2 na ɗan adam na iya canzawa.
A zahiri, nazarin cryo-EM ya nuna cewa haɗuwa tsakanin ACE2 na ɗan adam da furotin SARS-CoV S ya fi haɗuwa sau 10 zuwa 20.
Hakanan zai zama mai ban sha'awa don ƙayyade ko za a buƙaci wani mai karɓar mai karɓa don watsa SARS-CoV-2.
Abin sha'awa, HCoV-NL63 kuma yana haɗuwa da ACE2, amma daga wani ɓangare na S.
Akwai wasu masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E, da 9-O-acetylated sialic acid don HCoV-OC43.
Hakanan suna iya zama masu alhakin nasarar daidaita CoVs a cikin mutane bayan watsawar cikin gida daga dabbobi.
Sakamakon watsawar HCoVs tsakanin jinsuna yana sarrafawa ta hanyar sauran abubuwan dogaro da abinci da kuma hana abubuwa, ban da masu karɓar ƙwayoyin cuta.
Bambancin waɗannan sunadarai masu gina jiki tsakanin mutane da ƙwayoyin halitta na HCoVs, kamar su bargo, raƙumi mai ƙwanƙwasawa da ƙudaje na iya zama cikas ga watsawar cikin gida.
Don samun nasarar watsawar HCoVs cikin jinsuna, dole ne a kama abubuwan dogaro da abinci mai gina jiki da kuma juya abubuwan hana abinci mai gina jiki.
A wannan yanayin, har yanzu ba a gano da kuma bayyana abubuwan ƙayyade kwayoyin halitta a cikin wannan muhimmin yanki na hulɗar ƙwayar cuta da abinci ba.
Binciken da ba na al'ada ba na abubuwan da ke tattare da abinci mai gina jiki da kuma hanawa na SARS-CoV-2 ta amfani da sabuwar fasahar CRISPR na iya zama mai amfani.
Fitowar HCoVs: Komawa ga asalin asali
Bambancin CoVs na Batman yana ba da dama mai yawa don fitowar HCoVs na Novel.
A wannan ma'anar, CoVs na bat suna aiki azaman kwayar halittar HCoVs.
Hakanan, saurin maye gurbi da sake haɗuwa da kwayoyin halitta suna haifar da ci gaban HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan aikin.
Misali, sabon kwayar halitta mai gina jiki yana da ikon canza yanayin kwayar cutar ta hanyar saye ko asarar kwayoyin halitta.
A cikin furotin masu taimakawa SARS-CoV, ORF8 an ɗauka yana da mahimmanci a cikin daidaituwa a cikin mutane, tunda an ware ƙwayoyin cuta masu alaƙa da SARS-CoV, amma an same su suna ɓoye furotin ORF8 daban -daban.
An gano ɓarkewar nucleotide 29-na SARS-CoVs a cikin jinsunan da aka ware a farkon cutar ta ɗan adam.
Wannan kawarwa ta rushe ORF8 zuwa ORF8a da ORF8b kuma ana ɗaukarsa maye gurbin daidaitawa wanda ke haɓaka juyin halitta na sel.
Bugu da ƙari, SARS-CoV yana da tarihin sake haɗuwa da al'adun alpha- da gamma-CoVs, tare da gano adadi mai yawa na ƙananan yankuna masu haɗuwa a cikin RNA-based RNA polymerases.
An kuma gano wuraren sake haɗuwa a sassan nsp9, mafi yawa nsp10, da nsp14.
Hakazalika, an lura cewa cutar MERS-CoV ta sake yin rikici tsakanin zuriyoyi daban-daban, wanda ya faru a cikin raƙuman da ke da ƙwanƙwasa a Saudi Arabiya.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da abubuwan sake haɗuwa a cikin sauran HCoVs, inda HCoVs ke sake haɗuwa tare da sauran CoVs na dabbobi a cikin ƙwayoyin halittar su.
Dole ne kuma a lura cewa zaɓen wucin gadi na iya haifar da canje -canje ba da gangan ba a cikin kwayar halittar kwayar cuta, mai yiwuwa ta hanyar ƙwayoyin cuta da ke da ƙarancin zaɓin, kamar ta hanyar tsarin rigakafin abinci mai gina jiki.
Misali na waɗannan tasirin shine asarar cikakken tsayin ORF4 a cikin samfurin HCoV-229E saboda ɓarkewar nucleotide biyu.
Yayin da za a iya ganin ORF4 mara lalacewa a cikin ƙwayoyin cuta na bat da rakumi da ke da alaƙa da HCoV-229E, alpaca alpha-CoV yana nuna shigarwar nucleotide guda ɗaya, wanda ke haifar da canjin tsari.
A ƙarshe amma ba mafi mahimmanci ba, haɓakar haɓakar HCoVs na gaba ɗaya yana haifar da matsin lamba na zaɓi a cikin ƙwayoyin cuta.
Ba a gano alamun bayyanar cututtuka ba ko kuma kawai alamu masu laushi lokacin da aka kamu da CoVs a cikin fararen fata wanda ke nuna daidaituwa tsakanin CoVs da fararen fata.
Ya bayyana cewa jemage sun daidaita da kyau ga CoVs a tsari da kuma jiki.
Misali, lahani a cikin kunnawar amsawar kumburi a cikin fararen fata, yana rage cutar da CoVs ke haifarwa.
Bugu da ƙari, hanawa na ƙwayoyin halitta na halitta a cikin bat yana hanawa ta hanyar sarrafawa na mai karɓar ƙwayoyin halitta na NKG2/CD94 da ƙananan ƙwayoyin ƙwayoyin halitta na I.
Bugu da kari, yawan matakan kwayoyin oxygen masu amsawa (ROS) da ke haifar da yawan aiki na kwayoyin halitta na bat za su iya hana kwayar CoV kuma su shafi karatun hujja ta hanyar exoribonucleases, don haka samar da matsin lamba don samar da nau'ikan kwayar cutar da ke haifar da cutar idan suka shiga sabon abincin.
Hakanan za'a iya samar da nau'ikan CoV masu cutarwa ta hanyar sake haɗuwa, wanda zai haifar da sabbin sunadarai ko halayen sunadarai don haɓaka abinci mai gina jiki.
Saboda haka, ba daidaituwa ba ne cewa sababbin HCoVs uku sun fito a cikin shekaru ashirin da suka gabata.
CoVs ba su da cutarwa ko haifar da alamun cutar a cikin ƙwayoyin cuta kamar su bat da raƙumi.
Suna yin kwafi sosai ba tare da nuna ƙarfin ƙarfin abinci ba.
Wannan shine asirin dalilin da yasa ake ganin masu dauke da cutar marasa alamomi da kuma dalilin da yasa ke haifar da mummunan kamuwa da cutar a cikin mutane.
Babban bayyanar cututtuka, galibi saboda amsawar rigakafi da kuma wuce gona da iri na cytokine, tare da yawan amsawar rigakafi, lalacewar huhu mai tsanani.
Akasin haka, a cikin masu ɗaukar hoto marasa alamomi, amsar rigakafi ta bambanta da kwafin CoV.
Wannan dabarar ta ware martani na rigakafi na iya samun fa'idodi masu amfani a cikin maganin SARS-CoV-2.
Amsar interferon tana da ƙarfi musamman a cikin jemage.
Don haka, gudanar da nau'in I interferon a cikin mutane ya kamata ya kasance mai fa'ida aƙalla a farkon lokacin kamuwa da SARS-CoV-2.
Hakanan, NLRP3 kunnawar kumburi a cikin jemage yana da lahani.
Ta wannan hanyar, hana NLRP3 inflammasome tare da MCC950 na iya zama da amfani wajen maganin COVID-19.
Yaduwar SARS-CoV-2 yana bin wannan jigon da ya haifar da SARS-CoV da MERS-CoV.
Duk da yake an lura da kamanceceniya ta nucleotide 95% na Batman beta-CoV tare da SARS-CoV, Batman-CoV kuma yana da kamanceceniya ta nucleotide 96% tare da SARS-CoV-2.
Duk da yake an ga seals da sauran dabbobi a kasuwanni suna ba da kariya ga ƙwayoyin cuta masu kama da SARS-CoV, ba a gano mafi kusa da matsakaiciyar matsakaiciyar SARS-CoV-2 ba.
An sami wasu pangolin beta-CoVs masu kama da SARS-CoV-2, wanda ke nuna cewa pangolin na iya zama ɗayan matsakaitan abubuwan gina jiki ko kuma pangolin beta-CoVs na iya ba da gudummawa ga ɓangarorin kwayoyin halitta a cikin sigar ƙarshe ta SARS-CoV-2.
Ko da yake tambayoyi sun kasance, babu wata hujja da ta nuna cewa SARS-CoV-2 an yi shi ne da gangan ko kuma ba zato ba tsammani.
CoVs sun zama sananne saboda barkewar cutar SARS-CoV-2.
Nazarin CoVs a cikin barbashi da sauran dabbobi ya kawo canji mai yawa ga fahimtarmu game da ƙwayoyin HCoVs a cikin ƙwayoyin dabbobi da ke da asali da kuma daidaitaccen watsawa.
Shaida mai yawa ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 asalin su 'yan damisa ne kuma ana watsa su ga mutane ta hanyar matsakaitan masu gina jiki.
Ganin cewa kamuwa da SARS-CoV yana faruwa ne saboda hulɗa tsakanin mutane da sewer a kasuwanni, rufe kasuwanni mai danshi da kashe sewer a can ya kamata ya kawo ƙarshen cutar ta SARS.
Saboda wannan dalili, saboda gano yawancin zuriyar pangolin beta-CoVs da ke kusa da SARS-CoV-2, ya kamata a cire pangolin daga kasuwar mai don hana yaduwar kwayar halitta.
Koyaya, ko SARS-CoV-2 ana watsa shi ga mutane ta hanyar pangolins da sauran dabbobi masu shayarwa da yadda a cikin binciken gaba.
A gefe guda, MERS-CoV ya shiga cikin raƙuman da ke da ƙwanƙwasawa shekaru da yawa.
Waɗannan raƙuman suna da mahimmanci hanyar sufuri ga mazauna yankin, tare da manyan tushen kayan nama, madara, fata da kayan ulu.
An yadu da su a Gabas ta Tsakiya da Afirka.
Don haka ba zai yiwu a yi watsi da dukkan rakuma don sarrafa MERS kamar yadda aka yi a kasuwannin namun daji na kasar Sin don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana barkewar cutar MERS, ya kamata a ɗauki cikakkiyar hanyar haɓaka alluran rigakafi masu tasiri akan MERS-CoV don raƙuma a hade tare da sauran matakan kula da kamuwa da cuta.
Tun da ba mu iya kawar da waɗannan ƙwayoyin cuta ba, sababbin nau'ikan ƙwayoyin cuta na iya fitowa don haifar da ɓarkewa.
Akwai wasu CoVs da ke yawo a cikin namun daji.
Musamman, CoVs na bat da ke da damar haifar da dabbobi sun bambanta sosai.
Akwai yiwuwar cewa waɗannan CoVs na dabbobi zasu iya haɓaka da sake haɗuwa, wanda zai haifar da sababbin CoVs waɗanda zasu iya zama masu saurin yaduwa da / ko kisa ga mutane a nan gaba.
Don rage hulɗar da ba dole ba tsakanin mutane da dabbobi, dole ne a daina al'adun cin namun daji a wasu yankuna na kasar Sin.
Tare da gwaji mai wahala na SARS, MERS da COVID-19, yakamata a tsara shiri da shirin amsawa mafi kyau.
A gaskiya, akwai ƙwayoyin cuta da yawa da suka daɗe suna duniya.
Suna ci gaba da kasancewa a cikin yanayin da suka samo asali har sai sun sami damar yaduwa.
Kodayake malamun suna da halaye da yawa waɗanda ke taimakawa wajen yaduwar ƙwayoyin cuta, idan an ilimantar da mutane game da nisantar lamuran, ana iya rage yiwuwar haɗuwa da mutane da su da sauran nau'ikan daji.
Ana buƙatar ci gaba da lura da dabbobi masu shayarwa don fahimtar yanayin halittu na CoVs da abubuwan gina jiki na halitta wanda zai zama da amfani wajen hana yaduwar dabbobi zuwa mutane da kuma barkewar cutar nan gaba.
A ƙarshe, hanya mafi inganci don hana cututtukan da ke haifar da cutar ta hanyar kwayar cuta ita ce nisantar da mutane daga yanayin yanayin halitta na ƙwayoyin cuta na dabbobi.
Yawancin sassan wuyar warwarewa game da asalin SARS-CoV-2 har yanzu ba a gano su ba.
Na farko, idan har Batman ya watsa kwayar cutar SARS-CoV-2 zuwa pangolin, zai zama mai ban sha'awa ganin a wane yanayi ne Batman da pangolin zasu iya raba yanayin muhalli iri ɗaya.
Na biyu, idan kuwa jemage na taka rawa kai tsaye wajen yaduwar cutar a cikin mutane, to ya kamata a tantance yadda mutane ke hulɗa da jemage.
Na uku, idan dabba ta uku tana aiki a matsayin mai ba da abinci mai gina jiki na ainihi, ya kamata a bayyana yadda yake tasiri da nau'ikan halittu daban -daban, ciki har da mutane, bats da pangolins.
A ƙarshe, tunda dabbobi masu shayarwa da yawa, gami da dabbobin gida, na iya zama masu saurin kamuwa da SARS-CoV-2, yakamata a gudanar da sa ido da kuma kamuwa da cuta.
Ko kuwa jemage ne, pangolin ko kuma wata dabba mai shayarwa, ana sa ran cewa SARS-CoV-2 ko kuma kwayoyin halittar da suka yi kama da juna za a gano su a cikin abubuwan da ke cikin su a nan gaba.
Ci gaba da bincike a wannan fannin zai bayyana hanyoyin ci gaban SARS-CoV-2 a cikin dabbobi tare da mahimman tasiri a cikin rigakafi da sarrafa COVID-19 a cikin mutane.
Ana buƙatar sabunta ka'idodin bincike na "Lamarin da ake zargi" da "Lamarin da aka tabbatar" na COVID-19.
A ranar 6 ga Fabrairun 2020, ƙungiyarmu ta buga jagororin shawarwari na gaggawa don ganewa da magance kamuwa da cutar 2019 Novel Coronavirus (2019-nCoV), kuma waɗannan jagororin suna ba da ƙwarewarmu da kuma mahallin da ya dace don yaƙar cutar a duk duniya.
Kodayake cutar Coronavirus ta 2019 (COVID-19) sabuwar cuta ce, hankali da iliminmu suna ƙaruwa a hankali bisa ga binciken binciken da ake yi da kuma kwarewar aikin asibiti; saboda haka, ana ci gaba da sabunta dabarun bincike da magani.
A cikin wannan wasikar, mun amsa tsokaci kan jagororinmu kuma mun samar da sabbin ka'idojin bincike na "Laifin da ake zargi" da "Laifin da aka tabbatar" daidai da sabuwar Jagorar Ganowa da Kula da COVID-19 (Fitowar 7th) da Kwamitin Kiwon Lafiyar Jama'ar Jamhuriyar Sin ya fitar.
A watan Disamba na 2019, an sami barkewar cutar coronavirus ta 2019 (2019-nCoV), wanda yanzu aka sake masa suna zuwa cutar coronavirus ta 2019 (COVID-19) kuma an sake masa suna zuwa cutar mai saurin kamuwa da cutar coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-19 a matsayin annoba.
Don yaƙar kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta haɓaka jagororin shawarwari masu sauri kuma an buga su akan layi a cikin binciken likitancin soja a ranar 06 ga Fabrairu, 2020.
Tun lokacin da aka buga shi, ya jawo hankali sosai.
Koyaya, lura cewa COVID-19 sabuwar cuta ce, hankali da iliminmu suna ƙaruwa a hankali bisa ga binciken binciken da ake yi da kuma kwarewar aikin asibiti; sabili da haka, ana ci gaba da sabunta dabarun bincike da magani.
Misali, a tsakanin 16 ga Janairu 2020 zuwa 3 ga Maris 2020, Kwamitin Kiwon Lafiya na Jamhuriyar Jama'ar Sin ya fitar da jagororin da suka shafi ganewar asali da magani na COVID-19 (http://www.nhc.gov.cn/) tare da sauye-sauye na asali a wasu mahallin.
Yanzu da Zhou et al. suka yi tsokaci a kan jagororinmu, sun gabatar da shawara mai sauƙi na alama bisa ga kwarewarsu ta asibiti.
Ayyukansa sun kara sabbin shaidu ga jagororinmu kuma sun samar da mahimman bayanai game da wannan annoba a duk duniya.
Muna tallafawa muhimmin aikinsa kuma muna nuna godiyarmu.
Koyaya, aikin su yana buƙatar sabuntawa daidai da sabbin jagororin bincike da magani don COVID-19 (Fitarwa ta gwaji ta bakwai) da kuma binciken da aka yi kwanan nan.
A cewar fitowar ta bakwai (3 ga Maris 2020), don yin cikakken bincike don tabbatar da yanayin da ake zargi, ana buƙatar haɗa kowane abu guda na tarihin annobar tare da abubuwa biyu na bayyanar cututtuka, ko kuma idan babu bayyanar cututtuka, ana buƙatar cika abubuwa uku na bayyanar cututtuka:
Tarihin annoba: (1) Tarihin tafiya ko zama a cikin Wuhan City da kewayensa, ko wasu al'ummomin da aka ba da rahoton shari'ar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) Tarihin hulɗa tare da masu kamuwa da cutar SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) Tarihin hulɗa tare da marasa lafiya da ke da zazzabi ko cututtukan numfashi daga Wuhan City da kewayensa, ko wasu al'ummomin da aka ba da rahoton COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin hulɗa tare da rukunin tabbatar da shari'o'in (≥ 2 lokuta na zazzabi da / ko cututtukan numfashi a cikin makonni 2 a cikin ƙananan yankuna kamar gida, ofis, aji na makaranta, da sauransu).
Bayyanar cututtuka: (1) zazzabi da / ko bayyanar cututtuka na numfashi; (2) tare da halaye masu nuna alamun kamuwa da cutar COVID-19; (3) yawan adadin ƙwayoyin farin jini a farkon matakin farawa yana nuna al'ada, raguwa ko ƙarancin ƙwayoyin lymphocytes.
Gano cutar da aka tabbatar ya kamata ya dogara ne akan yanayin da ake zargi wanda ke da wata alama ta cututtukan cututtuka ko tabbacin ƙwayar cuta wanda ya ƙunshi: (1) gwajin PCR na ainihi don SARS-CoV-2 ya zama tabbatacce; (2) jerin kwayoyin halittar kwayar cuta na kwayar cuta yana nuna babban kama da sanannun coronavirus na labari; (3) gwajin ƙwayar cuta ya zama tabbatacce ga takamaiman IgM mai hanawa da IgG mai hanawa ga SARS-CoV-2; ko sauyawar takamaiman IgG mai hanawa daga mara kyau zuwa tabbatacce, ko kuma an sami karuwa ≥ 4x a cikin matakin lafiya fiye da matakin gaggawa.
Za mu iya ganin cewa an ƙara gwajin PCR na ainihi don nucleic acid a cikin tsarin numfashi ko samfuran jini a cikin na biyu (18 Janairu 2020) da na uku (22 Janairu 2020).
An kara gano cututtukan cututtukan jini a cikin na huɗu (27 Janairu 2020) da na biyar (8 Fabrairu 2020); sannan an ƙara shaidar siriyo a cikin na bakwai.
Waɗannan gyare-gyaren sun dogara ne da ci gaba da aikin masu binciken, waɗanda ke neman kayan aikin gano kwayar halitta mafi kyau don saurin ganewa, gami da samfuran tsarin numfashi, gami da samfuran jini, wanda ya haɓaka wadatar samfuran daban-daban, da kuma tallafawa kawo takamaiman sakamako mai kyau na rigakafi zuwa ƙa'idodin tabbatarwa.
Bugu da ƙari, akwai shaidu da yawa da ke tunatar da mu mu yi hankali da marasa lafiya marasa alamun bayyanar cututtuka da alamun cututtuka.
Don haka, dole ne a sabunta jadawalin kwararar Zhou et al., saboda sun rarraba mutum ba tare da alamun asibiti ba a matsayin "mai ƙarancin haɗari".
Tsarin maki yana buƙatar tabbatarwa a cikin ƙarin aikin gwaji da karatu.
A ƙarshe, muna fatan ƙarin shaidar kai tsaye za ta fito kuma muna gayyatar masu karatu su ba da ra'ayoyinsu.
Don gano "Laifin da ake zargi" da "Laifin da aka tabbatar", muna ba da shawarar ganowa da bin sabbin jagororin ƙasashensu.
Ourungiyarmu za ta kuma sabunta jagororinmu lokaci zuwa lokaci don ba da taimako.
Bangladesh ta samu sabbin mutuwar COVID-19 guda biyar, adadi mafi girma a rana daya
A jiya, Bangladesh ta tabbatar da wasu mutuwar biyar daga COVID-19 a rana daya.
Wannan shi ne adadin mafi girma da aka taba samu na mutuwar mutum guda a rana daya sakamakon cutar.
A jiya, cibiyar nazarin cututtuka ta Bangladesh, IEDCR ta bayyana cewa adadin masu kamuwa da cutar da aka rubuta ya hada da mutane 114 da ke aiki da kuma 33 da suka warke daga cutar yayin da suke gida.
A yanzu haka an samu mutuwar mutane 17.
A wani taron labarai na yanar gizo, Daraktan IEDCR, Dakta Mirzadi Sabrina Flora ta bayyana cewa maza hudu da mace daya sun mutu.
A cewar Dr. Mirzadi, marasa lafiya biyu sun haura shekaru 60, biyu sun kasance tsakanin shekaru 51 zuwa 60, daya kuma tsakanin shekaru 41 zuwa 50.
Ya kuma ce biyu daga cikin wadanda suka mutu 'yan Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba ta duniya a ranar 11 ga Maris.
Wani jami'in asibitin ya shaida wa wata cibiyar labarai ta Anadolu cewa, sunan wanda ya mutu Jalal Saifur Rahman ne, darektan hukumar hana cin hanci da rashawa ta Bengal, kuma ana kula da shi a asibitin Kuwait Ma'itri.
A cikin sanarwar bidiyo ta yanar gizo a ranar Asabar, Ministan Sufurin Hanya da Gadar Bangladesh, Ubaidul Qadar ya bayyana cewa za a rufe zirga -zirgar jiragen sama har zuwa ranar Asabar mai zuwa fiye da yadda aka tsara.
Wannan dokar hana zirga-zirgar jama'a ta fara ne a ranar 26 ga watan Maris kuma za ta kare a ranar Asabar, 4 ga watan Afrilu.
Ba a hana jigilar kayayyaki masu mahimmanci kamar kayan kiwon lafiya, mai da abinci ba.
An fara samun cutar COVID-19 a Bangladesh a ranar 8 ga Maris a cikin mutane biyu da matar ɗayan da suka dawo daga Italiya.
A ranar 19 ga watan Maris, duk ukun sun warke.
Yawan masu kamuwa da cutar SARS-CoV-2 ya zarce miliyan daya a duk duniya.
Bayanai daga Jami'ar Johns Hopkins sun nuna cewa a ranar Alhamis, yawan kamuwa da cutar SARS-CoV-2 a duniya ya zarce miliyan daya.
Cutar da ke haifar da cutar coronavirus, COVID-19, an danganta ta da mutuwar mutane akalla 52,000.
A ranar da aka wuce wannan adadin, an samu rahoton kamuwa da cutar coronavirus ta farko a Malawi da kuma mutuwar farko daga cutar coronavirus a Zambia.
Koriya ta Arewa ta yi ikirarin cewa a ranar Alhamis tana cikin wasu ƙasashe da har yanzu ba su da cututtukan coronavirus.
A jiya, Hukumar Lafiya ta Duniya ta ba da rahoton mutane 10,51,635, ciki har da mutane 79,332 da suka kamu da cutar a cikin sa'o'i ashirin da hudu kafin karfe 10 na safe (0800 UTC) a ranar 4 ga Afrilu.
An samu sama da mutane miliyan biyu da dubu arba'in da huɗu da suka kamu da cutar a Amurka, kuma an samu mutuwar mutane akalla 5,900.
CBS News ta ruwaito bayanan Jami'ar Johns Hopkins cewa sama da mutane 1,000 ne suka mutu a Amurka a ranar Laraba sakamakon kamuwa da cutar coronavirus.
Kasashe a duniya sun sanar da tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis ne magajin garin Moscow Sergei Sobyanin ya tsawaita dokar kulle a birnin har zuwa ranar 1 ga watan Mayu.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa har zuwa 30 ga Afrilu, 'yan Rasha za su ci gaba da samun albashi ba tare da zuwa aiki ba.
Majalisar Portugal ta kada kuri'ar da ta dace don tsawaita dokar ta baci ta kasa na kwanaki 15; an zartar da wannan shawarar da kuri'u 215, da 'yan majalisa 10 da ba sa nan, daya kuma ya yi adawa.
Saudiyya ta kafa dokar hana fita ta tsawon sa'o'i 24 a cikin biranen Makka da Madina, wanda a baya ya kasance daga karfe 3 na rana zuwa 6 na safe.
Thailand ta shirya kafa dokar hana fita daga karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio Mike Dwayne ya sanar da cewa an tsawaita dokar hana fita a jihar har zuwa ranar 1 ga Mayu.
A Ostiraliya, shaguna sun rage yawan takarda na bayan gida da za a iya saya a lokaci guda.
A ranar Lahadi da Asabar da yamma, shagunan Australiya Woolworths da Coles sun rage adadin takardar bayan gida da za a iya saya a lokaci guda a duk shagunan su a duk faɗin ƙasar zuwa fakiti biyu da ɗaya, bi da bi.
ALDI ma ta sanya iyakar fakiti guda a ranar Litinin.
An sanya waɗannan iyakokin a matsayin saƙonni a wuraren biya da kuma shafukan Facebook na jerin.
An ba da rahoton cewa masu siye suna yin sayayya tare don yanayin da ake buƙatar keɓe kansu saboda tsoron COVID-19.
A ranar Laraba, Woolworths ya iyakance iyakar sayan takarda na gidan wanka zuwa fakiti ɗaya a kowane tsari.
Kafin waɗannan canje -canjen, Woolworths da Coles sun sanya takunkumi kan siyan fakiti huɗu a lokaci ɗaya a ranar 4 ga Maris da 5 ga Maris, bi da bi.
Coles ya bayyana a cikin sanarwar manema labarai ta 8 ga Maris cewa duk da dokar hana kaya hudu, "yawancin shaguna suna ƙarancin kaya a cikin awa ɗaya bayan isarwa", kuma ya bayyana wannan buƙatar a matsayin ba a taɓa gani ba, yayin da ALDI ta kira shi "ba zato ba tsammani" a cikin wani sakon Facebook a ranar Talata.
A cewar wani mai magana da yawun kamfanin Woolworths, tallace - tallace sun yi tashin gwauron zabi a makon da ya gabata.
Shagon Costco da ke Canberra ya rage adadin zuwa fakiti biyu a makon da ya gabata.
Don rage ƙarancin, Coles ya ba da umarni ga manyan fakiti ga masu samar da kayayyaki kuma ya ƙara yawan isar da kayayyaki. Woolworths ya ba da umarnin ƙarin kaya, yayin da ALDI ta tara kaya don samar da takamaiman ranar Laraba da aka shirya.
Russell Zimmerman, darektan zartarwa na kungiyar 'yan kasuwa ta Australiya, ya ce yan kasuwa na iya kokarin kara yawan kaya, amma hakan na da wahala saboda takunkumin da majalisar ta sanya kan lokacin isar da motoci.
A yayin da masu samar da kayayyaki ke kokarin biyan bukatar kuma adadin na musamman ya ragu, Russell yana tsammanin farashin samarwa zai karu.
A ranar Talata ALDI ta sanar da cewa bayan sakin kaya kafin lokaci, wasu shagunan ba za su iya gudanar da na musamman na Laraba ba.
Wani rahoto daga News.com.au ya nuna cewa Dr. Gary Mortimer, masanin sayar da kayayyaki a Jami'ar Queensland na Fasaha, ya bayyana cewa shagunan suna cika kaya a kowane dare.
Ya ce takardar bayan gida abu ne mai nauyi, saboda haka ba za a iya samun adadi mai yawa ba, kuma idan aka sayar da duk kayan, sai a bar manyan ɗakunan ajiya a baya, wanda ke sa ƙarancin ya zama mai tsanani.
Russell Zimmerman ya ce, "Colls da Woolworths suna da ra'ayin cewa idan akwai wadataccen kaya a kan ɗakunan ajiya, da kuma samfurori kamar takarda na bayan gida da kuma tsabtace jiki, za a iya samun su kuma a cikin manyan yawa, za a iya rage tashin hankali".
Kamfanin da ke kera takarda na bayan gida mai sake amfani da shi, Who Gives a Crap, ya sanar a ranar Laraba cewa sun gama.
Kamar yadda News.com.au ta ruwaito, kamfanin kera kayan wanka na Klinex, Kimberly-Clark, da kamfanin samar da sorbent, Solaris Paper, sun jaddada cewa suna aiki 24/7 don ci gaba da samarwa.
Wani shafin yanar gizo mai suna Domain.com ya ruwaito cewa a Melbourne, inda ake samun karancin gwanjo saboda masu sayayya suna hutu a karshen mako na ranar ma'aikata, wasu masu sayar da kadara suna ba da takardar bayan gida kyauta ga masu neman farko a gwanjo.
A cikin jaridar NT News, jaridar da ke Darwin, a ranar Alhamis, an buga wani shafi mai shafuka takwas wanda aka yanke don amfani da shi azaman takardar bayan gida.
A cewar wani rahoto na ABC Australia na ranar 3 ga Maris, shagunan da farko ba su da sha'awar hanawa; a cikin wannan rahoton sun ce ba su da shirin hana cin kasuwa.
Russell Zimmerman ya kara da cewa akwai bukatar sauran kayayyaki, wadanda suka hada da masks, sanitizers, abubuwa masu bushewa, wanke hannu da gari.
Hakazalika, a waje da Ostiraliya, a ranar Lahadi da yamma an sanya iyaka na fakiti biyu na 12-rubuce a kan sayan takardar bayan gida ta Andres a cikin babban kanti na Burtaniya na kan layi Okado.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba ta duniya.
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar COVID-19 da ke faruwa a halin yanzu, cutar da ke haifar da coronavirus SARS CoV-2, a matsayin annoba ta duniya.
Ko da yake kalmar "annoba ta duniya" tana nufin kawai yadda cutar ta yadu, ba yadda hatsarin da ke tattare da ita yake ba, WHO ta tattauna bukatar tilasta gwamnatoci su dauki mataki.
Dukkanin kasashen duniya zasu iya canza yanayin wannan annoba ta duniya a yanzu.
Idan kasashe suka amsa, gano cutar, kula da marasa lafiya, ware su, gano su da kuma hada su, in ji Darakta Janar na WHO, Tedros Adhanom Ghebreyesus.
Muna matukar damuwa da yadda ake samun karuwar cutar da kuma yadda ake samun rashin aiki.
A cewar tsohon darektan cibiyar kula da cututtuka ta Amurka, Dokta Tom Friedan, annobar ta duniya "ba ta da misali".
A cikin bayanan da CNN ta wallafa a watan Fabrairu, ya ce babu wani kwayar cutar numfashi da aka gano daga ci gaba da yaduwar duniya sai mura.
Gabraysis ya bayyana irin wannan ra'ayin lokacin da ya ce, "Ba mu taɓa ganin annobar duniya da ke haifar da cutar coronavirus ba".
Ya kara da cewa, "Kuma har zuwa yau ba mu ga wata annoba ta duniya da za a iya sarrafa ta a lokaci guda ba".
Wannan sabon lakabi na annoba ta duniya ya biyo bayan hukuncin WHO a watan Janairu na ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiyar jama'a da ke da matukar damuwa a duniya.
Dokta Anthony Fauci, darektan Cibiyar Kula da Cututtuka da Cututtuka ta Amurka, ya ce game da annobar, "A cikin magana daya, zai kara muni".
Associated Press ta ruwaito cewa a ranar Alhamis akwai aƙalla mutane 126,000 da suka kamu da COVID-19 a duk duniya kuma ya haifar da mutuwar sama da 4,600.
Cutar annobar coronavirus ta 2019 20 annobar annobar annobar cutar coronavirus ta 2019 (COVID-19) ce mai gudana wacce ke haifar da mummunan ciwon numfashi mai tsanani coronavirus 2 (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China a watan Disamba na 2019, wanda aka ayyana a matsayin gaggawa ta lafiyar jama'a a duniya a ranar 30 ga Janairu, 2020 kuma aka ayyana a matsayin annoba a ranar 11 ga Maris, 2020.
Ya zuwa ranar 10 ga Afrilu, 2020, an bayar da rahoton kusan mutane miliyan 1.61 na COVID-19 a cikin ƙasashe da yankuna 210, wanda ya haifar da mutuwar kusan 97,000.
Kimanin mutane 364,000 sun warke.
An kiyasta yawan mutuwar a China da kashi 4%, yayin da a duniya ya kasance daga 13.04% a Algeria zuwa .08% a New Zealand.
Alamomin yau da kullun sun haɗa da zazzabi, tari da numfashi.
Matsaloli na iya haɗawa da cutar huhu da cututtukan numfashi mai tsanani.
Lokaci daga kamuwa da kwayar cutar zuwa bayyanar cututtuka yawanci kusan kwanaki biyar ne, amma zai iya wucewa daga kwana biyu zuwa goma sha huɗu.
Babu wani maganin rigakafi ko takamaiman maganin rigakafi.
Maganin farko shine alamun bayyanar cututtuka da kuma magani na taimako. Matakan kariya da aka ba da shawarar sun haɗa da: wanke hannu, rufe fuska lokacin da kake tari, nisantar wasu mutane da saka idanu da keɓe kai ga waɗanda ake zargi da kamuwa da cutar.
Hukumomi a duk duniya sun amsa ta hanyar sanya takunkumin tafiye -tafiye, keɓewa, dokar hana fita, kula da haɗarin wurin aiki da rufe wurare.
Cutar ta haifar da mummunan rikicewar zamantakewar tattalin arziki a duniya, ta haifar da jinkirta ko soke wasanni, abubuwan addini, siyasa da al'adu, kuma mutane suna cin kasuwa cikin tsoro wanda ke haifar da raguwar kayayyaki.
Makarantu da jami'o'i a kasashe 193 suna rufewa a duk fadin kasar ko kuma a yankunan su, wanda hakan ya shafi kusan kashi 99.4 na yawan daliban duniya.
Bayanai marasa kyau game da kwayar cutar sun bazu a kan layi, kuma akwai abubuwan nuna kyamar baki da nuna bambanci ga Sinawa, mutanen Gabas da kudu maso gabashin Asiya da sauran mutanen da ke da launi, da kuma wasu daga yankunan da ke da ƙarin cututtukan cutar.
Sauke tafiye -tafiye da rufe masana'antu masu nauyi sun rage gurɓatar iska da fitar da iskar carbon.
Hukumomin kiwon lafiya a Wuhan (babban birnin lardin Hubei) na kasar Sin sun ba da rahoton tarin lamuran cutar nimoniya da ba a san dalilin da ya sa ba a ranar 31 ga Disamba, 2019 kuma an fara bincike a farkon Janairu, 2020.
Yawancin shari'o'in sun shafi kasuwar sayar da abincin teku ta Hunan kuma saboda haka ana ganin kwayar cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ke haifar da barkewar cutar da aka sani da SARS-CoV-2, sabuwar kwayar cuta ce da aka gano wacce ke da alaƙa da cutar coronavirus, pangolin coronavirus da SARS-CoV. Daga baya an gano mutum na farko da aka sani da alamun cutar a ranar 1 ga Disamba, 2019, kuma ba a sami alaƙa da za a iya gani tare da rukunin masu sayar da nama ba.
Kashi biyu bisa uku na rukunin farko na shari'o'in da aka ruwaito a watan Disamba na 2019 an gano cewa suna da alaƙa da kasuwa.
A ranar 13 ga watan Maris na shekarar 2020, wani rahoto da ba a tabbatar da shi ba a cikin South China Morning Post ya ruwaito cewa wani mutum mai shekaru 55 daga lardin Hubei ne ya kamu da cutar a ranar 17 ga Nuwamba, 2019, wanda zai iya zama farkon lamarin. A ranar 26 ga Fabrairun 2020, WHO ta ba da rahoton cewa akwai karuwar kwatsam a Italiya, Iran da Koriya ta Kudu, tare da raguwar sabbin cututtukan a China, tare da yawan sabbin cututtukan a waje da China ya zarce adadin sabbin cututtukan a cikin China a karon farko.
Ana iya samun rahotanni kaɗan na shari'o'i, musamman a cikin mutanen da ke da alamun rashin lafiya.
Har zuwa ranar 26 ga Fabrairu, an samu karancin lokuta a cikin matasa, wadanda shekarunsu 19 zuwa kasa sun kai kashi 2.4% na dukkan masu cutar a duniya. Babban mai ba da shawara kan kimiyya a Burtaniya, Patrick Wallens, ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya za su buƙaci kamuwa da cutar kafin samun rigakafin kwayar cuta.
Lamura na nufin yawan mutanen da aka gwada COVID-19, kuma bisa ga ƙa'idodin hukuma waɗanda aka tabbatar da gwajin su.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawanta, kuma ƙasashe da yawa kamar Italiya, Netherlands, Spain da Switzerland suna da manufofin hukuma na ba da gwaji ga mutanen da ke da alamun cutar kawai.
Wani bincike da aka buga a ranar 16 ga watan Maris ya gano cewa a kasar Sin, a ranar 23 ga watan Janairu, kimanin kashi 86% na kamuwa da cutar COVID-19 ba a gano su ba, kuma wadannan kamuwa da cutar da ba a rubuta ba sune tushen kamuwa da cutar ga kashi 79% na wadanda aka rubuta.
Wani bincike na kididdiga da aka buga a ranar 30 ga Maris ya kiyasta cewa adadin mutanen da ke dauke da cutar a Italiya ya fi wadanda aka ruwaito.
Hasashen farko na asalin haifuwa (R0) don COVID-19 ya kasance 1.4 zuwa 2.4.
Wani binciken da Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta wallafa ya kammala cewa zai iya zama 5.7.
Yawancin mutanen da ke kamuwa da COVID-19 sun warke.
A cikin waɗanda ba su warke ba, lokacin daga bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, tare da mafi yawan kwanaki 14.
Ya zuwa ranar 10 ga Afrilu, 2020, COVID-19 ya kashe kusan mutane 97,000.
A China, ya zuwa ranar 5 ga watan Fabrairu, kusan kashi 80% na mutuwar sun kasance a cikin mutanen da suka haura shekaru 60, kuma kashi 75% na shari'o'in sun kasance suna da yanayin kiwon lafiya wanda ya riga ya wanzu, gami da cututtukan zuciya da ciwon sukari.
Adadin ainihin mutuwar COVID-19 na iya zama mafi girma, saboda ba zai iya haɗa da mutanen da ke mutuwa ba tare da gwaji ba kamar a gida, a gidajen jinya, da sauransu.
Bayanai na Italiya sun gano cewa ƙarin mutuwar da aka yi a lokacin annobar ta ninka na COVID sau 4-5 fiye da na hukuma.
"Mun san cewa an rage yawan [yawan mutuwar da aka ce]", in ji mai magana da yawun Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC), wata sanarwa da ke da goyan bayan rahotanni masu ƙarancin ƙididdiga a Amurka. Irin waɗannan ƙananan ƙididdiga suna faruwa a cikin annoba, kamar yadda ya faru a cikin annobar cutar ta 2009 H1N1.
Mutuwar farko a waje da kasar Sin ta fara a Philippines a ranar 1 ga watan Fabrairu, kuma mutuwar farko a waje da Asiya ta fara a Faransa a ranar 14 ga watan Fabrairu.
Har zuwa ranar 28 ga watan Fabrairu, a wajen kasar Sin, Iran, Koriya ta Kudu da Italiya kowannensu ya samu mutuwar sama da dozin.
A ranar 13 ga watan Maris, an bayar da rahoton mutuwar a kasashe da yankuna sama da arba'in a kowace nahiya sai Antarctica. Ana amfani da matakai da yawa don tantance yawan mutuwar.
Waɗannan lambobin sun bambanta ta yanki da lokaci, kuma ana rinjayar su da yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci tun farkon barkewar cutar, da halaye na yawan jama'a kamar shekaru, jinsi, da lafiyar gaba ɗaya.
Dangane da bayanan Jami'ar Johns Hopkins, adadin mutuwar duniya ya kai 6.0% (97,039/1,617,204) har zuwa 10 ga Afrilu, 2020.
Wannan adadi ya bambanta da yankin.
A China, an kiyasta cewa adadin mutuwar mutane daga cutar ya ragu daga kashi 17.3% (ga wadanda suka fara bayyanar cututtuka daga 1 zuwa 10 ga Janairu, 2020) zuwa kashi 0.7% (ga wadanda suka fara bayyanar cututtuka bayan 1 ga Fabrairu, 2020). Sauran matakan sun hada da yawan mace-mace (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mace-macen kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da suka kamu da cutar (masu kamuwa da cutar da marasa kamuwa da cutar).
Wadannan bayanan ba su da lokaci kuma suna bin wani yanki na musamman daga kamuwa da cuta zuwa warkewa.
Yawancin malaman kimiyya sun yi ƙoƙari su lissafa waɗannan lambobi don ƙayyadaddun yawan jama'a.
Cibiyar Nazarin Shaida ta Jami'ar Oxford ta kiyasta cewa yawan mace - macen kamuwa da cuta a cikin annobar gaba ɗaya ya kasance tsakanin 0.1% da 0.39%.
Wannan ƙididdigar ta sama ta dace da sakamakon binciken ƙididdigar da aka yi a farkon gwajin bazuwar COVID-19 a Jamus da kuma nazarin tasirin gwajin akan ƙididdigar CFR.
WHO ta yi ikirarin cewa ana iya sarrafa cutar.
Matsayi mafi girma da kuma ƙarshen lokacin ɓarkewar ba shi da tabbas kuma zai iya bambanta ta wurin wuri.
"A lokacin da aka bar su ba tare da an hana su ba, cututtukan cututtuka sukan daidaita kuma suna fara raguwa idan ba a sami abubuwan gina jiki don cutar ba", in ji Mackie Bonnie na Jami'ar Jihar Penn.
Amma ba zai yiwu a yi tunanin lokacin da hakan zai faru ba".
Zhong Nan Shan, babban mai ba da shawara kan lafiya ga gwamnatin kasar Sin, ya yi jayayya cewa "za a iya kawo karshen ta a watan Yuni" idan dukkan kasashen suka bi shawarar WHO kan matakan dakile yaduwar cutar.
A ranar 17 ga Maris, Adam Kucherski na Makarantar Kiwon Lafiya da Magungunan Yankin Gashi ta London ya ce SARS-CoV-2 "mai yiwuwa zai ci gaba da yawo har tsawon shekara ɗaya ko biyu".
A cewar wani binciken da kwalejin Imperial ta jagoranci wanda Neil Ferguson ya jagoranta, za a buƙaci nisantar jiki da sauran matakan "har sai an sami allurar rigakafi (mai yiwuwa: watanni 18 ko fiye)".
"Ina ganin ba zai yiwu wannan kwayar cutar ta coronavirus ta ƙare gaba ɗaya ba, saboda tana yaduwa cikin sauƙi" kuma tana iya "juyawa zuwa cutar yanayi, ta dawo kowace shekara", in ji William Schaffner na Jami'ar Vanderbilt.
Rashin dawowa zai dogara ne akan yawan rigakafin ƙungiya da kuma yawan maye gurbi.
Alamomin COVID-19 na iya zama marasa ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
Alamomi biyu da suka fi yawa sune zazzabi (88%) da bushewar tari (68%).
Alamomin da ba a saba gani ba sun hada da: gajiya, samar da mucous na numfashi (squal), rashin jin ƙamshi, numfashi, ciwon tsoka da haɗin gwiwa, ciwon makogwaro, ciwon kai, sanyi, amai, zubar da jini, zazzaɓi ko lemun tsami. A cewar WHO, kusan mutum ɗaya cikin shida yana rashin lafiya sosai kuma yana da wahalar numfashi.
Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta lissafa alamun gaggawa kamar wahalar numfashi, ciwon kirji ko matsin lamba, rikicewa kwatsam, wahalar farkawa, da launin shuɗi na fuska ko lebe; ana ba da shawarar kula da likita nan da nan idan waɗannan alamun sun bayyana. Hawan cutar na iya haifar da cutar nimoniya mai tsanani, cututtukan cututtukan numfashi, sepsis, septic shock, da mutuwa.
Wasu daga cikin mutanen da ke dauke da cutar na iya zama masu alamun rashin alamun cutar, amma sakamakon gwajin ya tabbatar da kamuwa da cutar, don haka masu binciken sun ba da shawarar cewa ya kamata a sanya ido sosai da kuma bincika mutanen da ke cikin kusanci da mutanen da aka tabbatar da kamuwa da cutar don kawar da kamuwa da cuta.
Tsinkayen Sinawa na yawan alamun alamun suna daga kadan zuwa 44%.
Lokacin bayyanar cututtuka na yau da kullun (lokaci tsakanin kamuwa da cuta da fara alamun bayyanar cututtuka) yana daga kwana ɗaya zuwa 14; mafi yawan lokuta kwanaki biyar ne. Misali na rashin tabbas, ƙididdigar yawan mutanen da ke da COVID-19 waɗanda suka rasa ƙanshin su, da farko ya kasance 30% kuma daga baya ya ragu zuwa 15%.
Har yanzu ana tantance wasu bayanai game da yadda cutar ke yaduwa.
Ana tsammanin cutar tana yaduwa ne ta hanyar ƙananan ɗigon ruwa da aka samar yayin kusanci da tari, hancinsa ko magana; lokacin da kusanci ya kasance tsakanin mita 1 zuwa 2 (ƙafa 3 zuwa 6).
Nazarin ya nuna cewa tari ba tare da rufe baki ba zai iya sa digo ya kai mita 4.5 zuwa mita 8.2.
Wasu sun ba da shawarar cewa ana iya yada kwayar cutar ta hanyar ƙananan ɗigon ruwa da aka samar yayin magana waɗanda ke rayuwa cikin iska na tsawon lokaci. Ana iya haifar da ɗigon iska yayin numfashi, gami da numfashi yayin magana, kodayake ƙwayoyin cuta ba yawanci iska ba ne.
Saukad da zai iya shiga cikin baki ko hanci na mutanen da suke kusa ko kuma zai iya shiga cikin huhu ta hanyar numfashi.
Wasu hanyoyin likita kamar shigar da tube da CPR na iya haifar da ɓarkewar numfashi kuma don haka yaduwar iska.
Hakanan yana iya yaduwa idan mutum ya taɓa wani abu mai gurbatawa, gami da fata, sannan ya taɓa idanunsa, hanci ko bakinsa.
Ko da yake akwai damuwa cewa za a iya yada shi ta hanyar stool, ana ganin cewa ba shi da haɗari.
Gwamnatin kasar Sin ta musanta yiwuwar SARS-CoV-2 na yaduwar baki da baki. Kwayar cutar tana da saurin kamuwa da cuta a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwa na iya yiwuwa kafin bayyanar cututtuka da kuma a matakai na gaba na cutar.
Mutane sun gwada tabbatacce ga cutar har zuwa kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa watsawa yana yiwuwa kafin su sami alamun bayyanar cututtuka.
Rahotanni kaɗan ne kawai na alamun alamun da aka tabbatar a cikin dakin gwaje -gwaje, amma an gano wasu ƙasashe masu alamun watsawa yayin binciken gano lamba.
A cewar Cibiyar Kula da Cututtuka ta Turai (ECDC), kodayake ba a san yadda cutar ke yaduwa ba, mutum ɗaya yana cutar da mutane biyu zuwa uku. Kwayar cutar tana rayuwa a kan farfajiya daga awanni zuwa kwanaki.
Musamman, an gano kwayar cutar a kan filastik (polypropylene) da 304 bakin karfe har tsawon kwanaki uku, a kan kwali har tsawon rana ɗaya, da kuma jan ƙarfe har tsawon awanni huɗu.
Koyaya, wannan ya bambanta dangane da zafi da zafin jiki. Dabbobin gida da sauran dabbobi sun gwada tabbatacce ga COVID-19.
Babu wata hujja da ke nuna cewa kwayar cutar na iya wucewa daga dabbobi zuwa mutane, kodayake hukumomin Burtaniya sun ba da shawarar wanke hannayenku bayan kun yi hulɗa da dabbobi, kamar bayan kun taɓa wasu farfajiyoyi da mutum mai cutar ya taɓa.
Babban Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar C
Dukkanin halaye na sabon kwayar cutar SARS-CoV-2 ana samun su a cikin kwayar cutar coronavirus da ke cikin yanayi. A waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, wanda ke lalata murfinta na kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Ana ganin cewa kwayar cutar ta samo asali ne daga dabbobi.
Binciken kwayoyin halitta ya nuna cewa coronavirus yana cikin rukunin betacoronavirus, subtype sarbacovirus (gidan B), tare da jinsunan biyu da aka samo daga kwari.
Ya yi daidai da kashi 96% na sauran samfuran kwayar cutar coronavirus (BatCov RaTG13) a matakin gabaɗaya.
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambanci na amino acid daya kawai a wasu sassan jerin kwayoyin halittar tsakanin kwayoyin cuta daga pangolins da kwayoyin cuta daga mutane.
A cikin kwatancen kwayoyin halittar mutum har yanzu, an sami matsakaicin kashi 92% na abubuwan da ke cikin kwayoyin halitta tsakanin pangolin coronavirus da SARS-CoV-2, wanda bai isa ya samar da abubuwan gina jiki na tsaka-tsaki ga pangolins ba.
Ana iya gano kamuwa da kwayar cutar ta hanyar alamomi a cikin lokaci, kodayake tabbatarwa daga ƙarshe ta hanyar jujjuyawar jujjuyawar polymerase chain reaction (rRT-PCR) ko hotunan CT na ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyay.
Wani binciken da aka yi a Wuhan wanda ya kwatanta PCR da CT ya nuna cewa CT ya fi PCR hankali sosai, kodayake ba shi da ƙwarewa sosai tare da yawancin halayen hotonta kamar sauran cututtukan huhu da hanyoyin cututtuka.
Ya zuwa watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "kada a yi amfani da CT a matsayin gwaji na farko don bincika ko gano COVID-19".
WHO ta wallafa wasu ka'idojin gwajin RNA don SARS-CoV-2, wanda aka fitar da sigar farko a ranar 17 ga Janairu.
Wannan gwajin yana amfani da ainihin lokacin juyawa juyawa polymerase chain reaction (rRT-PCR).
Ana iya yin wannan gwajin akan numfashi ko kuma jini.
Sakamakon yawanci ana samun su cikin awanni zuwa kwanaki.
Ana yin gwajin ne a kan hanci, amma ana iya amfani da ƙofar makogwaro. Yawancin dakunan gwaje -gwaje da kamfanoni suna haɓaka gwaje -gwajen ƙwayar cuta don gano rigakafi.
Har zuwa 6 ga Afrilu, 2020, babu ɗayan waɗannan da aka tabbatar da inganci don yarda da amfani da su sosai.
Wani gwajin ƙwayar cuta wanda Cellex ya haɓaka a Amurka an yarda da shi ne kawai don amfani da gaggawa ta hanyar dakunan gwaje -gwaje masu inganci.
Abubuwan da ke nuna hotuna a kan radiography da CT na mutanen da ke da alamun sun hada da rashin daidaituwa na gilashin gilashi da kuma rashin ƙwayar huhu.
Radiologicalungiyar Radiological ta Italiya tana tattara bayanan kan layi na duniya na binciken hoto don tabbatar da shari'o'in.
Saboda kamanceceniya da sauran cututtuka kamar adenoviruses, hoto yana da iyakantaccen ƙwarewa wajen gano COVID-19 ba tare da tabbatarwa ta PCR ba.
Wani babban binciken da aka yi a China ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa kodayake hoton ba shi da ƙarancin kamuwa da cuta, yana da sauri kuma yana da saukin kamuwa da cuta, wanda ke ba da shawarar ra'ayinsa a matsayin hanyar tantancewa a yankunan da ke fama da annoba.
An haɓaka hanyoyin sadarwar jijiyoyin jiki masu amfani da ilimin kere kere don gano halaye na hoto na kwayar cutar tare da duka radiography da CT.
Don hana yaduwar cutar, dabarun sun hada da kiyaye tsabtar mutum gaba daya, wanke hannu, kauce wa taɓa idanu, hanci ko baki ba tare da wanke hannu ba, da tari ko hancin cikin nama da kuma jefa shi kai tsaye cikin kwandon shara.
Ana ba da shawarar mutanen da ke da yiwuwar kamuwa da cutar su sanya abin rufe fuska a wuraren jama'a.
Ana kuma ba da shawarar ɗaukar matakan nisantar jiki don hana yaduwa. Gwamnatoci da yawa sun hana ko kuma ba da shawarar duk balaguron da ba dole ba zuwa ƙasashe da yankuna da cutar ta shafa.
Koyaya, kwayar cutar ta kai ga yaduwar al'umma a manyan sassan duniya.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin al'ummomi, kuma wasu membobin al'umma ba su san inda ko ta yaya suka kamu ba. Ana ba da shawarar masu kula da ke kula da mai kamuwa da cutar su ɗauki ƙa'idodin kiyayewa, kiyaye kariya ta tuntuɓar, da kare idanu. Binciken tuntuɓar hanya ce mai mahimmanci ga hukumomin kiwon lafiya don gano asalin kamuwa da cuta da hana ci gaba da watsawa.
Amfani da bayanan wurin wayar salula ta gwamnatoci don wannan dalili ya haifar da damuwa game da sirrin sirri, wanda ya sa Amnesty International da wasu kungiyoyi sama da 100 suka fitar da sanarwa game da iyakokin irin wannan sa ido.
An aiwatar ko kuma an ba da shawarar aikace-aikacen wayoyi daban-daban don amfani da son rai, kuma har zuwa 7 ga Afrilu, 2020, sama da rukunin masana dozin suna aiki kan hanyoyin magance sirrin sirri, kamar amfani da Bluetooth don shiga kusanci da sauran wayoyin salula na mai amfani.
Masu amfani za su sami saƙo idan sun kasance cikin kusanci da wani wanda ya gwada tabbatacce ga COVID-19. Ra'ayoyi marasa kyau suna yaduwa game da hanyoyin hana kamuwa da cuta; misali, shafa hanci da kuma yin gargadi da muryar ba shi da tasiri.
Babu allurar rigakafin COVID-19, kodayake ƙungiyoyi da yawa suna aiki don haɓaka allurar rigakafi.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa akai-akai na aƙalla dakika ashirin, musamman bayan sun je bayan gida ko idan hannayensu sun kasance masu datti; kafin cin abinci; da bayan fesawa, tari ko hancin.
Wannan saboda a waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, wanda ke fashe da kumfa mai kariya.
Bugu da ƙari, CDC ta ba da shawarar yin amfani da tsabtace hannu na giya wanda ke da aƙalla kashi 60% na giya, lokacin da sabulu da ruwa ba su da sauƙi.
WHO ta shawarci mutane da su guji taɓa idanu, hanci ko baki ba tare da wanke hannayensu ba.
Za a iya kashe kwayoyin cuta da yawa daga cikin hanyoyin da suka hada da 6271% ethanol, 50100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine (a cikin minti daya na saduwa da maganin kashe kwayoyin cuta don farfajiyar bakin karfe).
Sauran magunguna, kamar su benzalkonium chloride da chryoxydine gluconate, ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan an yi zargin ko tabbatar da cutar COVID a wani ofishi ko wurin kulawa kamar su wuraren kula da rana, ya kamata a kashe duk wuraren kamar ofisoshi, dakunan wanka, wuraren jama'a, kayan aikin lantarki da aka raba kamar su allunan, allon taɓawa, mabuɗan maɓalli, sarrafawa ta nesa, da injunan ATM da marasa lafiya ke amfani da su, da sauransu.
Kungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hancinsu da gwiwoyi ko kuma su rufe su da wani kayan shafawa yayin da suke tari ko hancin, sannan su zubar da duk wani kayan shafawa nan da nan.
Ana ba da shawarar rufe fuska na tiyata ga mutanen da za su iya kamuwa da cutar, saboda sanya abin rufe fuska na iya iyakance adadin digo da nesa da za a bi yayin magana, hancinsa da tari.
WHO ta ba da umarni kan lokacin da kuma yadda za a yi amfani da masks.
A cewar Stephen Griffin, masanin kwayar cuta a Jami'ar Leeds, "Sanya abin rufe fuska na iya rage yawan mutanen da ke taba fuskokinsu, wanda shine babban tushen kamuwa da cuta ba tare da tsabtace hannu ba".
WHO ta ba da shawarar sanya abin rufe fuska ta lafiyayyun mutane ne kawai idan suna cikin haɗari, kamar waɗanda ke kula da wani da ke da COVID-19, kodayake sun kuma yarda cewa sanya abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskokinsu.
Kasashe da yawa sun fara karfafa amfani da abin rufe fuska ta hanyar mutane na yau da kullun.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska na ba da magani wanda aka yi da masana'anta. China ta ba da shawarar musamman amfani da abin rufe fuska na likita wanda za a iya amfani da shi ta hanyar mutane masu lafiya, musamman lokacin da suke kusanci da wasu mutane (mita 1 (ƙafa 3) ko ƙasa da haka).
Hong Kong ta ba da shawarar sanya abin rufe fuska na tiyata yayin amfani da jigilar jama'a ko kasancewa a wuraren da jama'a ke yawa.
Jami'an kiwon lafiya na Thailand suna ƙarfafa mutane su yi abin rufe fuska na masana'anta a gida kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun hana fita waje a wuraren jama'a ba tare da sanya abin rufe fuska ko rufe hanci da baki ba.
A ranar 16 ga Maris, Vietnam ta nemi kowa ya sanya abin rufe fuska yayin da yake zuwa wuraren jama'a don kare kansa da sauran mutane.
Gwamnatin Austriya ta tilasta wa duk wanda ya shiga kantin sayar da kayan masarufi sanya abin rufe fuska.
Isra'ila ta bukaci dukkan 'yan kasar da su sanya abin rufe fuska idan sun fita zuwa wuraren jama'a.
Taiwan, wanda ke samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar watan Maris, ya tilasta wa fasinjoji sanya abin rufe fuska a jiragen kasa da bas na tsakanin birane a ranar 1 ga Afrilu.
Panama ta tilasta sanya abin rufe fuska yayin fita waje, yayin da kuma ta ba da shawarar yin abin rufe fuska na gida ga waɗanda ba za su iya sayan abin rufe fuska ba.
An kuma yi amfani da abin rufe fuska sosai a Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa nesa (wanda kuma ake kira nesa ta jiki) ya ƙunshi ayyukan kula da kamuwa da cuta, wanda ke da nufin rage yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyinsa sun hada da keɓewa; ƙuntatawa na tafiya; da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo, ko cibiyoyin kasuwanci.
Mutane na iya aiwatar da hanyoyin nisantar da jama'a ta hanyar zama a gida, ta hanyar takaita tafiye-tafiye, guje wa wuraren da jama'a ke yawa, ta amfani da gaisuwa ba tare da tuntuɓar juna ba, da nisantar da kansu daga wasu.
Gwamnatoci da yawa yanzu suna tilasta ko ba da shawarar nisantar da jama'a a yankunan da cutar ta shafa.
An rage yawan jama'ar da hukumomin gwamnati da kungiyoyin kiwon lafiya na Amurka suka ba da shawarar daga mutane 250 (idan babu sanannen watsa COVID-19 a yankin) zuwa mutane 50, sannan zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a na mutane sama da biyu. Tsofaffi da kuma mutanen da ke da cututtukan kiwon lafiya irin su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini, da kuma lalacewar tsarin garkuwar jiki suna da haɗarin kamuwa da cututtuka da matsaloli masu tsanani kuma CDC ta shawarce su da su zauna a gida gwargwadon iko a yankunan da ke fama da cutar. A ƙarshen Maris, 2020, WHO da sauran cibiyoyin kiwon lafiya sun fara maye gurbin amfani da kalmar "nisan zamantakewa" da "nisan jiki", don bayyana cewa makasudin shine a yi hulɗa ta zahiri yayin da ake kiyaye hulɗar zamantakewa ta kama-da-wane ko ta ɗan nesa.
Amfani da kalmar "nisanci" ya haifar da ma'anar cewa, maimakon ƙarfafa mutane su ci gaba da hulɗa da wasu ta hanyar madadin, ya kamata a bi ƙa'idodin keɓewar zamantakewar gaba ɗaya. Wasu hukumomi sun ba da jagororin kiwon lafiyar jima'i don amfani da su yayin annobar.
Wadannan sun hada da shawarwari don yin jima'i kawai tare da mutumin da kuke zaune tare da shi wanda ba shi da cutar ko alamun cutar.
Ana ba da shawarar keɓe kai a gida ga mutanen da aka gano da COVID-19 da waɗanda ake zargi da kamuwa da cutar.
Hukumomin kiwon lafiya sun bayar da cikakkun bayanai game da yadda za a kebe kai. Gwamnatoci da yawa sun ba da umarnin ko kuma sun ba da shawarar keɓe kai ga duk mutanen da ke zaune a yankunan da abin ya shafa.
An ba da umarnin keɓe kai mafi tsauri a cikin manyan ƙungiyoyin haɗari.
Mutanen da ke iya kasancewa cikin hulɗa da wani wanda ke da cutar COVID-19 da kuma waɗanda suka ziyarci wata ƙasa ko yanki da ke da yaduwar yaduwar cutar kwanan nan an shawarce su da su keɓe kansu na kwanaki 14 daga lokacin haɗarin ƙarshe.
Dabarun sarrafa barkewar cutar sune hanawa ko hanawa, da kuma ragewa.
Ana yin keɓewa a farkon lokacin ɓarkewar cutar kuma ana nufin gano mutanen da ke da cutar tare da aiwatar da wasu matakan sarrafa kamuwa da cuta da allurar rigakafi don hana cutar yaduwa zuwa sauran jama'a.
Lokacin da ba zai yiwu a hana yaduwar cutar ba, ana yin ƙoƙari don rage yaduwar cutar: ana ɗaukar matakan rage yaduwar cutar da rage tasirinsa ga tsarin kiwon lafiya da al'umma.
Za a iya haɗa duka matakan hanawa da ragewa a lokaci guda.
Don hanawa, ana buƙatar ƙarin matakan matsananci, don juyar da annobar ta hanyar rage ainihin yawan haifuwa zuwa ƙasa da 1. Wani ɓangare na sarrafa ɓarkewar cutar mai yaduwa shine ƙoƙarin rage ƙarancin annobar, wanda aka sani da rage ƙimar annobar.
Wannan yana rage haɗarin rashin lafiyar kiwon lafiya kuma yana ba da ƙarin lokaci don haɓaka alluran rigakafi da magunguna.
Abubuwan da ba magunguna ba waɗanda za su iya sarrafa barkewar cutar sun haɗa da matakan rigakafin mutum, kamar tsabtace hannu, sanya abin rufe fuska da keɓe kai; matakan al'umma da aka yi niyya don nisantar da jiki kamar rufe makarantu da soke taron jama'a; hulɗar al'umma don ƙarfafa karɓa da shiga cikin irin waɗannan ayyukan; da kuma matakan tsabtace muhalli. An aiwatar da ƙarin tsauraran matakai don hana barkewar cutar a China lokacin da tsananin barkewar cutar ya bayyana, kamar keɓewa da keɓe birane da tsauraran takunkumin balaguro.
Sauran kasashen ma sun dauki matakai da dama da nufin takaita yaduwar kwayar cutar.
Koriya ta Kudu ta fara gudanar da bincike mai yawa da keɓewar gida, da kuma ba da gargaɗi game da motsi na mutanen da ke da cutar.
Singapore ta ba da tallafin kuɗi ga mutanen da ke da cutar da suka keɓe kansu kuma ta ɗora wa waɗanda suka kasa yin hakan manyan tarar kuɗi.
Taiwan ta kara samar da abin rufe fuska da hukunta tarin kayan aikin likita. Misalai ga Burtaniya da Amurka sun nuna cewa akwai manyan kalubale a cikin ragewa (ragewa amma ba hana yaduwar cutar ba) da kuma dakile (juyawa ci gaban cutar).
Manufofin ragewa mafi kyau zasu iya rage buƙatun kula da lafiya ta hanyar 2/3 da mutuwar ta hanyar rabi, amma har yanzu daruruwan mutane suna mutuwa kuma tsarin kiwon lafiya ya lalace.
Za a iya fifita hanawa, amma ana buƙatar ci gaba da shi har sai kwayar cutar ta bazu cikin yawan mutane (ko har sai an sami allurar rigakafi, idan ta kasance da wuri), in ba haka ba saurin watsawa zai dawo cikin sauri ta hanyar sassaucin matakan.
Matsayi na dogon lokaci don hana annobar yana haifar da farashi na zamantakewa da tattalin arziki.
Babu takamaiman magungunan rigakafin cutar COVID-19 da aka amince da su, amma ana ci gaba da kokarin ci gaba, gami da gwajin magungunan da ake dasu.
Shan magungunan sanyi da ba a ba da takardar sayan magani ba, shan ruwa da hutawa na iya taimakawa rage alamun.
Dangane da tsananin cutar, ana iya buƙatar maganin oxygen, ruwan intravenous da taimakon numfashi.
Yin amfani da steroids na iya haifar da sakamako mafi muni.
Yawancin mahaɗan da aka riga aka amince da su don magance wasu cututtukan kwayar cutar ana bincika su don amfani da su don magance COVID-19.
Wasu "magungunan gargajiya da na gida" na iya sauƙaƙa alamun da SARS-CoV-19 ke haifarwa, a cewar WHO.
WHO ta bayyana haɓaka ƙarfin aiki don bukatun marasa lafiya na COVID-19 da daidaita kiwon lafiya a matsayin mahimmin matakin mayar da martani ga barkewar cutar.
ECDC da ofishin Yankin Turai na WHO sun ba da jagororin don canja wurin albarkatu ga asibitoci da sabis na kula da kiwon lafiya na farko a matakai da yawa, gami da: mai da hankali kan ayyukan dakin gwaje-gwaje kan gwajin COVID-19, soke hanyoyin zaɓaɓɓu a duk lokacin da zai yiwu, warewa da keɓe marasa lafiya da ke da cutar COVID-19, da haɓaka ƙarfin kulawa ta musamman ta hanyar horar da ma'aikata da haɓaka adadin masu ba da iska da gadaje.
Akwai ra'ayoyi da yawa game da inda farkon yanayin (abin da ake kira mai haƙuri ba) ya samo asali.
An gano farkon sanannen cutar ta Novel Coronavirus a Wuhan, Hubei, China a ranar 1 ga Disamba, 2019.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu a hankali.
Wadannan sun fi dacewa da kasuwar sayar da abincin teku ta Hunan, wanda kuma ke sayar da dabbobi masu rai, kuma ra'ayi daya shine kwayar cutar ta fito ne daga daya daga cikin wadannan dabbobi; ko kuma, a wasu kalmomin, asalin dabba ne. An gano wani nau'in cutar nimoniya da ba a san dalilinsa ba a ranar 26 ga Disamba kuma likitan Zhang Jixian ne ya kula da shi a asibitin lardin Hubei, wanda ya sanar da Wuhan Jiangnan CDC a ranar 27 ga Disamba.
A ranar 30 ga Disamba, wata ƙungiyar likitoci a asibitin Wuhan ta gargadi abokan aikinta game da "SARS-like coronavirus".
'Yan sanda sun gargadi likitoci takwas, ciki har da Li Wenliang, kan zargin yada jita - jita, kuma wani likita, I Feng, ya fusata da manyan jami'an sa.
Hukumar Kiwon Lafiyar Birnin Wuhan ta fitar da sanarwar jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
An ba da rahoton adadin cututtukan cutar nimoniya da ba a sani ba ga hukumomin kiwon lafiya a Wuhan, wanda ya haifar da fara bincike a farkon watan Janairu. A lokacin farkon barkewar cutar, yawan masu cutar ya ninka kusan kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairun 2020, cutar ta yadu zuwa wasu lardunan China saboda zirga-zirga da kuma Wuhan cibiyar sufuri da babbar hanyar jirgin kasa saboda Sabuwar Shekarar China.
A ranar 20 ga watan Janairu, kasar Sin ta samu sabbin mutane 140 a rana daya, ciki har da mutum biyu a Beijing da daya a Shenzhen.
Bayanan hukuma na baya-bayan nan sun nuna cewa mutane 6,174 sun riga sun sami alamun cutar a ranar 20 ga Janairun 2020. Ya zuwa ranar 26 ga Maris, Amurka ta zarce China da Italiya tare da yawan adadin wadanda aka tabbatar a duniya. Ya zuwa ranar 9 ga Afrilu, 2020, an samu rahotanni sama da miliyan 1.61 a duk duniya; sama da mutane 97,000 sun mutu kuma sama da mutane 364,000 sun warke.
Akwai aƙalla mutum ɗaya a cikin ƙasashe da yankuna kusan 200.
Saboda annobar a Turai, kasashe da dama a yankin Schengen sun takaita motsi kyauta kuma sun kafa iyakokin.
Amsoshin ƙasa sun haɗa da matakan keɓewa kamar keɓewa (wanda aka sani da umarnin zama a gida, umarnin mafaka a wurinka, ko kullewa). Ya zuwa 2 ga Afrilu, kusan mutane miliyan 300 a Amurka ko kusan kashi 90% na yawan jama'a suna cikin wasu nau'ikan kullewa, sama da mutane miliyan 50 a Philippines suna cikin kullewa, kusan mutane miliyan 59 a Afirka ta Kudu suna cikin kullewa, kuma mutane biliyan 1.3 a Indiya suna cikin kullewa.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna cikin wasu nau'ikan kulle-kulle, wanda ya karu zuwa mutane biliyan 2.6 bayan kwana biyu - kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An gano farkon yanayin tabbatar da COVID-19 a Wuhan a ranar 1 ga Disamba, 2019; wani rahoto da ba a tabbatar da shi ba ya nuna cewa farkon lamarin ya faru ne a ranar 17 ga Nuwamba.
Likita Zhang Jixian ya lura da tarin cututtukan cutar nimoniya da ba a san dalilin da ya sa ba a ranar 26 ga Disamba, bayan asibitin sa ya sanar da Wuhan Jiangnan CDC a ranar 27 ga Disamba.
Gwajin farko na kwayoyin halittar samfurin mai haƙuri a ranar 27 ga Disamba, 2019 ya nuna kasancewar kwayar cutar coronavirus mai kama da SARS.
Hukumar Kiwon Lafiyar Birnin Wuhan ta ba da sanarwar jama'a a ranar 31 ga Disamba.
An sanar da WHO a ranar.
Bayan wadannan rahotanni sun zo, 'yan sanda a Wuhan sun gargadi likitoci da su " yada jita-jita " game da barkewar cutar.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara da'awar cewa babu "tabbacin tabbatacce" na yaduwar mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani mummunan yunkuri na dakile yaduwar cutar, wanda babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya kira "yaƙin mutane".
An bayyana shi a matsayin "garkuwa mafi girma a tarihin ɗan adam", an ba da sanarwar yankin kewayewa don hana motsi a Wuhan a ranar 23 ga Janairu, wanda aka faɗaɗa zuwa birane 15 a Hubei, wanda ya shafi mutane miliyan 57 gaba ɗaya.
An haramta amfani da motocin mutane a cikin garin.
An soke bukukuwan sabuwar shekara ta kasar Sin (Janairu 25) a wurare da dama.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, asibitin Hoshensen, wanda aka kammala a cikin kwanaki 10.
Daga baya an gina wani asibiti, asibitin Leichensson, don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka gina, kasar Sin ta kuma mayar da wasu wurare 14 a Wuhan kamar cibiyoyin taro da filayen wasa zuwa asibitoci na wucin gadi.A ranar 26 ga Janairu, gwamnati ta kafa karin matakan dakile barkewar COVID-19, ciki har da bayar da sanarwar kiwon lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
An kuma rufe jami'o'i da makarantu a duk fadin kasar.
Yankunan Hong Kong da Macau sun kafa matakan da yawa, musamman game da makarantu da jami'o'i.
An kafa matakan aiki daga nesa a yankuna da yawa na kasar Sin.
An sanya takunkumin hana zirga -zirga a ciki da wajen Hubei.
An gyara hanyoyin sufuri na jama'a, kuma an rufe gidajen tarihi na dan lokaci a duk fadin kasar Sin.
An sanya takunkumi kan motsi na jama'a a birane da yawa, kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan) sun fuskanci wasu nau'ikan takunkumin waje. Bayan barkewar cutar a watan Maris, hukumomin China sun dauki tsauraran matakai don hana cutar "fitowa" daga wasu ƙasashe.
Alal misali, Beijing ta sanya dokar killace mutane na kwanaki 14 ga duk matafiya na kasa da kasa da ke shiga birnin. A ranar 23 ga watan Maris, mutum daya ne kawai ya kamu da cutar a cikin kwanaki biyar da suka gabata a kasar Sin, a wannan yanayin ta hanyar matafiyi da ke dawowa Guangzhou daga Istanbul.
A ranar 24 ga watan Maris na 2020, Firayim Ministan kasar Sin Li Keqiang ya sanar da cewa an dakatar da yaduwar cututtukan da ake yadawa a cikin gida kuma an shawo kan barkewar cutar a kasar Sin.
An sassauta takunkumin tafiye-tafiye a Hubei banda Wuhan a ranar da ta gabata, watanni biyu bayan an fara dokar kulle. Ma'aikatar Harkokin Wajen China ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shigarwa ga masu biza ko izinin zama daga ranar 28 ga Maris, ba tare da wani bayani na musamman game da lokacin da wannan manufar za ta kare ba.
Wadanda suke son shiga kasar Sin dole ne su nemi biza a ofisoshin jakadancin kasar Sin ko ofisoshin jakadancin kasar.
Gwamnatin kasar Sin ta karfafawa kasuwanci da masana'antu gwiwa su sake budewa a ranar 30 ga watan Maris, tare da samar da fakitin karfafa tattalin arziki ga kasuwanci. Majalisar Jiha ta ayyana ranar makoki da karfe 10:00 na ranar 4 ga watan Afrilu, ta fara da yin shiru na mintuna uku a duk fadin kasar, wanda ya dace da bikin Qingming, kodayake gwamnatin tsakiya ta bukaci iyalai su yi jana'izar kan layi yayin da suke bin ka'idojin nisantar jiki don guje wa sabon barkewar COVID-19.
An tabbatar da yaduwar COVID-19 daga China zuwa Koriya ta Kudu a ranar 20 ga Janairun 2020.
Hukumar kiwon lafiya ta kasar ta rubuta wani karuwa mai ban mamaki a cikin shari'o'in da aka tabbatar a ranar 20 ga Fabrairu, wanda ya danganci taron jama'a a Daigu na wani sabon motsi na addini da aka fi sani da Cocin Shincheonji na Yesu.
Masu bautar Shincheon da suka zo Daegu daga Wuhan sun yi shakkar asalin cutar.
A ranar 22 ga Fabrairu, 1,261 ko kusan 13% na mabiyan Cocin 9,336 sun ba da rahoton bayyanar cututtuka.
A ranar 28 ga watan Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga watan Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan da gwaje -gwaje suka tabbatar da cewa sojoji uku sun kamu da cutar.
Shirye-shiryen jiragen sama ma sun sami matsala kuma saboda haka an canza su. Shirin da Koriya ta Kudu ta gabatar shine mafi girma kuma mafi kyawun tsari a duniya don bincika yawan jama'a don cutar da kuma ware duk waɗanda ke da cutar, gami da ganowa da keɓe waɗanda suka tuntube su.
Hanyoyin tantancewa sun hada da tilasta kai-da-kai na alamun cututtuka ta hanyar sabbin masu shigowa na duniya ta hanyar aikace-aikacen wayar hannu, saurin gwaji don kwayar cutar tare da sakamakon da ke samuwa a washegari, da haɓaka ƙarfin gwaji don gwada mutane 20,000 kowace rana.
Ana ganin shirin Koriya ta Kudu a matsayin nasara wajen shawo kan barkewar cutar duk da cewa ba a killace dukkan biranen ba. Da farko dai al'ummar Koriya ta Kudu sun rabu biyu kan yadda Shugaba Moon Jae-in ya mayar da martani kan rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun da ke kira da a tsige Moon, suna zargin gwamnatin ta yi mummunan aiki da barkewar cutar, ko kuma sun yaba da yadda ta amsa.
A ranar 23 ga watan Maris, an bayar da rahoton cewa Koriya ta Kudu tana da mafi ƙarancin adadin masu cutar a cikin mako huɗu.
A ranar 29 ga Maris, an sanar da cewa daga ranar 1 ga Afrilu, duk sabbin masu shigowa daga ƙasashen waje za a killace su na makonni biyu.
A cewar rahotannin kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta sami buƙatun taimako na gwaji daga ƙasashe 121 daban -daban.
Iran ta ba da rahoton lamuranta na farko da aka tabbatar da cutar SARS-CoV-2 a Qom a ranar 19 ga Fabrairu, inda mutane biyu suka mutu a ranar, a cewar ma'aikatar lafiya da ilimin likitanci.
Matakan farko da gwamnatin ta sanar sun hada da rufe kide kide da sauran al'adu, wasanni, da sallar Juma'a, da rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ware Riyal tiriliyan biyar don magance cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairun 2020 cewa babu wani shiri na killace yankunan da cutar ta shafa kuma za a killace mutane ne kawai.
An sanar da shirin takaita zirga-zirga tsakanin biranen a watan Maris, kodayake yawan zirga-zirgar ababen hawa ya ci gaba da kasancewa tsakanin biranen kafin sabuwar shekarar Farisa ta Navroz.
Har zuwa ranar 16 ga Maris, 2020, wuraren bautar Shia a Qom sun bude wa mahajjata. A lokacin watan Fabrairu, Iran ta zama cibiyar watsa kwayar cutar bayan China.
A tsakanin da'awar ɓoye girman barkewar cutar a Iran, sama da ƙasashe goma sun gano alaƙar da ke tsakanin shari'arsu da Iran har zuwa 28 ga Fabrairu, wanda ke nuna cewa ƙimar barkewar cutar na iya zama mafi tsanani fiye da shari'o'in 388 da gwamnatin Iran ta yi rikodin har zuwa wannan ranar.
An rufe majalisar dokokin Iran bayan da 23 daga cikin mambobi 290 suka yi gwajin cutar a ranar 3 ga watan Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta kuma bukaci hukumomin kurkukun Iran da su saki masu kare hakkin dan Adam da aka tsare saboda zanga-zangar lumana ba tare da wani sharadi ba, da kuma sakin dukkan fursunonin da suka cancanta.
Ya ce akwai babban hadarin yaduwar cutar a cibiyoyin da aka rufe kamar cibiyoyin killacewa, wadanda kuma ba su da isasshen kulawar likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana guda, mafi yawan adadin da aka rubuta a kasar tun lokacin da barkewar cutar ta fara.
A ranar 17 ga watan Maris, a kalla wasu 'yan siyasa da jami'an gwamnati 12 na yanzu ko kuma na baya sun mutu sakamakon cutar.
A ranar 23 ga watan Maris, Iran tana samun sabbin mutane 50 a kowace awa da kuma mutuwar mutum daya a kowace minti goma sakamakon cutar coronavirus.
A cewar wani jami'in WHO, akwai yiwuwar akwai karin mutane sau biyar a Iran fiye da adadin wadanda ake bayar da rahoton.
An kuma ba da shawarar cewa takunkumin da Amurka ta sanya wa Iran na iya shafar ikon kuɗin ƙasar don amsa barkewar cutar.
Babban Kwamishinan Majalisar Dinkin Duniya don 'yancin dan adam ya bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da yaduwar cutar zuwa Italiya a ranar 31 ga Janairu, lokacin da wasu 'yan yawon bude ido' yan kasar Sin biyu a Rome suka gwada tabbatacce ga SARS-CoV-2.
Lamuran sun fara karuwa cikin sauri, wanda ya sa gwamnatin Italiya ta dakatar da dukkan jiragen da ke zuwa da dawowa daga China da kuma ayyana dokar ta baci.
An gano wasu kungiyoyi marasa dangantaka na COVID-19 a Lombardy, farawa da tabbatar da shari'o'i 16 a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sanarwar sabuwar dokar shari'a don hana barkewar cutar, ta killace mutane sama da 50,000 daga birane daban-daban 11 a arewacin Italiya.
"A yankunan da cutar ta bulla, ba za a ba da izinin shiga da fita ba", in ji Firayim Minista Giuseppe Conte.
A ranar 4 ga watan Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk fadin kasar, saboda mutuwar mutane 100 a Italiya.
Duk manyan wasannin wasanni, gami da wasannin kwallon kafa na Serie A, an shirya su ne ba tare da masu gani ba har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da dukkan wasannin gaba ɗaya na aƙalla wata ɗaya.
A ranar 11 ga watan Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan duk ayyukan kasuwanci ban da manyan kantuna da kantin magani. A ranar 6 ga Maris, Kwalejin Anesthesiology, Analgesia, Resuscitation and Intensive Care (SIAARTI) ta buga shawarwarin ka'idodin likita game da hanyoyin da za a iya amfani da su, na rarrabe marasa lafiya masu tsanani.
A ranar 19 ga Maris, Italiya ta zarce China a duniya a kan yawan mutuwar da ke da alaƙa da cutar coronavirus bayan ta ba da rahoton mutuwar 3,405 daga cutar.
A ranar 22 ga watan Maris, an bayar da rahoton cewa Rasha ta aika da jiragen sama na soja guda tara zuwa Italiya tare da kayan aikin likita.
Zuwa ranar 5 ga Afrilu, Italiya tana da mutane 128,948 da aka tabbatar, 15,887 da suka mutu, da kuma 21,815 da suka warke, tare da yawancin shari'o'in da ke faruwa a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa haɗuwa da yawan tsofaffin mutanen Italiya da rashin iya yin gwajin waɗanda ke da cutar har zuwa wannan lokacin na iya taimakawa ga yawan mutuwar.
Amsar da Burtaniya ta bayar ga kwayar cutar da farko ta fito ne a matsayin mafi sassaucin ra'ayi daga cikin kasashen da cutar ta shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta aiwatar da wani nau'in nisantar zamantakewa ko matakan killacewa a kan 'yan kasarta ba.
A sakamakon haka, gwamnati ta fuskanci suka saboda rashin saurin aiki da kuma saurin amsawa ga damuwar da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da shawarar dakatar da duk balaguron da ba dole ba da kuma hulɗar zamantakewa, yana ba mutane shawarar yin aiki daga gida inda zai yiwu kuma su guji wurare kamar mashaya, gidajen abinci da gidajen wasan kwaikwayo.
A ranar 20 ga watan Maris, gwamnati ta sanar da cewa za a rufe dukkan wuraren nishadi kamar mashaya da dakin motsa jiki da wuri-wuri, kuma ta yi alkawarin biyan ma'aikata har zuwa kashi 80% na albashin su har zuwa iyakar £2,500 a wata don hana rashin aikin yi a cikin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da tsauraran matakan nisantar da jama'a, tare da hana taron mutane sama da biyu da kuma takaita balaguro da ayyukan waje zuwa ayyukan da ake ganin suna da mahimmanci.
Ba kamar matakan da suka gabata ba, 'yan sanda sun sanya takunkumi ta hanyar tara kudi da tarwatsa jama'a.
An ba da umarnin rufe yawancin kasuwancin ban da waɗanda aka ɗauka "mahimmanci", waɗanda suka haɗa da manyan kantuna, kantunan magani, bankuna, shagunan kayan aiki, tashoshin mai da garages.
A ranar 20 ga Janairu, an tabbatar da sanannen shari'ar COVID-19 ta farko a cikin jihar Pacific Northwest ta Washington a cikin wani mutum wanda ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rundunar White House Coronavirus Task Force ne a ranar 29 ga Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya, tare da hana matafiya daga China shiga.
A ranar 28 ga Janairun 2020, Cibiyar Kula da Cututtuka - babbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka - ta sanar da cewa ta samar da kayan gwajin ta.
Duk da haka, Amurka ta yi jinkirin fara gwajin, wanda hakan ya sa fahimtar ainihin yaduwar cutar a lokacin ya zama da wahala.
Gwajin ya katse ta ta hanyar samar da kayan gwaji na kasa da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan gwajin da ba na gwamnati ba (ta malaman makaranta, kamfanoni da asibitoci) a ƙarshen Fabrairu, da kuma ƙuntatawa ga mutane don cancanta don gwaji (wanda ke buƙatar umarnin likita bayan haka) a farkon Maris.
A ranar 27 ga watan Fabrairu, jaridar Washington Post ta ruwaito cewa an yi gwaji kasa da 4,000 a Amurka.
A ranar 13 ga watan Maris, The Atlantic ta ruwaito cewa an yi gwaji kasa da 14,000.
A ranar 22 ga Maris, The Associated Press ta ba da rahoton: "Mutane da yawa da ke da alamomi kuma suna da umarnin likita sun jira na sa'o'i ko kwanaki don gwaji". Gwamna J. Inslee ya ayyana dokar ta baci a Amurka bayan an ba da rahoton mutuwar farko a jihar Washington a ranar 29 ga Fabrairu, wani mataki da sauran jihohi suka bi.
Makarantu a yankin Seattle sun soke azuzuwan a ranar 3 ga Maris kuma a tsakiyar watan Maris, ana rufe makarantu a duk fadin kasar. A ranar 6 ga Maris, 2020, wani rukunin masana ilimin annoba a kwalejin Imperial College London sun shawarci Amurka game da kimanta tasirin sabon coronavirus a kasar.
A wannan ranar ne Shugaba Trump ya rattaba hannu kan Dokar Kula da Shirye-shiryen Cutar Coronavirus da Amsoshi, wanda ya samar da dala biliyan 8.3 a cikin kudaden gaggawa ga hukumomin tarayya don magance barkewar cutar.
Kamfanoni sun sanya takunkumin hana ma'aikata tafiya, soke taro da karfafa ma'aikata su yi aiki daga gida.
An soke wasannin motsa jiki da zaman. A ranar 11 ga Maris, mai tasiri daga ranar 13 ga Maris, Trump ya ba da sanarwar takunkumin hana tafiye-tafiye na kwanaki 30 ga yawancin Turai ban da Burtaniya.
Kashegari, sun faɗaɗa takunkumin zuwa Burtaniya da Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci ta kasa, wanda ya samar da kudaden tarayya don amsawa ga rikicin.
Tun daga ranar 15 ga watan Maris, kamfanoni da dama sun dakatar da aiki ko rage sa'o'i a duk faɗin Amurka don rage yaduwar kwayar cutar.
A ranar 17 ga watan Maris, an tabbatar da annobar a dukkan jihohi 50 da gundumar Columbia. A ranar 23 ga Maris, an bayar da rahoton cewa New York City tana da mutane 10,700 da suka kamu da cutar coronavirus, wanda ya fi adadin mutanen da ke Koriya ta Kudu.
A ranar 25 ga Maris, gwamna ya ce nisantar da jama'a na aiki, yayin da aka rage hasashen ninki biyu daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga watan Maris, New York City ta samu mutum 32,308 da suka kamu da cutar, kuma mutane 672 sun mutu sakamakon cutar. A ranar 26 ga watan Maris, Amurka ta samu karin mutane da suka kamu da cutar coronavirus fiye da kowace kasa a duniya, ciki har da China da Italiya.
Rahotanni a kafafen yada labarai sun ce a ranar 30 ga watan Maris ne shugaban Amurka Trump ya yanke shawarar tsawaita ka'idojin nisantar da mutane har zuwa ranar 30 ga watan Afrilu.
A wannan rana, jirgin ruwan asibiti mai suna USNS Comfort, wanda ke da gadaje kusan 1,000, ya sauka a New York.
A ranar 3 ga Afrilu, Amurka ta sami mutuwar mutane 884 a cikin awanni 24 saboda cutar coronavirus.
A ranar 3 ga watan Afrilu, adadin masu cutar a jihar New York ya zarce 100,000. An soki Fadar White House saboda takaita saƙonni ta hanyar raina barazanar da kuma umarci jami'an kiwon lafiya da masana kimiyya da su daidaita maganganun jama'a da wallafe-wallafe da suka shafi cutar tare da ofishin Mataimakin Shugaban Amurka Mike Pence.
Gabaɗaya zaɓin da Trump ya yi na kula da rikicin ya bambanta da na masu son kai.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayayyaki masu mahimmanci daga China, gami da kayayyakin kiwon lafiya masu mahimmanci.
An yi amfani da nazarin tsarin zirga -zirgar jiragen sama don yin taswira da hasashen yaduwar cutar kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar Janairu 2020.
Bangkok, Hong Kong, Tokyo, da Taipei sun sami yawan fasinjoji daga Wuhan bisa ga bayanan 2018 daga Kungiyar Sufurin Jiragen Sama ta Duniya.
An kuma ba da rahoton cewa Dubai, Sydney da Melbourne sanannun wurare ne ga mutanen da ke tafiya daga Wuhan.
Bali an bayyana ta da mafi karancin iyawa daga cikin biranen 20 da suka fi shahara dangane da shirye-shirye, yayin da biranen Ostiraliya suka kasance mafi iyawa.
Ya ce ba a san abubuwa da yawa game da COVID-19 ba, kuma cewa Ostiraliya za ta ci gaba da ba da fifiko ga kula da kan iyakoki da sadarwa a cikin amsar cutar.
A ranar 21 ga Maris, an ayyana gaggawa ta lafiyar ɗan adam a Ostiraliya.
Saboda tsananin keɓewar sufuri na jama'a a Wuhan da Hubei, ƙasashe da yawa suna shirin kwashe 'yan ƙasa da ma'aikatan diflomasiyya daga yankin, galibi ta hanyar jiragen sama masu haya zuwa ƙasar, wanda hukumomin China suka ba da izini.
Kasashen Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand sune kasashe na farko da suka fara shirin kwashe 'yan kasarsu.
Pakistan ta ce ba za ta fitar da wani dan kasar ta daga kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu, ban da 'yan sanda hudu, wani dan kasar Sin da kuma wani dan kasar Indiya.
'Yan kasar Poland, China, da Indiya sun sauka daga jirgin a Poland, inda jirgin na Brazil ya tashi zuwa Brazil bayan ya tsaya.
'Yan Brazil da suka je Wuhan an killace su a wani sansanin soja kusa da Brasilia.
A wannan ranar, an kwashe 'yan kasar Kanada 215 (daga jirgin farko 176, da kuma jirgin sama na biyu 39 da gwamnatin Amurka ta ba da izini) daga Wuhan zuwa CFB Trenton kuma an killace su na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama mai dauke da 'yan kasar Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Ostiraliya sun kwashe 'yan ƙasa 277 a ranar 3 da 4 ga Fabrairu kuma suka kai su Cibiyar Kula da Tsibirin Kirsimeti, wanda aka sake gina shi a matsayin wurin keɓewa, inda suka zauna na kwanaki 14.
Jirgin saukar da New Zealand ya isa Auckland a ranar 5 ga Fabrairu; an killace fasinjojinsa (ciki har da wasu daga Ostiraliya da yankin Pacific) a wani sansanin jiragen ruwa a Wangaparoa, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa da ke cikin jirgin ruwan Diamond Princess.
A ranar 21 ga Fabrairu, jirgin sama ya sauka a Trenton, Ontario tare da fasinjojin Kanada 129 da aka kwashe daga Diamond Princess.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga Maris, jirgin saman South African Airways wanda gwamnatin Afirka ta Kudu ta ba da izini ya dawo da' yan Afirka ta Kudu 112.
An yi gwajin likita kafin tashi, kuma an bar 'yan Afirka ta Kudu huɗu da ke nuna alamun cutar coronavirus don rage haɗarin.
Sai kawai 'yan Afirka ta Kudu da suka gwada mummunan gwaji aka dawo da su.
Sakamakon gwajin ya bayyana cewa duk 'yan Afirka ta Kudu ba su da cutar, ciki har da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal,' yan sanda da sojoji da ke cikin aikin jin kai, dukansu suna cikin kulawa ta hankali kuma suna cikin keɓewa a The Ranch Resort na tsawon kwanaki 14.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da tallafi ga kasar Sin.
Wasu daliban kasar Sin daga jami'o'in Amurka sun hada kai don taimakawa wajen aika da agaji zuwa sassan kasar Sin da suka kamu da cutar, tare da rahotanni cewa wata kungiya a yankin Chicago ta aika da abin rufe fuska N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu. Kungiyar agajin jin kai ta Direct Relief, a cikin hadin gwiwa tare da FedEx, ta aika da abin rufe fuska 200,000 tare da sauran kayan kariya na sirri, gami da safar hannu da riguna, zuwa asibitin Wuhan Union ta jirgin gaggawa har zuwa ranar 30 ga Janairu.
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da tallafin dala miliyan 100 ga WHO don kare "mutanen da ke cikin haɗari a Afirka da Kudancin Asiya" da kuma ba da kuɗin bincike da ƙoƙarin maganin rigakafi.
Interaction ta ruwaito cewa gwamnatin kasar Sin ta ba da gudummawar masks 200,000 ga Philippines a ranar 6 ga watan Fabrairu, lokacin da Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura tallafin dala miliyan 2.26 ga kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan a Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayayyakin kiwon lafiya sama da tan 13 zuwa Wuhan, Malaysia ta sanar da ba da gudummawar safar hannu na kiwon lafiya miliyan 18 ga China, Jamus ta ba da gudummawar kayayyakin kiwon lafiya daban-daban, gami da kwat da wando 10,000, kuma Amurka ta ba da gudummawar tan 17.8 na kayayyakin kiwon lafiya ga China tare da yin alkawarin dala miliyan 100 na kudi a cikin ƙarin tallafi ga ƙasashen da abin ya shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayayyakin kiwon lafiya da kwararru zuwa Italiya don taimakawa wajen magance barkewar cutar coronavirus.
Dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1, da abin rufe fuska miliyan 6, da kayan kariya 60,000 zuwa Addis Ababa, Habasha don rarraba ta Tarayyar Afirka.
Daga baya sun aika da kayan gwaji 5,000, abin rufe fuska 100,000 da na'urorin numfashi 5 zuwa Panama.
Ma ya kuma ba da gudummawar kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkey, Georgia da Czech Republic sun nuna damuwarsu game da abin rufe fuska da kayan gwaji da aka yi a China.
Misali, Spain ta dawo da kayan gwajin coronavirus 58,000 da aka yi a China tare da daidaito na kashi 30%, yayin da Netherlands ta dawo da abin rufe fuska 600,000 na Sinawa waɗanda ke da lahani.
Belgium ta dawo da abin rufe fuska 100,000 da ba za a iya amfani da su ba, waɗanda aka ɗauka sun fito ne daga China, amma a zahiri sun fito ne daga Colombia.
A gefe guda kuma, an samu tallafin kasar Sin sosai a sassan Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya fara ayyukan agaji na gaggawa ga kasashe masu tasowa.
WHO ta yaba da kokarin da hukumomin kasar Sin ke yi wajen gudanar da yaduwar cutar.
WHO ta yi nuni da bambanci tsakanin barkewar cutar SARS ta 2002-2004, inda aka zargi hukumomin kasar Sin da yin sirri wanda ya kawo cikas ga kokarin hanawa da kuma kawar da cutar, da kuma rikicin yanzu inda gwamnatin tsakiya ta "ba da sabuntawa akai-akai don kauce wa tsoro kafin hutun sabuwar shekara ta Lunar".
A ranar 23 ga Janairu, a mayar da martani ga shawarar da hukumomin tsakiya suka yanke na sanya dokar hana zirga-zirga a Wuhan, wakilin WHO Gauden Gallia ya yi sharhi cewa yayin da "ba a ba da shawarar WHO ba" wannan "alamu ne masu matukar muhimmanci na jajircewar hana barkewar cutar a inda ta fi mayar da hankali" kuma ya kira ta "marasa misali a tarihin kiwon lafiyar jama'a". A ranar 30 ga Janairu, WHO ta ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiyar jama'a ta damuwar kasa da kasa (PHEIC), wanda shine PHEIC na shida tun lokacin da aka fara daukar matakan a lokacin annobar cutar ta 2009 ta alade.
Darakta Janar na WHO Tedros Adhanom ya ce PHEIC ya haifar da "hadarin yaduwar duniya, musamman a ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi ba tare da ingantaccen tsarin kiwon lafiya ba.
A cikin martani game da aiwatar da takunkumin tafiye-tafiye, Tedros ya ce "babu wani dalili da zai sa a dauki irin waɗannan matakan da za su tsoma baki ba tare da bukatar tafiya da kasuwanci ba" kuma "WHO ba ta ba da shawarar ƙuntata kasuwanci da motsi ba".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya da su bada gudummawar dala miliyan 675 don shirye-shiryen dabaru a kasashe masu karamin karfi, suna mai cewa akwai bukatar taimakawa kasashen da "ba su da tsarin da za su gano mutanen da ke dauke da kwayar cutar, ko da kuwa tana kan tasowa".
Tedros ya ci gaba da bayyanawa a cikin wasu kalamai, cewa "mu ne kawai muke da ƙarfi kamar yadda mafi rauni ke da ƙarfi" kuma ya bukaci al'ummar duniya da su "sa hannun jari a yau ko kuma su biya ƙarin daga baya". A ranar 11 ga Fabrairu, WHO ta kafa COVID-19 a matsayin sunan cutar a wani taron manema labarai.
A wannan rana, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya Antonio Guterres ya amince da "ba da ƙarfin tsarin Majalisar Dinkin Duniya gaba ɗaya a cikin martani".
Sakamakon haka an kunna wata kungiyar kula da rikicin Majalisar Dinkin Duniya, wacce ta daidaita martani na Majalisar Dinkin Duniya, wanda a cewar WHO zai basu damar "mai da hankali kan martanin kiwon lafiya, yayin da sauran hukumomin za su iya amfani da kwarewarsu wajen magance manyan matsalolin zamantakewa, tattalin arziki da ci gaban barkewar cutar".
A ranar 14 ga Fabrairu, an tura wata ƙungiyar haɗin gwiwa ta WHO tare da China don ziyarci yankin don ba da ƙwarewar ƙasa ga ƙwararrun ƙasashen duniya da WHO a China, don taimakawa cikin gudanar da gida da kuma shirya bita da tarurruka tare da manyan cibiyoyin ƙasa don tantance "tsananin cutar da kamuwa da cuta" da kuma kimanta "tasirin ayyukan amsawa a matakin lardi da na gunduma, gami da birane da yankuna.
A sakamakon barkewar cutar a Iran, WHO ta tura wata kungiyar hadin gwiwa don tantance lamarin. A ranar 28 ga watan Fabrairu, hukumomin WHO sun ce za a tantance barazanar coronavirus a duniya daga "mai girma" zuwa "mai matukar girma", wanda shine matakin tsaro da kimanta hadarin.
Mike Ryan, darektan zartarwa na shirin gaggawa na lafiya na WHO, ya yi gargadin a cikin wata sanarwa cewa "wannan gwaji ne na gaskiya ga kowace gwamnati a duniya: lokaci ya yi da za a farka.
Wannan kwayar cutar na iya zuwa kuma kuna buƙatar kasancewa cikin shiri, "yana mai cewa matakan da suka dace na iya taimakawa duniya ta guje wa" mafi munin yanayin ta. "
Ryan ya ci gaba da cewa, alkaluman da ake da su yanzu ba su tabbatar da hukumomin kiwon lafiya na duniya da su ayyana cutar a duniya ba, yana mai cewa irin wannan sanarwar za ta nuna cewa "muna da tabbacin cewa kowane dan Adam a duniya zai kamu da cutar".
A ranar 11 ga Maris, WHO ta ayyana barkewar cutar coronavirus a matsayin annoba.
Darakta Janar ya ce WHO "ta damu matuka da yadda ake samun yaduwar cutar da kuma yadda ake fama da cutar da kuma yadda ake fama da rashin aiki". WHO ta fuskanci babban suka a matsayin rashin kula da cutar, gami da jinkirin ayyana dokar ta baci ta kiwon lafiya da kuma rarraba kwayar cutar a matsayin annoba.
Wannan takarda ta kunshi takardar neman murabus din Darakta Janar na WHO, Tedros Adhanom, wanda mutane 733,000 suka sanya hannu a ranar 6 ga watan Afrilu.
A ranar 26 ga Maris, 2020, wasu kwararru na Majalisar Dinkin Duniya kan kare hakkin dan adam sun yi kira ga girmama hakkin kowa a lokacin annobar COVID-19.
Kwararru sun ce kowa ya cancanci sa baki don ceton rayuka kuma wannan alhakin na gwamnati ne.
Kungiyar ta jaddada cewa bai kamata a taba amfani da karancin albarkatu ko inshorar lafiya a matsayin hujjar nuna bambanci ga wata kungiya ba.
Masana sun jaddada cewa kowane mutum, gami da nakasassu, kungiyoyin 'yan tsiraru, tsofaffi, mutanen da aka kwashe cikin gida, marasa gida, mutanen da ke rayuwa cikin mawuyacin hali, mutanen da ke zaune a cikin keɓewa, da kuma 'yan gudun hijira da sauran kungiyoyin da ba a kayyade ba waɗanda ke buƙatar taimakon gwamnati, suna da' yancin samun lafiya.
Kungiyoyin gwamnati na kasa da kasa suna magance tasirin tattalin arziki da zamantakewar rikicin COVID-19.
Kungiyar hadin gwiwar tattalin arziki da ci gaba ta kafa wani dandamali don samar da cikakken bayani da kuma ra'ayoyi da shawarwari kan martani kan manufofi a cikin kasashen duniya.
Daga manufofi zuwa ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa magance tasirin hanawa da ƙuntatawa kan balaguro, cibiyar dijital ta ƙunshi mai bin diddigin manufofin ƙasa, kuma an yi niyyar taimaka wa ƙasashe su koya daga juna da sauƙaƙe daidaitaccen martani na duniya ga ƙalubalen coronavirus.
Ministan Amurka, Michael Gove, ministan Burtaniya don ofishin majalisar ministoci, da kuma Eduardo Bolsonaro, dan Shugaba Jair Bolsonaro na Brazil, sun soki gwamnatin China kan yadda ta magance cutar da ta fara a lardin Hubei na kasar Sin.
An kori wasu gwamnoni na jam'iyyar kwaminis ta kasar Sin (CPC) a lardin domin magance kokarin killace mutane a tsakiyar kasar Sin, a matsayin wata alama ta rashin jin dadin yadda kungiyar siyasa ta mayar da martani ga barkewar cutar a yankunan.
Wasu masu sharhi sun yi imanin cewa wannan matakin na nufin kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a kan barkewar cutar coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijian sun yi watsi da yarda da cutar coronavirus da ta barke a Wuhan, suna goyon bayan jita-jita game da COVID-19 da ta samo asali daga Amurka ko Italiya.
Gwamnatin Amurka ta Donald Trump ta kira coronavirus "Cinema Virus" ko "Wuhan Virus", tana mai cewa "Tsarin sarrafawa na China ya juya kwayar cutar zuwa annobar duniya yanzu", wanda wasu masu sukar suka yi la'akari da wariyar launin fata da "rashin nasarar gwamnatinsa wajen dakile cutar".
Jaridar Daily Beast ta samu wata wayar gwamnatin Amurka da ke nuna cewa an yi amfani da hanyoyin sadarwa a cikin Majalisar Tsaro ta kasa, tare da ambaton dabarun cewa "dukkanin China ne".
Ana tambayarmu mu yi kokarin isar da wannan sakon ta kowace hanya, gami da taron manema labarai da kuma halartar talabijin. "Kasuwanci kamar Politico, Foreign Policy da Bloomberg sun yi iƙirarin cewa ƙoƙarin da China ke yi na aika taimako ga ƙasashen da ke fama da cutar wani ɓangare ne na farfaganda don haɓaka tasirin duniya.
Shugaban harkokin wajen EU, Josep Borrell ya yi gargadin cewa akwai "wani bangare na siyasa wanda ya hada da gwagwarmayar samun tasiri ta hanyar sauyawa da kuma 'siyasa ta sassaucin ra'ayi.'"
Borel ya kuma ce "China tana ta kai hare-hare ta hanyar isar da sakon cewa, sabanin Amurka, ita abokiyar zama ce mai alhakin abin dogaro".
Kasar Sin ta kuma yi kira ga Amurka da ta dage takunkumin da ta kakaba wa kasashen Syria, Venezuela da Iran, wadanda ake zargin sun ba da tallafi ga kasashen biyu.
An toshe kyautar Jack Ma na masks 100,000 zuwa Cuba a ranar 3 ga Afrilu ta takunkumin Amurka.
Har ila yau, an zargi hukumomin Amurka da karkatar da tallafin da ake nufi ga wasu ƙasashe zuwa ƙasarsu.
Kuma an sami rikice-rikice game da abin rufe fuska tsakanin wasu ƙasashe, kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Bugu da kari, Turkiyya ta kwace daruruwan na'urorin numfashi da aka yi niyyar zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kan Tarayyar Turai da Italiya da ke fama da cutar coronavirus.
"China ce kawai ta mayar da martani ta hanyar biyu", in ji jakadan Italiya a EU Maurizio Massari.
Hakika, wannan ba alama ce mai kyau ba ta haɗin kan Turai".
A ranar 22 ga watan Maris, bayan kiran waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya wa sojojin Rasha tura likitocin soja, motocin kashe kwayoyin cuta na musamman da sauran kayan aikin likita.
Jaridar La Stampa ta Italiya ta kawo wani "manyan majiyoyin siyasa" da ba a bayyana sunansu ba, inda ta ce kashi 80 cikin dari na taimakon da Rasha ta bayar "ba shi da amfani ko kuma ba shi da amfani ga Italiya".
Majiyar ta zargi Rasha da yin "ciniki da diplomasiyya".
Shugaban Lombardy Attilio Fontana da Ministan Harkokin Wajen Italiya Luigi Di Meo sun musanta rahotannin kafofin watsa labarai kuma sun nuna godiyarsu.
Rasha ta aika da kayan agaji na likita zuwa Amurka a cikin jirgin sama.
"Yin tayin taimako ga abokan aikin Amurka, [Putin] ya yi imanin cewa yayin da masana'antun Amurka na kayan aikin likita da kayan aiki suka kara samarwa, za su iya biyan diyya idan ya cancanta", in ji kakakin Kremlin Dmitry Peskov.
A cikin Jamus, Poland, da Baltic States, za a gudanar da atisayen soja na NATO "Defender 2020", mafi girma daga cikin atisayen yakin NATO tun bayan ƙarshen Cold War.
Sakatari Janar na Yakin Nukiliya Kate Hudson ya soki atisayen Defender 2020: "A cikin rikicin kiwon lafiyar jama'a na yanzu, ba wai kawai yana barazanar rayuwar sojojin Amurka da na kasashen Turai da dama ba, har ma da mazauna kasashen da ke halartar taron inda suke aiki". Gwamnatin Iran ta yi fama da cutar sosai, tare da kusan 'yan majalisa biyu da suka kamu da cutar da kuma wasu mutane goma sha biyar na yanzu ko tsoffin siyasa.
Shugaban Iran Hassan Rouhani ya rubuta wata wasika ta jama'a ga shugabannin duniya a ranar 14 ga Maris, 2020 don neman taimako, yana mai cewa kasarsa na fama da fama da barkewar cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin Amurka kan Iran. Wannan barkewar cutar ta haifar da kira ga Amurka da ta bi ka'idodin zamantakewar da suka dace da sauran ƙasashe masu arziki, gami da kula da lafiyar duniya, kula da yara na duniya, izinin dangi da aka biya, da kuma babban matakin kuɗi don lafiyar jama'a.
Masu sharhi kan siyasa sun yi hasashen cewa hakan na iya shafar yiwuwar sake zaben Donald Trump a zaben shugaban kasa na 2020.
Koriya ta Kudu ta soki "ƙoƙarin keɓewa da rashin aiki" na Japan lokacin da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a keɓe shi har tsawon makonni biyu a wuraren da gwamnati ta tsara.
Da farko dai al'ummar Koriya ta Kudu sun rabu biyu a kan yadda Shugaba Moon Jae - in ya amsa wannan rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun daukaka kara da ke kira da a tsige Moon, suna zargin gwamnati ta yi mummunan aiki da barkewar cutar, ko kuma sun yaba da yadda ta amsa. Cutar ta sa kasashen da ke fama da cutar suka zartar da dokar ta baci.
Wasu masu sharhi sun nuna damuwa cewa hakan na iya taimaka wa gwamnatoci su karfafa ikon su.
A Hungary, majalisarta ta kada kuri'ar da ta ba Firayim Minista, Viktor Orban damar yin mulki har abada, ta dakatar da majalisa da kuma zabukan, tare da hukunta mutanen da aka samu suna magance cutar da rikicin da kuma yada labaran karya game da gwamnati.
An zargi barkewar cutar coronavirus da misalai da yawa na karancin kayayyaki, wanda ya samo asali ne daga amfani da kayan aiki don yaƙar barkewar cutar a duniya, sayayya da ke haifar da tsoro, da katsewar masana'antu da ayyukan dabaru.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da karancin magunguna da na'urorin kiwon lafiya saboda karuwar bukatar mabukaci da katsewar masu samar da kayayyaki.
Hakanan an sami yanayin cin kasuwa mai saurin tsoro a yankuna da yawa, wanda ya haifar da karancin kayan masarufi kamar abinci, takarda na bayan gida, da ruwan kwalba daga kan ɗakunan ajiya, wanda ya rage wadata.
Musamman masana'antar fasaha an yi musu gargadi game da jinkirin jigilar kayan lantarki.
A cewar Darakta Janar na WHO, Tedros Adhanom, bukatar kayan kariya na mutum ya karu sau 100.
Wannan buƙatar ta haifar da ƙaruwar farashin al'ada har sau ashirin kuma tare da jinkirin samar da kayayyakin kiwon lafiya na watanni huɗu zuwa shida.
Wannan ya haifar da karancin kayan kariya na mutum a duk duniya, wanda WHO ta yi gargadin cewa zai sanya ma'aikatan lafiya cikin hadari.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu siyayya na Daigu don sayar da kayayyakin Australiya a China.
Wannan aikin ya haifar da karancin abinci na jarirai a wasu manyan kantunan sayar da kayayyaki kuma daga baya gwamnatin Australiya ta haramta shi. Duk da yawan yaduwar cututtukan COVID-19 da kuma yawan bukatar kayayyakin abinci a arewacin Italiya da Wuhan, yankuna biyu suna fama da karancin abinci.
Matakan da China da Italiya suka dauka kan tara kayayyaki da kuma cinikin kayayyaki masu mahimmanci sun yi nasara, wanda ya hana karancin abinci da ake tsammani a Turai da kuma Arewacin Amurka.
Arewacin Italiya ba ta ga raguwar yawan kayan aikin gona ba, amma farashin na iya ƙaruwa, a cewar wakilan masana'antu.
Har ila yau, an ga shelves na abinci a cikin birnin Wuhan na ɗan lokaci, yayin da jami'an gwamnatin China suka saki kayan abinci don tabbatar da wadataccen abinci ga yawan jama'a.
Irin wannan dokar a Italiya ta tilasta masu samar da abinci su ajiye kayayyaki don irin wannan gaggawa.
An ji rauni ga tattalin arzikin duniya a China: A cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, matakan gwamnati don dakile yaduwar kwayar cutar, da kuma faduwar tallace-tallace da kashi 20.5%, sun yi mummunan tasiri ga tattalin arzikin kasar Sin a farkon watanni biyu na 2020.
Tunda babban yankin kasar Sin babban cibiyar tattalin arziki da masana'antu ne, an yi la'akari da barkewar cutar a matsayin babbar barazana ga tattalin arzikin duniya.
Agathe Demaris na Economist Intelligence Unit ya yi hasashen cewa kasuwanni za su ci gaba da yin tashin hankali har sai an sami cikakken hoto game da yiwuwar sakamakon.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa tasirin tattalin arzikin cutar a kan ci gaban duniya zai iya zama mafi girma fiye da barkewar SARS na 2002-2004.
Wani ƙwararre daga Jami'ar Washington a St. Louis ya kiyasta tasirin dala biliyan 300+ akan sarkar samar da kayayyaki ta duniya wanda zai iya wucewa shekaru biyu.
Kungiyar Kasashen Fetur da ke Fitar da Man Fetur (OPEC) ta ce ta "sake" bayan faduwar farashin mai saboda karancin bukatar da ake samu daga kasar Sin.
Kasuwannin hannayen jari na duniya sun fadi a ranar 24 ga watan Fabrairu saboda karuwar adadin masu kamuwa da COVID-19 a wajen kasar Sin.
A ranar 27 ga Fabrairu, saboda damuwa game da barkewar cutar coronavirus, alamun hannun jari daban -daban na Amurka, gami da NASDAQ-100, S&amp;P 500 Index, Dow Jones Industrial Average sun ba da rahoton faɗuwar da ta fi sauri tun 2008, tare da Dow ya faɗi maki 1,191, wanda shine mafi girman faɗuwa a rana ɗaya tun rikicin kuɗi na 200708.
Dukkanin alamun uku sun fadi sama da kashi 10 cikin dari a wannan makon.
A ranar 28 ga watan Fabrairu, Scope Ratings GmbH ta tabbatar da kimantawa na darajar darajar kasar Sin, amma ta ci gaba da kasancewa da mummunan fata.
Hannun jari sun sake faduwa bisa tsoron coronavirus, tare da faɗuwa mafi girma a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa za a iya samun koma bayan tattalin arziki.
Masanin tattalin arziki Mohammed Al-Erian ya yaba da matakan gaggawa na bankunan tsakiya da jihohi a kan lokaci.
Babban bankuna suna amsawa da sauri fiye da yadda suka amsawa da rikicin kudi na 2008.
Yawon shakatawa yana daya daga cikin yankunan da suka fi fama da matsalar saboda takunkumin zirga-zirga, rufe wuraren taruwar jama'a da abubuwan jan hankali, da shawarwarin gwamnatoci na hana duk wani tafiya a duk duniya.
Sakamakon haka, kamfanonin jiragen sama da dama ciki har da British Airways, China Eastern Airlines da Quantus sun soke zirga-zirgar jiragen sama saboda karancin bukatar, yayin da kamfanin jirgin sama na yankin na Burtaniya Flybe ya fadi.
Wannan shi ne mafi girman tasirin da aka taɓa gani a masana'antar jirgin ruwa.
An kuma rufe tashoshin jirgin kasa da tashoshin jiragen ruwa da yawa.
Lokaci na annobar ya yi daidai da lokacin babban lokacin tafiye -tafiye, Chunyuan, wanda ke da alaƙa da hutun Sabuwar Shekarar Sin.
Gwamnatocin ƙasa da na yanki sun soke manyan abubuwan da za su faru, gami da bikin Sabuwar Shekara ta shekara, tare da kamfanoni masu zaman kansu suna rufe shagunan su da abubuwan jan hankali na yawon buɗe ido kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe abubuwan da ake yi na sabuwar shekara da kuma wuraren shakatawa da yawa a Beijing don hana taron jama'a, gami da haramtaccen birni da bikin bikin haikalin gargajiya.
A larduna 24, da kananan hukumomi da yankuna 31 na kasar Sin, hukumomi sun tsawaita hutun sabuwar shekara zuwa ranar 10 ga watan Fabrairu, tare da umarnin kada a sake bude yawancin wuraren aiki har zuwa wannan ranar.
Waɗannan yankuna sun kasance suna wakiltar kashi 80% na GDP na ƙasar da kashi 90% na fitarwa.
Hong Kong ta kara yawan cututtukan da ke tattare da cututtuka zuwa mafi girma kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris kuma ta soke bikin sabuwar shekara. An yi tasiri a duniya, tare da rage sa'o'in shago ko rufe su na ɗan lokaci.
Ziyarar da masu sayarwa a Turai da Latin Amurka suka yi ta ragu da kashi 40 cikin dari.
Masu sayarwa a Arewacin Amurka da Gabas ta Tsakiya sun ga raguwar kashi 50-60 cikin dari.
Yawan masu tafiya zuwa cibiyoyin cin kasuwa ya ragu da kashi 33 zuwa 43 cikin dari a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da cibiyoyin kasuwanci a duk duniya sun ɗauki ƙarin matakai, kamar haɓaka tsafta, sanya na'urorin daukar hotan takardu don bincika zafin jiki na masu siyayya, da soke tarurruka. A cewar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, ƙididdigar cutar ta haifar da koma bayan tattalin arziki na iya barin mutane miliyan 14 zuwa 22 a Latin Amurka cikin matsanancin talauci waɗanda ba za su kasance a cikin yanayin ba tare da annobar ba.
A watan Janairu da Fabrairun 2020, a lokacin da annobar ta yi kamari a Wuhan, kusan mutane miliyan 5 a China sun rasa ayyukansu.
Yawancin kusan 'yan gudun hijira miliyan 300 na kasar Sin sun makale a gida a lardunan cikin gida ko kuma a lardin Hubei. A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Barkewar cutar coronavirus na iya yanke ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi na iya faduwa da kashi 32%, a cewar kimantawar Babban Bankin Tarayya na St. Louis. Miliyoyin ma'aikata masu ƙaura sun rasa aikin yi (waɗanda ake biyan su ta hanyar albashi na yau da kullun) saboda kulle-kulle a Indiya. Binciken Cibiyar Angus Reed ya gano cewa kashi 44% na iyalai a Kanada sun sami wani nau'in rashin aikin yi.
A lokacin rabin rabin watan Maris, ma'aikata Faransanci miliyan 4 sun nemi taimakon rashin aikin yi na wucin gadi kuma ma'aikata Burtaniya miliyan 1 sun nemi shirin bashi na duniya. Kusan kamfanoni miliyan rabin a Jamus sun tura ma'aikatansu zuwa gajerun shirye-shiryen aiki na gajeren lokaci da gwamnati ke tallafawa da ake kira Kurzarbet.
Faransa da Burtaniya sun karɓi tsarin biyan diyya na gajeren lokaci na Jamus.
Sashen fasahar wasan kwaikwayo da al'adun gargajiya sun yi matukar tasiri ta hanyar cutar, wanda ya shafi ayyukan kungiyoyi a duniya da kuma mutane masu aiki da kuma masu zaman kansu.
Kungiyoyin da ke cikin fannin fasaha da al'adu sun yi ƙoƙari su ci gaba da aikinsu (wanda galibi ana tallafawa jama'a) don ba da damar al'adun al'adu ga al'umma, don kiyaye lafiyar ma'aikatansu da jama'a da kuma tallafawa masu fasaha a duk inda zai yiwu.
Har zuwa watan Maris na 2020, a duk duniya da kuma a wasu yankuna, gidajen tarihi, dakunan karatu, wuraren baje kolin, da sauran cibiyoyin al'adu sun kasance a rufe har abada tare da soke ko jinkirta baje kolin su, tarurruka da zanga-zangarsu.
A cikin martani, an yi ƙoƙari sosai don samar da madadin sabis ta hanyar dandamali na dijital. Wani sakamako na kwanan nan na cutar da ke ƙaruwa cikin sauri shine soke ayyukan addini, manyan tarurrukan wasanni, da sauran tarurrukan zamantakewa, kamar bukukuwan kiɗa da taron fasaha da nunin salon.
Har ila yau, masana'antar fim din ta fuskanci rikice-rikice. Vatican ta sanar da cewa an soke abubuwan da ake yi a mako mai tsarki a Rome, wanda ke faruwa a makon karshe na zaman makoki na Kirista na Lent.
Yawancin bishops-areas sun ba da shawarar cewa tsofaffin Kiristoci su zauna a gida maimakon halartar taro a ranar Lahadi; wasu majami'u sun ba da sabis na coci ta hanyar rediyo, watsa shirye-shiryen kan layi ko talabijin, yayin da wasu ke ba da bautar drive-in.
Tare da Roman Katolika bishopric na Rome rufe majami'unsu da wuraren addu'a da kuma kwashe mahajjata Kirista daga St. Peter's Square, sauran kungiyoyin addinai sun soke ayyuka a majami'u, masallatai, gidajen ibada, wuraren ibada da gurudwarori kuma sun takaita taron jama'a.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da annobar ta shafa kuma daga baya an rufe wuraren ibada, yayin da Saudiyya ta hana baƙi masu zuwa baƙi da kuma 'yan ƙasa shiga wuraren tsarki a Makka da Madina.
Cutar ta haifar da babbar matsala ga kalandar wasanni a duk duniya tun bayan yakin duniya na biyu.
Yawancin manyan wasannin wasanni, gami da gasar zakarun Turai ta 2019/20 UEFA Champions League, gasar Premier ta 2019-20, UEFA Euro 2020, kakar NBA ta 2019-20, da kakar NHL ta 2019-20, an soke ko an dage su.
Fashewar ta katse shirin wasannin Olympics na bazara na 2020, wanda aka tsara za a fara a ƙarshen Yuli; Kwamitin Olympics na Duniya ya ba da sanarwar ranar 24 ga Maris cewa za a sake shirya taron "zuwa ranar da ta wuce 2020 amma ba ta wuce bazara ta 2021 ba".
Wannan ya sa yawancin masu caca suna karɓar hanyar kan layi, tare da rahotanni da yawa game da ƙimar sabon sa hannu a shafukan caca na kan layi. Har ila yau, masana'antar nishaɗi ta sami matsala, tare da ƙungiyoyin kiɗa daban-daban da ke dakatar ko soke kide kide.
Wasu manyan gidajen wasan kwaikwayo kamar Broadway sun dakatar da duk wasan kwaikwayon.
Wasu masu fasaha sun bincika hanyoyin ci gaba da raba aiki akan Intanet a matsayin madadin wasan kwaikwayon raye-raye na gargajiya, kamar yin raye-raye na raye-raye ko "taron" na yanar gizo don nunawa, rarrabawa da tallata aikin masu fasaha.
A kan layi, yawancin abubuwan da ke tattare da kwayar cutar coronavirus sun bazu a cikin yanayin ban dariya da damuwa a cikin rashin tabbas.
Tun bayan barkewar COVID-19, an lura da karuwar nuna bambanci, wariyar launin fata da wariyar launin fata ga mutanen asalin Sinawa da na Gabashin Asiya, da kuma mutanen da ke da wuraren zafi a Turai, Amurka da sauran ƙasashe.
Akwai abubuwa da yawa na tsoro, shakka da ƙiyayya a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amurka da yankin Asiya-Fasifik.
A cikin rahotanni tun daga watan Fabrairu (lokacin da yawancin shari'o'in har yanzu ke iyakance ga China), an rubuta ra'ayoyin wariyar launin fata na Sinawa a cikin ƙungiyoyi daban-daban a duniya game da cancantar karɓar kwayar cutar ko samun hukunci mai kyau.
Wasu kasashen Afirka ma sun ga karuwar adawa da kasar Sin.
Yawancin mazauna Wuhan da Hubei sun ba da rahoton nuna bambanci bisa asalin yankin su.
Akwai taimako ta yanar gizo da ta layi ga Sinawa da mutanen da ke yankunan da cutar ta shafa.
Bayan ci gaban barkewar cutar a cikin sabbin kasashe masu zafi, mutanen Italiya, kasar farko a Turai da ta fara fuskantar mummunar barkewar COVID-19, na iya fuskantar shakku da kuma jin tsoron baƙi. 'Yan ƙasa daga ƙasashe ciki har da Malaysia, New Zealand, Singapore da Koriya ta Kudu sun fara sanya hannu kan takardun neman izinin hana Sinawa shiga ƙasashensu a ƙoƙarin hana cutar.
A Japan, hashtag #ChineseDontComeToJapan ya zama sananne a shafin Twitter.
Wasu 'yan Asiya a Burtaniya da Amurka da Sinawa sun ba da rahoton karuwar cin zarafin wariyar launin fata da kuma hare-hare.
Shugaban Amurka Donald Trump ya fuskanci suka saboda ya kira coronavirus "Cinema Virus", wanda masu sukar suka yi la'akari da wariyar launin fata da kuma adawa da kasar Sin.
Masu zanga-zanga a Ukraine sun kai hari kan bas din da ke dauke da 'yan gudun hijirar Ukrainian da kasashen waje daga Wuhan zuwa Novi Sad.
Dalibai daga arewa maso gabashin Indiya, wanda ke da iyaka da China, da ke karatu a manyan biranen Indiya, an ce sun fuskanci tsangwama da ke da alaƙa da barkewar cutar coronavirus.
Shugaban jam'iyyar BJP na jihar a West Bengal, Dilip Ghosh, ya ce Sinawa sun lalata yanayi kuma "don haka Allah ya rama musu".
Daga baya ofishin jakadancin kasar Sin da ke Kolkata ya yi tir da wannan bayanin, yana mai cewa "ba daidai ba ne". A China, cutar ta kara tsananta wa 'yan kasar Sin da wariyar launin fata da ke nunawa baƙi baƙi, tare da bayyana baƙi a matsayin "sharar waje" da kuma "ƙaddamar da" manufa.
Yawancin jaridu da ke da paywalls sun cire su don wani ɓangare ko duka ɗaukar hoto na coronavirus.
Yawancin masu wallafa kimiyya sun samar da takardun kimiyya game da barkewar cutar tare da samun damar buɗewa.
Wasu masana kimiyya sun zaɓi raba sakamakon su da sauri akan sabobin da aka riga aka buga kamar bioRxiv.
Cutar cututtuka mai tasowa - cuta mai tasowa ta cutar cuta, sau da yawa: sabon abu a cikin yanayin cutar ko hanyar watsawa
Duniya da cututtuka - Bayani game da Duniya da Cutar Cutar
Jerin cututtuka da cututtuka na duniya - Jerin mutanen da suka mutu saboda cututtuka masu yaduwa
Cinikin namun daji da cututtuka masu yaduwa - haɗarin kiwon lafiya da ke tattare da cinikin namun daji na waje
Binciken dakin gwaje -gwaje don cutar coronavirus ta numfashi ta 2019 (COVID-19) da kuma SARS-CoV-2 mai alaƙa da ita ya haɗa da hanyoyin gano kasancewar ƙwayoyin cuta da kuma gano ƙwayoyin cuta da aka samar don amsawa ga kamuwa da cuta.
Ana tabbatar da kasancewar ƙwayoyin cuta a cikin samfuran ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na kwayar SARS-CoV-2 kawai.
Ana amfani dashi don tabbatar da cututtukan da suka faru kwanan nan ko masu aiki.
Ana iya amfani da ganowar rigakafi (hematobiology) don duka ganewar asali da kuma lura da mutane.
Gwaje - gwaje na rigakafi suna nuna yawan mutanen da suka kamu da cutar, gami da waɗanda alamun su ke da laushi sosai don bayar da rahoto ko waɗanda ba su da alamun cutar.
Sakamakon wannan binciken zai iya tabbatar da ainihin mutuwar cutar da kuma yawan rigakafin mutane.
Saboda iyakancewar bincike, babu wata ƙasa da ke da ingantattun bayanai game da yaduwar cutar a cikin mutane har zuwa Maris 2020.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawanta kuma akwai bambance-bambance sosai a cikin yawan waɗanda aka gwada a ƙasashe daban-daban.
Wannan bambancin yana da yuwuwar tasiri sosai ga yawan mutuwar da aka ruwaito, wanda a wasu ƙasashe ana iya hasashen ya fi hakan.
Ta amfani da ainihin lokacin juyawa na juyawa na polymerase chain reaction (rRT-PCR), ana iya bincika samfurori na numfashi da aka samo ta hanyoyi daban -daban, gami da samfurin hanci ko mucous.
Yawancin lokaci ana samun sakamako a cikin awanni biyu zuwa kwana biyu.
RT - PCR gwajin da aka yi tare da bakin makogwaro yana da tabbaci a farkon makon cutar.
Daga baya kwayar cutar na iya ɓacewa daga makogwaro, yayin da ta ci gaba da ƙaruwa a cikin huhu.
Ga mutanen da suka kamu da cutar da aka bincika a mako na biyu, a madadin haka ana iya ɗaukar samfurin daga cikin iska ta hanyar bututun tsotsa ko amfani da kayan da aka fitar a cikin tari (fuka - fuki).
An haɓaka ɗayan farkon gwajin PCR ta amfani da ainihin lokacin juyawa na juyawa polymerase chain reaction (rRT-PCR) a cikin Janairu 2020 a Charité a Berlin, kuma ya zama tushen rarraba kayan aiki 250,000 ta Hukumar Lafiya ta Duniya (WHO).
Kasar Ingila ma ta samar da kayan gwaji har zuwa 23 ga Janairun 2020. Kamfanin KogenBiotech na Koriya ta Kudu ya samar da kayan gwaji na PCR-based SARS-CoV-2 (Powercheck coronavirus) a ranar 28 ga Janairun 2020.
Yana gano kwayoyin halittar "E" da dukkan beta coronaviruses ke rabawa, musamman kuma kwayoyin halittar RdRp da aka samo a SARS-CoV-2. A China, BGI Group na daya daga cikin kamfanoni na farko da suka sami amincewar gaggawa don amfani da kayan gwajin SARS-CoV-2 na PCR daga Hukumar Kula da Kayayyakin Kiwon Lafiyar Kasa ta kasar Sin. A Amurka, Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) suna rarraba kwamitin bincikar cutar 2019-novel coronavirus (2019-nCoV) na RT-PCR na ainihi ga dakunan gwaje-gwajen kiwon lafiyar jama'a ta hanyar albarkatun kasa da kasa.
Tsoffin juzu'in kayan aikin gwajin sun sami sakamako mara kyau saboda magungunan da ba daidai ba a cikin ɗayan gwaje -gwajen kwayoyin halitta guda uku, kuma sun haifar da matsala a cikin gwaji a CDC a Atlanta; hakan ya haifar da ƙarancin samfuran da aka sarrafa cikin nasara a cikin Fabrairu 2020 gaba ɗaya zuwa ƙasa da samfuran 100 a rana.
Gwaje -gwajen da ke amfani da abubuwa biyu ba a amince da su ba har zuwa 28 ga Fabrairun 2020 kuma ba a ba da izinin dakunan gwaje -gwaje na Jiha da na gida su fara gwaji ba.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin izinin Amfani da Gaggawa. Labs na kasuwanci na Amurka sun fara gwajin a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da wadatar COVID-19 a duk faɗin ƙasar bisa ga RT-PCR.
Quest Diagnostics ta samar da gwajin COVID-19 a duk faɗin ƙasar har zuwa 9 ga Maris, 2020.
Babu iyakancewar adadi da aka sanar; dole ne a tattara da sarrafa samfuran daidai da bukatun CDC.
A Rasha, Cibiyar Nazarin Virology da Biotechnology ta VECTOR ce ta haɓaka da kuma samar da gwajin COVID-19.
A ranar 11 ga Fabrairun 2020, Hukumar Kula da Kiwon Lafiya ta Tarayya ta yi rajistar wannan gwajin. A ranar 12 ga Maris, 2020, Mayo Clinic ta ba da rahoton cewa ta haɓaka gwajin don gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami izini daga FDA don gwajin da za a iya yi a cikin manyan girma a cikin awanni 3.5, wanda hakan ya haifar da yiwuwar yin gwaji kusan 4,128 a cikin awanni 24 daga na'ura ɗaya.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don yin gwaji a kan tsarin m2000 na Abbott; FDA ta ba da irin wannan izinin ga Hologic, LabCorp, da ThermoFisher Scientific.
Hakazalika a ranar 21 ga Maris, 2020, Sheffield ta sami EUA daga FDA don binciken da ke ɗaukar kimanin mintuna 45.
FDA ta amince da gwajin da ke amfani da fasahar haɓaka nucleic acid na isothermal maimakon PCR.
Tun da ba ya buƙatar jerin zafin jiki mai canzawa, wannan hanyar na iya ba da sakamako mai kyau a cikin ƙasa da minti biyar da sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kusan 18,000 irin waɗannan injunan a cikin Amurka kuma Abbott yana son haɓaka masana'antu don gwaji 50,000 a kowace rana. Ana haɓaka kayan gwaji a Taiwan wanda ke amfani da rigakafin monoclonal wanda ke ɗaure da ƙwayoyin nucleocapsid (N) na Novel Coronavirus, tare da fatan cewa wannan gwajin mai saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin sa
Wani bita na wallafe -wallafen Maris 2020 ya kammala cewa radiography na kirji yana da ƙarancin mahimmancin asibiti a farkon matakin, yayin da sakamakon CT [kimita na tomography] na iya kasancewa kafin bayyanar cututtuka.
Abubuwan da ke da alaƙa da CT sun haɗa da haɗin gwiwar Multilobular Ground - Glass tare da rarrabawa na gefe, asymmetrical da backward.
Yayin da cutar ta ci gaba, tasirin subplural, hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan ha hawan hawan hawan ha hawan hawan hawan ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha ha
Nazarin da ya kwatanta PCR da CT a Wuhan, tushen asalin annobar ta yanzu, ya nuna cewa CT ta fi PCR hankali sosai, duk da cewa ba ta da ƙwarewa, tare da yawancin siffofin hoto na CT suna kama da sauran cututtukan huhu da tsarin cuta.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa kada a yi amfani da CT a matsayin gwaji ko gwajin farko don gano COVID-19.
Wani ɓangare na amsawar rigakafi ga kamuwa da cuta ya ƙunshi samar da rigakafi, gami da IgM da IgG.
Ana iya amfani dasu don gano kamuwa da cuta don tantance rigakafi da farawa a cikin mutane daga kwanaki 7 ko makamancin haka bayan bayyanar cututtuka da kuma lura da mutane. Ana iya gwada gwaje -gwaje a cikin cibiyoyin bincike na tsakiya (CLT) ko ta hanyar gwajin wurin kulawa (PoCT).
Yawancin dakunan gwaje - gwaje masu saurin aiki a cikin dakunan gwaje - gwaje masu yawa za su iya yin waɗannan gwaje - gwaje amma kasancewar su zai dogara da yawan samar da kowane tsarin.
Ana amfani da samfurin jini guda ɗaya don CLT, kodayake ana iya amfani da jerin samfuran don ganin amsawar rigakafi.
Ana samun samfurin jini guda ɗaya don PoCT daga fatar jiki.
Ba a buƙatar matakin farko na cirewa na gwaji daban da hanyoyin PCR. A ranar 26 ga Maris, 2020, FDA ta sanya sunayen raka'a 29 waɗanda ke ba da bayanai ga hukumar idan an buƙata kuma don haka yanzu suna iya rarraba gwajin rigakafin su.
Har zuwa 7 ga Afrilu 2020, FDA ta amince da gwaji guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris 2020, EuroImmun Medical Laboratory Diagnostics & Epitop Diagnostics sun sami amincewar Turai don kayan aikin gwajin su waɗanda zasu iya gano IgG da IgA rigakafi ga kwayar cutar a cikin samfuran jini.
Yana da ikon gwada ɗaruruwan samfurori a cikin fewan awanni kaɗan kuma saboda haka ya fi saurin gwajin PCR na gargajiya na RNA na kwayar cuta.
Ana iya gano rigakafi bayan kwanaki 14 da fara kamuwa da cutar. A farkon watan Afrilu, Burtaniya ta gano cewa babu wani kayan gwajin rigakafin da ta saya da ya isa amfani da shi.
Hong Kong ta tsara shirin da zai ba marasa lafiya da ake zargi damar zama a gida, sashen gaggawa zai samar da bututun samfurin ga mai haƙuri, su yi ta fantsama a ciki kuma su sami sakamakon gwajin a cikin ɗan lokaci. NHS na Burtaniya ta sanar da cewa suna ƙaddamar da shirin don bincika magungunan da ake zargi a gida, wanda ke kawar da haɗarin mai haƙuri ya kamu da wasu idan ya je asibiti ko kuma kashe cutar ambulances da aka yi amfani da su.
Cibiyoyin gwajin motsa jiki sun taimaka wa Koriya ta Kudu ta gudanar da bincike mafi sauri, mafi yawa daga kowace ƙasa.A Jamus, Associationungiyar ofungiyar ofwararrun Likitocin Inshorar Lafiya ta Nationalasa ta ce a ranar 2 ga Maris suna da damar yin bincike kusan 12,000 kowace rana a cikin yanayin asibiti kuma sun gudanar da bincike 10,700 a makon da ya gabata.
Idan likita ne ya ba da umarnin binciken, asibiti zai biya kuɗin.
A cewar shugaban cibiyar Robert Koch, jimlar damar Jamus na gwaji 160,000 ne a kowane mako.
An ba da rajistar tuki a manyan birane har zuwa 19 ga Maris.
Har zuwa 26 ga Maris, 2020, ba a san yawan gwaje -gwajen da aka yi a Jamus ba, saboda sakamakon tabbatacce ne kawai aka ruwaito.
Binciken farko na dakin gwaje-gwaje ya nuna cewa a kalla a total 483,295 samfurori an gwada su har zuwa mako 12/2020, ciki har da mako 12/2020 kuma 33,491 (6.9%) samfurori sun gwada tabbatacce ga SARS-CoV-2. A Isra'ila, masu bincike a asibitin Technion & Rembrandt sun kirkiro da kuma gwada hanyar da za ta iya hada samfurori kuma idan an sami samfurin hadewa mai kyau, za a iya gwada samfurori daga marasa lafiya 64 a lokaci guda. A cikin gaggawa, an fara aiki a ranar 5 ga Fabrairu, 2020 a wani dakin gwaje-gwaje na wucin gadi na mita 2000 da ake kira "Huo-Yan" (Cinese: 火眼, ko "Fire Eye" a Turanci) da BGI ta gina a Wuhan, wanda zai iya sarrafa samfurori sama da 10,000 a rana.
Tare da kula da ginin da wanda ya kafa BGI Wang Jian ya yi da kuma daukar kwanaki 5, samfurin ya nuna cewa idan ba a fara wannan damar ba, adadin masu cutar a Hubei zai zama kashi 47% mafi girma kuma farashin da ya shafi kula da keɓewa zai ninka sau biyu.
An bi dakin gwaje - gwaje na Wuhan da sauri ta hanyar Hu-Yen Labs a Shenzhen, Tianjin, Beijing da Shanghai, a cikin birane 12 a duk faɗin China.
Zuwa 4 ga Maris, 2020, jimlar yawan kwararar yau da kullun ya kai gwaje-gwaje 50,000 a kowace rana. Origami Essay ya fitar da tsarin buɗe tushen da aka samar wanda zai iya gwadawa har zuwa samfurori 1122 na marasa lafiya na COVID19 ta amfani da gwaje-gwaje 93. Ana iya gudanar da waɗannan daidaitaccen tsarin a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar mai sarrafa ruwa na robotic ba.
Kafin Maris, rashi da rashin isasshen adadin reagent sun zama matsala a cikin manyan bincike a cikin EU, UK da US.
Wannan ya sa wasu marubuta su binciki hanyoyin samar da samfurin wanda ya hada da dumama samfuran zuwa 98 °C (208 °F) na tsawon mintuna 5 don sakin kwayoyin halittar RNA don ƙarin gwaji. A ranar 31 ga Maris, an ba da sanarwar cewa UAE yanzu tana gwada yawan jama'arta don coronavirus a kowace mutum fiye da kowace ƙasa, kuma tana kan hanyar haɓaka matakan gwaji don isa ga yawancin jama'a.
Wannan ya faru ne saboda haɗuwa da ikon yin gwajin tuki da siyan dakin gwaje - gwaje mai yawan jama'a daga Group 42 da BGI (wanda ya dogara da "Huo - Yan" dakunan gwaje - gwaje na gaggawa a China).
An gina shi cikin kwanaki 14, dakin gwaje-gwaje yana da ikon yin dubban gwaje-gwaje na RT-PCR a kowace rana kuma shine farkon dakin gwaje-gwaje a duniya da ke aiki a irin wannan babban matakin a wajen China.
An samar da hanyoyi daban-daban na gwaji da ke niyya ga sassa daban-daban na bayanan kwayoyin cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta karɓi kuma ta tura hanyar Jamus don samar da kayan aiki don ƙasashe masu ƙarancin kuɗi da ke da ƙarancin albarkatu don haɓaka kansu.
An buga hanyar Jamus a ranar 17 ga Janairun 2020; yarjejeniyar da Cibiyar Kula da Cututtuka ta Amurka ta samar ba ta samuwa har zuwa 28 ga Janairu, wanda hakan ya jinkirta samun gwajin a Amurka. Akwai matsaloli kan amincin kayan gwajin tsakanin China da Amurka a farkon barkewar cutar kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isassun kayan aikin don biyan buƙatun gwaji da shawarwari daga masana kiwon lafiya ba.
Akasin haka, masana sun bayyana cewa samun gwajin a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar coronavirus.
Gwaninta na gwaji, musamman a dakunan gwaje - gwaje na kamfanoni masu zaman kansu, Gwamnatin Koriya ta Kudu ta haɓaka tsawon shekaru.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta ce kara yawan shirye-shiryen gwaji shine hanya mafi kyau don rage saurin yaduwar cutar COVID-19. Yawan yaduwar kwayar cutar ya haifar da dubban gwaje-gwaje masu yawa a cikin dakunan gwaje-gwaje na Amurka kuma samar da kayan aiki da masu aikin sinadarai ya zama damuwa.
A watan Maris na 2020, China ta ba da rahoton matsalolin daidaito a cikin kayan aikin gwajin ta.
A Amurka, akwai karancin kayan gwajin da CDC ta samar; Gwamnati ta sake kawar da matsalolin da ke hana gwajin masu zaman kansu. Spain ta sayi kayan gwajin daga kamfanin kasar Sin na Shenzhen Bioiji Biotechnology Co., Ltd, amma ta gano cewa sakamakon bai dace ba.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba na iya faruwa ne saboda rashin nasarar tattara samfuran ko amfani da kayan aiki yadda yakamata.
Ma'aikatar ta Spain ta ce za ta cire kayan gwajin da ke nuna kuskure kuma ta maye gurbin su da wasu kayan gwajin da Shenzhen BioEgy ta samar. 80% na kayan gwajin da Jamhuriyar Czech ta saya daga China sun ba da sakamakon kuskure. Slovakia ta sayi kayan gwajin miliyan 1.2 daga China, wanda ba a same su daidai ba.
Firayim Minista Matovič ya ba da shawarar cewa ya kamata a jefa su a cikin Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da "ƙimar kuskure" kuma ba ta yi amfani da su ba.
An samu sakamako mai kyau daga keɓewar mutanen da suka gwada tabbatacce da kuma gano mutanen da suka haɗu da mutanen da ke da SARS-CoV-2 mai tabbatacce.
A wurin mutuwar COVID-19 ta farko a Italiya, masu bincike da ke aiki a garin Vò na Italiya sun gwada kusan mutane 3,400 sau biyu a cikin kusan kwanaki goma.
Kusan rabin mutanen da suka sami sakamako mai kyau ba su da alamun cutar, kuma duk mutanen da aka gano sun keɓe.
An kawar da sabbin cututtukan gaba daya ta hanyar hana zirga -zirgar tafiya a wurin da ake zuwa.
Cutar coronavirus ta 2020 ta fi saurin tafiya a Singapore fiye da sauran ƙasashe masu tasowa ta hanyar gano lamba, ta hanyar hana tafiye-tafiye na cikin gida, dubawa da keɓewa, amma ba tare da matsanancin ƙuntatawa kamar rufe gidajen abinci da wuraren sayar da kayayyaki ba.
An soke abubuwa da yawa, kuma Singapore ta fara ba da shawarar mazauna su zauna a gida daga 28 ga Maris, amma sun sake buɗewa a kan lokaci a ranar 23 ga Maris bayan hutun makaranta.
Wasu ƙasashe da yawa, kamar Iceland da Koriya ta Kudu, suma sun gudanar da annobar ta hanyar gano lamba, ta hanyar hana tafiye-tafiye na cikin gida, ta hanyar dubawa da keɓewa, amma ba ta hanyar kulle-kulle ba.
Nazarin kididdiga ya nuna cewa ƙasashe da ke da ƙarin gwaji fiye da yawan mutuwar suna da ƙananan mutuwar, mai yiwuwa saboda waɗannan ƙasashe sun fi iya gano mutanen da ke da sauƙi ko marasa alamun cutar.
WHO ta ba da shawarar cewa ƙasashe waɗanda ba su da ikon yin gwaji kuma waɗanda ke da ƙarancin ƙwarewar dakunan gwaje-gwaje na ƙasa akan COVID-19 su aika da samfuran COVID-19 biyar na farko da na farko goma don tabbatarwa ga ɗaya daga cikin dakunan gwaje-gwaje 16 na WHO.
Daga cikin dakunan gwaje - gwaje 16, bakwai suna cikin Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amurka, ɗaya kuma a Ostiraliya.
A cikin jadawalin da ke ƙasa, shafi na % of positive in tests yana shafar manufofin gwajin ƙasar.
Idan aka kwatanta da sauran abubuwa, kasar da ke gwada marasa lafiya kawai, za ta sami kashi mafi yawa na gwajin da aka yi wa duk 'yan ƙasa, ko da suna da alamun cutar ko a'a.
Wanke hannu (ko wanke hannu), wanda kuma aka sani da tsabtace hannu, aiki ne na tsabtace hannayenku don kawar da datti, mai, ƙwayoyin cuta ko wasu abubuwa marasa kyau.
Wanke hannuwan hannu da sabulu a wasu "lokaci masu mahimmanci" a cikin rana yana hana yaduwar cututtuka da yawa, misali gudawa da hausa, waɗanda ke yaduwa ta hanyar hanyar bargo.
Mutane na iya kamuwa da cututtukan numfashi kamar mura ko sanyi, misali, idan ba su wanke hannayensu kafin su taɓa idanunsu, hanci ko bakinsu (watau mucous membranes).
Abubuwa biyar masu mahimmanci a rana inda wanke hannu da sabulu ke da mahimmanci sune: kafin da bayan bayan bayan bayan bayan bayan bayan wankewa ko canza yarinyar yarinyar, kafin ciyar da jariri, kafin cin abinci da kuma kafin da bayan shirya abinci ko cin nama, kifi ko kaji.
Idan babu sabulu da ruwa, za a iya wanke hannaye da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu a lokutan da suka biyo baya:
Kafin ka shirya abinci, sa'ad da kake dafa shi da kuma bayan ka dafa.
Kafin ka kula da marar lafiya da kuma bayan ka kula da shi.
Bayan canza diapers ko wanke yaro da ke amfani da bayan gida.
Bayan ka yayyafa hanci, tari ko hancinka.
Bayan taɓa dabba, abincin dabba, ko ƙazamin dabba.
Tsabtace hannu na likita yana nufin ayyukan tsabtace jiki da suka shafi hanyoyin magani.
Wanke hannu kafin bayar da magani ko kulawar likita na iya hana ko rage yaduwar cutar.
Babban manufar wanke hannu shine tsabtace hannayen daga cututtukan cututtuka (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta da zasu iya haifar da cuta) da sunadarai waɗanda zasu iya haifar da lahani ko cuta.
Wannan yana da mahimmanci ga mutanen da ke sarrafa abinci ko aiki a fannin kiwon lafiya, amma kuma muhimmin aiki ne ga talakawa.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, gami da: rage yaduwar mura, coronavirus da sauran cututtukan cututtuka; hana cututtukan cututtukan gudawa; rage kamuwa da cututtukan numfashi;
Kuma rage yawan mutuwar jarirai a gida.
Wani bincike da aka yi a shekarar 2013 ya nuna cewa wanke hannu sosai a cikin yara 'yan kasa da shekaru biyar na iya inganta tsawon su.
A cikin ƙasashe masu tasowa, sauye - sauyen halayya masu sauƙi, kamar fara wanke hannuwan hannu da sabulu, na iya rage yawan mutuwar jarirai da ke da alaƙa da cututtukan numfashi da gudawa.
Wannan aiki mai sauki zai iya rage mutuwar mutane daga cututtuka da kusan kashi 50 cikin dari.
Matakan da ke inganta wanke hannu na iya rage cututtukan gudawa da kusan kashi ɗaya bisa uku, kuma wannan daidai yake da samar da ruwa mai tsafta a yankunan da ke da ƙarancin kuɗi.
Rage kashi 48 cikin dari na cututtukan gudawa na iya danganta da wanke hannu da sabulu. Wanke hannu da sabulu a matsayin halayyar kai tsaye a cikin gidaje, makarantu da al'ummomi a duk duniya shine hanya mafi inganci da arha don hana gudawa da cututtukan cututtukan numfashi (ARI).
Babban ARI, cutar huhu ita ce babbar hanyar mutuwa a cikin yara 'yan kasa da shekaru biyar, tare da kashe kimanin yara miliyan 18 a kowace shekara.
Yara kusan miliyan 35 ne ke mutuwa a kowace shekara saboda zazzaɓi da cutar huhu.
A cewar UNICEF, yin amfani da sabulu da wanke hannu kafin cin abinci da kuma bayan amfani da bayan gida zai iya ceton rayuka fiye da kowane rigakafi ko magani, yana rage yawan mutuwar da ake samu daga zawo da kusan rabi da kuma mutuwar da ke faruwa daga cututtukan numfashi mai tsanani da kashi ɗaya cikin huɗu.
Ana haɗa wanke hannu da sauran matakan tsabtace jiki a matsayin ɓangare na shirye -shiryen ruwa, tsaftacewa da tsaftacewa (WASH).
Wanke hannu yana hana kamuwa da cutar impetigo ta hanyar saduwa ta jiki.
Wani ɗan ƙaramin sakamako mai cutarwa na wanke hannu shine cewa yawan wanke hannu na iya haifar da lalacewar fata saboda bushewar fata.
Wani binciken Danish na 2012 ya gano cewa wanke hannu da yawa na iya haifar da yanayin fata mai laushi da ake kira eczema na hannu ko kuma dermatitis na hannu, wanda ya zama ruwan dare musamman tsakanin ma'aikatan kiwon lafiya.
Ana kuma ganin yawan wanke hannu a matsayin wata alama ta cuta ta OCD.
Akwai lokuta guda biyar masu mahimmanci a rana lokacin da wanke hannu da sabulu yana da mahimmanci don rage yaduwar cutar ta hanyar hanyar bayan gida: bayan amfani da bayan gida (yin fitsari, bayan bayan gida), bayan wanke buttocks na jariri (bayan canza tufafi), kafin ciyar da jariri, kafin cin abinci da kuma kafin / bayan shirya abinci ko cin nama, kifi, ko kaji.
Sauran lokutan da ya kamata a yi amfani da fasahar wanke hannu don hana yaduwar cutar sune: kafin da bayan kula da cizon ko rauni; bayan yin fitsari, tari ko yayyafa hanci; bayan taɓa ƙazamar dabba ko sarrafa dabbobi; da kuma bayan taɓa shara.
A kasashe da dama, yawan wanke hannu da sabulu ya ragu.
Wani bincike da aka yi a kan wanke hannu a cikin kasashe 54 a shekarar 2015 ya gano cewa a matsakaita kashi 38.7% na iyalai sun yi amfani da sabulu wajen wanke hannu. Wani bincike da aka yi a shekarar 2014 ya nuna cewa Saudiyya tana da kashi 97 cikin dari; Amurka tana da matsakaici da kashi 77 cikin dari; kuma China tana da mafi karancin kashi 23 cikin dari.
"Shirin Kula da Kiwon Lafiya na Bukatar" wanda Ma'aikatar Ilimi ta aiwatar a Philippines misali ne na babban matakin aiki don inganta lafiyar yara da iliminsu.
Babban shirin na kasa ya hada da tsabtace hakora da fluoride a kullum, wanke hannuwan hannu da sabulu, maganin kwari sau biyu a shekara.
An kuma yi nasarar aiwatar da shi a Indonesia.
Za a iya cire ƙwayoyin cuta daga fata ta hanyar haɗa sabulu ko kayan wanki da ruwa.
Babban aikin sabulu da kayan wanki shine rage shinge a cikin bayani, da kuma kara narkewa.
Ruwa kadai shine mai tsabtace fata mara kyau saboda kitse da furotin, waɗanda sune abubuwan da ke cikin ƙasa na ƙasa, ba sa narkewa cikin ruwa.
Duk da haka, isasshen ruwa yana taimakawa wajen tsabtace.
Saboda maimaita amfani, sabulu mai ƙarfi na iya ƙunsar ƙwayoyin cuta da suka rage daga amfani da baya.
Wasu nazarin da suka kalli canja wurin kwayoyin cuta daga sabulu mai gurbataccen abu sun kammala cewa ba za a iya canzawa ba saboda an wanke kwayoyin cuta da kumfa.
Duk da haka, a cewar CDC, "sabulu tare da maganin da ke da kayan aiki wanda ke sa ruwa ya sauko a kan dabino ba tare da taɓa hannayen ba ya fi kyau".
An ba da babbar mahimmanci ga sabulu na antibacterial don jama'a masu kula da lafiya.
Zuwa yau, babu wata hujja da ke nuna cewa amfani da maganin kashe kwayoyin cuta ko maganin kashe kwayoyin cuta yana haifar da kwayoyin cuta masu jurewa a yanayi.
Koyaya, sabulu na antibacterial suna ƙunshe da wakilai na yau da kullun kamar trichlose, wanda ke da jerin nau'ikan ƙwayoyin cuta masu ƙarancin ƙwayoyin cuta.
Don haka, koda kuwa sabulu na antibacterial ba zai haifar da nau'in maganin rigakafi ba, ba zai iya zama mai tasiri kamar yadda ake tallata shi ba.
Baya ga abubuwan da ke ba da danshi da kare fata, ƙwararrun ƙirar na iya ƙunsar acid a matsayin mai daidaita pH (acetic acid, ascorbic acid, lactic acid), benzoic acid mai aiki da ƙwayoyin cuta da sauran masu haɓaka fata (aloe vera, bitamin, menthol, tsire-tsire masu tsire-tsire). Wani bincike mai zurfi daga Jami'ar Oregon School of Public Health ya nuna cewa sabulu mai tsabta, trichloroquine, yana da tasiri kamar sabulu mai amfani da maganin ƙwayoyin cuta na masu amfani da su.
Ruwan zafi mai kyau don wanke hannu ba shi da zafi sosai don kashe ƙwayoyin cuta.
Kwayoyin cuta suna girma cikin sauri a zafin jiki (37 ° C).
Koyaya, ruwan sabulu mai zafi yafi tasiri fiye da ruwan sanyi, sabulu don cire ƙura da ƙwayoyin cuta da ke ƙunshe da man natural.
Koyaya, akasin shahararren imani, nazarin kimiyya ya nuna cewa amfani da ruwan zafi ba shi da tasiri kan rage adadin ƙwayoyin cuta a hannaye.
Mai tsabtace hannu ko mai tsabtace hannu shine mai tsabtace hannu tare da tushen ruwa.
A ƙarshen shekarun 1990s da farkon karni na 21, masu tsabtace hannu marasa ruwa na ruwa (wanda aka fi sani da rubs na hannu, rubs na hannu ko masu tsabtace hannu) sun fara samun karbuwa.
Yawancin waɗannan suna dogara ne akan isopropyl barasa ko ethanol, waɗanda aka tsara tare da carbomer (polymer na acrylic acid) a cikin gel a cikin mai kara kuzari, ko glycerin a cikin ruwa ko kumfa kamar moisturizer, don sauƙin amfani da rage tasirin bushewar barasa.
Haɗin hydrogen-peroxide yana ƙara haɓaka aikin rigakafin ƙwayoyin cuta. Sanitizers na hannu masu amfani da giya 60 zuwa 95% suna da ingancin kashe ƙwayoyin cuta.
Alcohol rub sanitizers suna kashe kwayoyin cuta, kwayoyin cuta masu jurewa da magunguna (MRSA da VRE), tarin fuka da wasu ƙwayoyin cuta (gami da HIV, herpes, RSV, rhinovirus, vaccinia, mura da hepatitis) da kuma ƙwayoyin cuta.
Alcohol rub sanitizers dauke da kashi 70% na barasa, suna kashe kwayoyin 99.97% bayan dakika 30 na amfani (ƙarancin 3.5 log, daidai da raguwar decibel 35) kuma suna kashe kwayoyin 99.99% zuwa 99.999% bayan minti 1 na amfani (ƙarancin 4 zuwa 5 log).
Sanitizers na hannu masu amfani da giya kusan ba su da tasiri ga nau'in kwayar cutar norovirus (ko Norwalk) wanda shine mafi yawan sanadin cututtukan gastrointestinal. Ya kamata a yi amfani da isasshen mai tsabtace hannu ko ruwan sha don rufe duka hannuwan biyu ko kuma rufe su gaba ɗaya.
Ana shafawa gaba da baya na hannaye biyu da tsakiyar da yatsun yatsunsu na kusan dakika 30, har sai ruwan, kumfa ko gel ya bushe.
Dole ne a wanke yatsun hannu sosai ta hanyar shafawa a cikin dabino biyu. Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ba da shawarar wanke hannu maimakon rubs na tsabtace hannu, musamman idan hannayen suna da datti.
Ana amfani da waɗannan magungunan don sauƙaƙe amfani da su da kuma saurin kashe ƙwayoyin cuta; duk da haka, bai kamata a yi amfani da su azaman maye gurbin wanke hannu ba idan sabulu da ruwa ba su da shi.
Amfani da tsabtace hannu na giya sau da yawa na iya haifar da bushewar fata sai dai idan an haɗa man shafawa da / ko moisturizer na fata a cikin tsari.
Za a iya rage ko kawar da tasirin bushewar giya ta hanyar hada glycerin da / ko wasu lubricants a cikin tsari.
A cikin gwajin asibiti, maganin wanke hannu mai dauke da barasa wanda ke dauke da man shafawa ya rage yawan zafin jiki da bushewar fata idan aka kwatanta da sabulu ko kayan shafawa.
Abun da ke haifar da rashin lafiyar haɗuwa da giya ko abubuwan da ke cikin rubs na hannu suna da cututtukan fata, haɗuwa da cututtukan urticaria ko kuma rashin lafiyan.
Ƙananan yanayin da ke haifar da cututtukan fata na haɗuwa da sabulu da ruwa ya zama abin sha'awa.
Duk da ingancinsu, masu aikin ruwa ba sa tsabtace kwayoyin halitta da hannu, amma kawai suna kashe su.
Wannan shine dalilin da ya sa masu tsabtace hannu ba su da tasiri kamar sabulu da ruwa wajen hana yaduwar ƙwayoyin cuta, saboda ƙwayoyin cuta har yanzu suna kan hannu.
Ingancin tsabtace hannu mara giya ya dogara sosai da kayan aiki da tsari, kuma a tarihi sun kasance masu ƙarancin tasiri fiye da barasa da rubs na giya.
Kwanan nan, sabanin barasa, wanda aka nuna yana rage tasiri bayan amfani da shi sau da yawa saboda yiwuwar mummunan halayen fata, an nuna cewa abubuwan da ke amfani da benzalkonium chloride suna da ci gaba da haɓaka aikin antimicrobial bayan amfani.
Mutane da yawa a cikin ƙananan al'ummomi ba za su iya sayen sabulu ba kuma suna amfani da toka ko ƙasa a maimakon haka.
Ash ko ƙasa na iya zama mafi tasiri fiye da ruwa kadai, amma ba su da tasiri fiye da sabulu.
Damuwa ita ce idan ƙasa ko toka ta gurɓata da ƙwayoyin cuta, zai iya ƙara yaduwar cutar maimakon rage ta.
Kamar sabulu, toka ma wakili ne mai kashe ƙwayoyin cuta saboda yana samar da bayani mai ƙanshi idan ya haɗu da ruwa.
WHO ta ba da shawarar ash ko yashi a matsayin madadin sabulu idan sabulu bai samu ba.
Daidaitaccen hanyar wanke hannu da Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar don hana yaduwar cutar ta ƙunshi waɗannan matakan:
Ka wanke hannayenka da ruwan zafi ko ruwan sanyi.
Ana ba da shawarar ruwan da ke gudana saboda kwantena masu ruwa mai tsafta na iya gurɓata, kodayake ba komai yawan zafin ruwan.
Ka sanya sabulu mai kyau a hannunka, ciki har da bayan hannayenka, tsakanin yatsunsu da ƙarƙashin ƙusoshinka.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma nazarin ya nuna cewa mutane suna wanke hannayensu sosai idan sun yi amfani da sabulu maimakon ruwa kawai.
Ka shafa don akalla dakika 20.
Rubbing yana haifar da abrasion, wanda ke taimakawa wajen kawar da ƙwayoyin cuta daga fata, kuma rubbing na dogon lokaci yana fitar da ƙwayoyin cuta da yawa.
Ka wanke sosai a ƙarƙashin ruwa mai gudu.
Wankewa a cikin kwandon ruwa zai iya sake gurɓata hannaye.
Ka bushe da tawul mai tsabta ko ka bar iska ta bushe.
Ruwa da rigar hannaye suna sake gurɓatawa cikin sauƙi. Yankunan da aka fi watsi da su sune yatsun hannu, wuyan hannu, tsakanin yatsunsu da ƙarƙashin ƙusa.
Na'urori masu ƙyalli da kuma goge ƙusa na iya ba da mafaka ga ƙwayoyin cuta.
Ana ba da shawarar lotion mai danshi sau da yawa don hana hannaye bushewa; bushewar fata na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin kamuwa da cuta.
A cikin ƙasashe masu tasowa inda babu ruwan famfo da / ko sabulu, idan ya cancanta, za a iya yin zaɓuɓɓuka masu rahusa don sauƙaƙe wanke hannu, misali, zuba ruwa daga kwanon rufi ko kwanon rufi tare da ramuka masu dacewa da / ko amfani da toka. A cikin yanayin iyakancewar samar da ruwa (kamar makaranta ko yankunan karkara a ƙasashe masu tasowa), akwai hanyoyin kiyaye ruwa, kamar "tippy-tap" da sauran zaɓuɓɓuka masu rahusa.
Tippy - tap wata fasaha ce mai sauƙi wacce ke amfani da lever mai aiki da ƙafa, don ɗora ruwa kaɗan a kan hannaye da kuma sabulu.
Drying hannu yadda yakamata wani bangare ne na aikin tsabtace hannu, amma akwai wasu rikice -rikice kan mafi ingancin bushewa a wuraren wanka na jama'a.
Yawancin bincike sun nuna cewa tawul ɗin takarda suna ba da tsabtace jiki fiye da na lantarki na lantarki da aka samo a cikin ɗakunan wanka da yawa.
A shekara ta 2008, an gudanar da wani bincike da Jami'ar Westminster, London, ta yi, wanda masana'antar takarda ta bayar da tallafi a taron kolin Turai, wanda ya yi niyyar kwatanta matakan tsabtace jiki da takarda takarda, masu bushewa da iska mai zafi da masu bushewa da iska.
Bayan wanke hannu da bushewa da busassun iska mai zafi, yawan ƙwayoyin cuta ya karu da kashi 194% a kan yatsun yatsunsu da 254% a kan dabino.
Drying tare da jet-air dryer ya kara yawan kwayoyin cuta a matsakaicin kashi 42% a kan yatsun yatsunsu da 15% a kan dabino.
Bayan wanke hannu da bushewa da tawul ɗin takarda, jimlar ƙwayoyin cuta sun ragu da kashi 76% a kan matasan yatsunsu da kashi 77% a kan dabino. Masana kimiyya sun kuma gudanar da gwaje -gwaje don tabbatar da ko kowane nau'in bushewa yana haifar da yiwuwar gurɓata sauran masu amfani da bayan gida da kuma yanayin bayan gida.
Jet-air dryer, wanda ke fitar da iska daga cikin na'urar a cikin saurin saurin 180 m/s (650 km/h; 400 mph), ya iya busa ƙwayoyin cuta daga hannaye da na'urar kuma mai yiwuwa ya gurɓata sauran masu amfani da bayan gida da kuma yanayin bayan gida har zuwa mita 2.
Amfani da na'urar busar hannu mai iska mai zafi ya yada ƙwayoyin cuta zuwa mita 0. 25 daga na'urar busar.
Takardar tawul din ba ta nuna wani muhimmin yaduwar kwayoyin cuta ba. A shekara ta 2005, wani binciken da TÜV Produkt und Umwelt ya yi, ya kimanta hanyoyin bushewa hannaye daban-daban.
An lura da canje -canje masu zuwa a ƙididdigar ƙwayoyin cuta bayan bushe hannaye:
Akwai masana'antun bushewa da yawa, kuma an kwatanta bushewar hannu da bushewa da tawul ɗin takarda.
Wanke hannu da tsabtace hannu yana da zaɓi yayin tafiya idan babu sabulu da ruwa.
Sanitizer na hannu mai shan giya ya kamata ya ƙunshi aƙalla kashi 60% na giya.
Wanke hannu na likita ya zama tilas ne tun da daɗewa bayan likitan Hungary Ignaz Semmelweis ya gano ingancinsa wajen hana cututtuka a cikin yanayin asibiti (a cikin 1846).
Akwai na'urorin lantarki da ke ba da ra'ayoyi don tunatar da ma'aikatan asibiti game da wanke hannayensu idan sun manta.
Wani bincike ya nuna cewa amfani da su ya rage yawan kamuwa da cutar.
Ana wanke hannaye a cikin magani na aƙalla dakika 15, tare da yin kumfa ta amfani da sabulu da ruwa ko gel mai dacewa da shafa kowane ɓangaren hannaye.
Dole ne yatsun hannu biyu su kasance tare da juna.
Idan akwai datti a ƙarƙashin ƙusa, za a iya amfani da goga mai gashi mai ƙarfi don cire shi.
Tun da ƙwayoyin cuta na iya rayuwa a cikin ruwa a kan hannaye, yana da mahimmanci a wanke su sosai kuma a goge su da tawul mai tsabta.
Bayan bushewa, dole ne a yi amfani da tawul na takarda don rufe ruwa (kuma buɗe duk wani ƙofar fitarwa idan ya cancanta).
Wannan yana hana hannaye sake gurɓata daga waɗannan farfajiyoyi.
A cikin tsarin kiwon lafiya, wanke hannu yana nufin kawar da ƙwayoyin cuta ("kwayoyin cuta") da hana su watsawa.
Rahoton jaridar New England Journal of Medicine ya nuna cewa rashin wanke hannu ya kasance a matakan da ba za a iya karɓa ba a yawancin wuraren kiwon lafiya, inda yawancin likitoci da ma'aikatan jinya ke mantawa da wanke hannayensu a kai a kai kafin su taɓa marasa lafiya, wanda ke haifar da yaduwar ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da sauran hanyoyin sauki na iya rage yawan kamuwa da cutar da ke tattare da jini da ke da alaƙa da catheter da kashi 66 cikin ɗari.
Hakanan ana iya samun jagororin takaddun hannu na tsabtace hannu da wannan ƙungiyar ke bayarwa akan gidan yanar gizon ta don tsokaci ga jama'a.
An yi wani bita mai dacewa da Whitby da sauransu.
Idan ana buƙatar nuna bin ƙa'idodi, kayan aikin kasuwanci na iya auna da tabbatar da tsabtace hannu.
Hukumar Lafiya ta Duniya ta tsara "lokatai biyar" don wanke hannu:
Bayan ya zo cikin jini / ruwa na jiki
kafin aikin kashe kwayoyin cuta, da kuma
Bayan kula da mai haƙuri. Ƙara sunadarai masu guba a cikin sabulu ("magungunan magani" ko "antibacterial" sabulu) yana ba da damar kashewa ga mai wanke hannu.
Don 'rubbing' hannayenka don yaduwar tiyata, yana da mahimmanci a sami bututun da za a iya kunnawa da rufewa ba tare da taɓa hannayen ba, wasu chlorhexidine ko iodine wash, tawul ɗin da ba a kashewa don bushe hannayen bayan wanka, da kuma goga mai tsabta don tsabtace rubber da kuma wani kayan aikin tsabtace tsabta don tsabtace ƙusa.
Dole ne a cire dukan kayan ado.
Wannan aikin yawanci yana buƙatar wanke hannu da gwiwoyi har zuwa gwiwar hannu na mintina 2-6.
Ba a buƙatar shafawa na dogon lokaci (minti 10).
Lokacin wankewa, ya kamata a hana ruwa daga wuyan hannu ya koma hannaye.
Bayan an gama wanke hannu, ana bushe hannaye da masana'anta mai kashe kwayoyin cuta kuma ana sanya rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko amfani da maganin kashe ƙwayoyin cuta kafin da bayan kula da mara lafiya.
Don kula da kamuwa da cutar staph a asibitoci, an gano cewa mafi girman fa'idar tsabtace hannu ya zo daga 20% na wankewa kafin, kuma kaɗan daga cikin ƙarin fa'idodin da aka samu lokacin da aka ƙara yawan tsabtace hannu sama da 35%.
Wanke hannu da sabulu mai tsabta ya ninka sau uku na yaduwar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututut
Amma sabulu da ruwa sun fi tasiri fiye da rubs na hannu na barasa don rage kwayar cutar H1N1 da cutar ta Clostridium difficile daga hannaye. Matakan don inganta tsabtace hannu a cikin tsarin kiwon lafiya na iya haɗawa da ilimantar da ma'aikata kan wanke hannu, ƙara wadatar rubs na hannu na barasa, da tunatarwa na rubutu da na magana ga ma'aikata.
Ana buƙatar ƙarin bincike kan waɗanne daga cikin waɗannan hanyoyin ne suka fi tasiri a cikin tsarin kiwon lafiya daban -daban.
A cikin ƙasashe masu tasowa, wanke hannu da sabulu ana ɗaukarsa mai araha, hanya mai mahimmanci don samun lafiya mai kyau, har ma da abinci mai gina jiki.
Koyaya, samun dabi'ar wanke hannu a ko'ina yana da ƙalubale saboda rashin ingantaccen samar da ruwa, sabulu ko wuraren wanke hannu a cikin gidajen mutane, makarantu da wuraren aiki.
Misali, a yawancin yankunan karkara na Afirka, akwai karancin famfunan wanke hannu kusa da kowane gidan wanka na masu zaman kansu ko na jama'a, duk da cewa akwai wasu hanyoyin da ba su da tsada don gina tashoshin wanke hannu.
Koyaya, ƙananan yawan wanke hannu na iya zama saboda halaye da aka sanya maimakon rashin sabulu ko ruwa.
Karfafawa da tallafawa wanke hannu da sabulu na iya tasiri yanke shawara na manufofi, haɓaka wayar da kan jama'a game da fa'idodin wanke hannu da kawo canji a cikin halayen al'umma na dogon lokaci.
Don yin aiki yadda ya kamata, saka idanu da kimantawa suna da mahimmanci.
Binciken tsarin karatu 70 ya gano cewa hanyoyin da ke cikin al'umma suna da tasiri wajen kara wanke hannu a cikin LMICs, yayin da kamfen na yada zamantakewar ba shi da tasiri. Misali na inganta wanke hannu a makarantu shine "Hanyar Tauraruwa Uku" ta UNICEF wacce ke karfafawa makarantu gwiwa su dauki matakai masu sauki, masu sauki don tabbatar da cewa dalibai suna wanke hannayensu da sabulu, tare da sauran bukatun tsafta.
Lokacin da aka cimma mafi ƙarancin ƙa'idodi, makarantu na iya zuwa taurari ɗaya zuwa uku, bi da bi.
Gina tashoshin wanke hannu na iya zama wani ɓangare na kamfen ɗin yada wanke hannu don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya ita ce wani misali na yakin wayar da kan jama'a da nufin kokarin kawo canji a dabi'a. A sakamakon annobar cutar coronavirus ta 2019-20, UNICEF ta karfafa karbar emojis na wanke hannu.
Wasu nazarin sun yi la'akari da tasirin tasirin kuɗin wanke hannu a cikin ƙasashe masu tasowa dangane da rigakafin DALYs.
Koyaya, wani bita ya nuna cewa inganta wanke hannu da sabulu ya fi sauran hanyoyin ruwa da tsaftacewa tsada.
Muhimmancin wanke hannu ga lafiyar dan adam - musamman ga mutanen da ke da mawuyacin hali, kamar uwaye da suka haifi jariri ko kuma sojoji da suka ji rauni a asibitoci - an fara gano su ne a tsakiyar karni na 19 ta hanyar masu gabatar da tsabtace hannu biyu: likitan Hungary Ignaz Semmelweis wanda ya yi aiki a Vienna, Austria da Florence Nightingale, Ingilishi wanda shine "mai kafa aikin jinya na zamani".
A lokacin, yawancin mutane sun yi imani cewa kamuwa da cuta ta haifar da ƙanshi mai ƙanshi da ake kira miasma.
A cikin shekarun 1980, barkewar cututtukan abinci da cututtukan da suka shafi kiwon lafiya sun sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka su ƙara haɓaka tsabtace hannu a matsayin muhimmiyar hanyar hana yaduwar kamuwa da cuta.
Cutar mura ta alade a cikin 2009 da cutar COVID-19 a cikin 2020 sun haɓaka wayar da kan mutane a ƙasashe da yawa game da mahimmancin wanke hannu da sabulu don kare kansu daga irin waɗannan cututtukan.
Misali, an rataye allon tallace -tallace da ke nuna "daidaitaccen hanyoyin wanke hannu" a kusa da wankin wanke hannu a wuraren wanka na jama'a da gine -ginen ofis da kuma wuraren wanka na filayen jirgin sama a Jamus.
Furcin nan "wanke hannuwanku" yana nufin cewa ba ku son ku ɗauki hakkin abin da kuka yi ko kuma ku yi abin da ya sa kuka yi hakan.
Wannan ya samo asali ne daga babi na Matta na Littafi Mai Tsarki inda Pontius Bilatus ya ware kansa daga yanke shawarar gicciye Yesu Almasihu, amma ya zama magana tare da amfani da yawa a wasu al'ummomin Ingilishi.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta a cikin ƙoƙari na wanke wani abu mai ban mamaki wanda ya nuna laifin da ta aikata da kuma laifin da ta yi wa mijinta.
An kuma gano cewa mutane suna wanke hannayensu sau da yawa fiye da wasu, bayan tunawa ko yin tunani game da ayyukan lalata, kuma suna ba da fifiko ga kayan aikin wanke hannu.
Bugu da kari, mutanen da aka ba su damar wanke hannayensu bayan irin wannan tunani ba su da damar shiga wasu ayyukan "tsabtace" kamar aikin sa kai.
Addinai suna ba da shawarar wanke hannu don dalilai na tsabta da na alama. Wanke hannu da ruwa ba tare da sabulu ba don wanke hannu wani ɓangare ne na al'ada wanke hannu da aka bayyana a cikin addinai da yawa, gami da Baha'i, Hindu, Tewila da Netilat Yadayim a Yahudanci, Lavo in Kiristanci, da Wazu a Musulunci. Addinai ma suna ba da shawarar wanke hannu musamman don samar da tsafta bayan wasu ayyuka.
Wanke hannu bayan amfani da bayan gida wajibi ne a addinin Hindu, Yahudanci da Musulunci.
Kuma, wanke hannu kafin da bayan kowane abinci ya zama tilas a addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci.
Kula da haɗarin yaduwar kamuwa da COVID-19 a wuraren aiki
Kula da haɗarin yaduwar kamuwa da cutar COVID-19 a wuraren aiki, don hana cutar coronavirus ta 2019 (COVID-19), aikace -aikacen tsarin lafiya da kiwon lafiya ne don sarrafa haɗarin.
Kulawa da haɗarin yaduwar cutar a wuraren aiki ya dogara da wurin aiki da aikin da ake yi, wanda ya dogara da kimanta haɗarin hanyoyin haɗuwa, tsananin cutar a cikin al'umma, da kuma abubuwan haɗarin ma'aikatan da ke da haɗarin kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ke da haɗarin haɗari suna da ƙarancin hulɗa da mutane da sauran abokan aiki, wanda ke ba da shawarar matakan rigakafin kamuwa da cuta na asali, gami da: wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, bin ƙa'idodin numfashi, da tsaftacewa da tsabtace yanayin aiki a kai a kai.
Ayyukan haɗarin haɗari masu matsakaici sune waɗanda ke buƙatar yin hulɗa akai-akai ko kusanci da mutanen da ba a san su ba ko ake zargin suna da kamuwa da COVID-19, amma waɗanda ƙila sun kamu da cutar saboda yaduwar al'umma ko balaguron ƙasa da ƙasa.
Wannan ya hada da ma'aikatan da ke hulɗa da jama'a kamar makarantu, yanayin aiki mai yawan jama'a, da kuma wasu manyan tallace - tallace.
Baya ga matakan rigakafin kamuwa da cuta na asali, matakan kula da haɗari ga wannan rukunin sun haɗa da: sadarwa tare da matattarar iska mai inganci, amfani da masu kare sneezing, da kiyaye kayan kariya na mutum don yanayin idan mutum mai kamuwa da COVID-19 ya fuskanci.
OSHA ta ɗauki ma'aikatan kiwon lafiya da ma'aikatan gidan gawawwaki a matsayin masu haɗarin haɗari mafi girma waɗanda ke haɗuwa da mai kamuwa da COVID-19 ko wanda ake zargi da cutar, kuma wannan haɗarin ya ƙaru zuwa haɗarin haɗari mafi girma idan ma'aikata suka tattara, ko tattara ko sarrafa samfuran da ke haifar da aerosol akan mai kamuwa da COVID-19 ko wanda ake zargi.
Kula da haɗari da suka dace da waɗannan ma'aikatan sun haɗa da sarrafa injiniya kamar ɗakunan sadarwa na matsin lamba da kayan aikin kariya na mutum da suka dace da aiki.
Cutar COVID-19 na iya haifar da tasiri da yawa a cikin wurin aiki.
Ma'aikata na iya yin rashin aiki saboda rashin lafiya, buƙatar kula da wasu, ko tsoron yiwuwar haɗuwa.
Yanayin kasuwanci na iya canzawa dangane da abin da ake buƙata, da kuma hanyoyin da za a samu waɗannan kayayyaki (kamar lokacin ƙarancin buƙata ko siye ta hanyar bayarwa ko sabis na motsi).
A ƙarshe, motsi na kaya daga yankuna masu tasowa da COVID-19 na iya shafar. Shirye-shiryen shirye-shirye da kuma amsawa ga cutar mai yaduwa za a iya amfani da su don jagorantar ayyukan kariya.
Shirye -shiryen suna magance matakan haɗari da ke tattare da wurare daban -daban na aiki da ayyukan aiki, gami da tushen haɗari, abubuwan haɗari da ke tasowa daga gida da tsarin al'umma, da abubuwan haɗari na ma'aikata na mutum kamar tsufa ko yanayin likita na dindindin.
Sun kuma tsara abubuwan da ake buƙata don magance haɗarin da kuma shirye -shiryen gaggawa don yanayin da zai iya tasowa sakamakon barkewar cutar.
Shirye -shiryen shirye -shirye da shirye -shiryen amsawa ga cututtukan cututtuka na iya zama batun shawarwari na ƙasa ko na ƙasa.
Manufofin mayar da martani ga barkewar cutar sun hada da: rage yaduwar cutar tsakanin ma'aikata, kare mutanen da ke da haɗarin kamuwa da cututtukan kiwon lafiya, ci gaba da ayyukan kasuwanci da rage tasirin tasirin tasirin tasirin sauran rukunin yanar gizon su.
Matsayin cutar a cikin al'ummar da ke wurin kasuwancin yana shafar martani da aka ɗauka.
Tsarin sarrafa haɗari tsari ne wanda aka yi amfani dashi sosai don rukuni na sarrafa haɗari bisa ga inganci a cikin lafiyar aiki da lafiya.
Inda ba za a iya kawar da barazanar COVID-19 ba, mafi ingancin sarrafawa shine sarrafa injiniya, sannan sarrafawa na gudanarwa, kuma a ƙarshe kayan aikin kariya na mutum.
Kulawar injiniya ta ƙunshi ware ma'aikata daga haɗarin da ke tattare da aiki ba tare da dogaro da halayyar ma'aikaci ba, kuma wannan na iya zama mafita mafi arha don aiwatarwa.
Kulawa na gudanarwa shine canje -canje a cikin manufofin aiki ko hanyoyin da ke buƙatar aiki daga ma'aikaci ko mai aiki.
Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan
Ma'aikata dole ne a zaɓi duk nau'ikan PPE bisa haɗarin, sanya su yadda ya dace (misali, injin numfashi), saka su akai -akai da kuma yadda yakamata, bincika su akai -akai, kiyaye su da maye gurbinsu kamar yadda ake buƙata, kuma cire su yadda yakamata, tsabtace su da adana su ko kuma zubar da su don guje wa gurɓata.
A cewar Hukumar Kula da Lafiya da Kiwon Lafiya ta Amurka (OSHA), ayyukan da ke da haɗarin haɗari suna da ƙarancin haɗuwa da mutane da sauran abokan aiki.
Matakan rigakafin kamuwa da cuta na asali da aka ba da shawarar ga duk wuraren aiki sun haɗa da: wanke hannuwa akai -akai da kyau, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, samar da ladabi na numfashi wanda ke rufe tari da hancin, samar da kayan ɗamara da shara, shirya juzu'i ko sauye -sauye na yau da kullun idan ya cancanta, hana ma'aikata amfani da kayan aiki da kayan aikin wasu, da tsaftacewa da tsabtace yanayin aiki akai -akai.
Ganowa da kuma ware mutanen da ke da cutarwa a wuraren aiki yana da mahimmanci don kare ma'aikata, abokan ciniki, baƙi da sauransu.
Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta ba da shawarar cewa ma'aikatan da ke da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
A cewar OSHA, ayyukan haɗarin matsakaici sun haɗa da ayyukan da ke buƙatar maimaitawa ko kusanci da mutane a cikin ƙafa shida (1.8 m) waɗanda ba a san su ko kuma ake zargin suna da cutar COVID-19 ba, amma suna iya kamuwa da SARS-CoV-2 saboda yaduwar al'umma a kusa da wurin aiki, ko kuma saboda mutumin ya yi balaguron ƙasa da ƙasa kwanan nan zuwa wurin da ke da yaduwar COVID-19.
Waɗannan sun haɗa da ma'aikatan da ke da hulɗa da jama'a kamar makarantu, yanayin aiki mai yawan jama'a, da wasu tsarin tallace-tallace masu girma. Don wannan da kuma rukunin haɗarin haɗari, sarrafawar injiniya sun haɗa da shigar da matattarar iska mai inganci, haɓaka ƙimar sadarwa, kafa shingen jiki kamar masu tsaron filastik mai haske, da kafa taga-tafiyar-tafiyar don sabis na abokin ciniki. Don wannan da rukunin haɗari, sarrafawar gudanarwa ta ƙunshi ƙarfafa ma'aikata marasa lafiya su zauna a gida, maye gurbin kariya ta fuska da fuska da sadarwar kama-da-wane, samar da kayan aiki na musamman, samar da albarkatu masu tsayi, ba da izinin balaguron da ba dole ba zuwa wuraren da ke da kayan aikin COVID-19 na yau da kullun, samar da shirye-shiryen sadarwa na gaggawa waɗanda ke hana mutane yin amfani da kayan aikin, gami da: samar da kayan aikin aiki masu amfani da kayan aiki masu amfani da kayan aiki don amsawa ga damuwa, samar da sabbin hanyoyin da ake buƙata don samar da kariya ga abokan ciniki, gami da sanya fuska ko fuska a wuraren aiki, rage haɗarin haɗari ko rage haɗarin COVID-19, da kuma samar da horo da kayan aikin mutum da na musamman, da kuma samar da kayan aikin hannu, da kayan aikin hannu, da kayan aikin hannu, da sauran abubuwan da ke iya taimakawa wajen rage haɗarin haɗari.
Ma'aikata a cikin wannan rukunin haɗarin suna buƙatar amfani da injin numfashi a cikin ƙananan lokuta.
Idan wani ya kamu da rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da: nisantar da mara lafiya daga wasu har zuwa ƙafa 6, sanya wani memba na ma'aikatan jirgin don kula da mara lafiya da ba da abin rufe fuska ga mara lafiya ko kuma tambayar mara lafiya ya rufe bakinsa da hanci da nama idan ya tari ko ya yi fitsari.
Ma'aikatan jirgin za su sa safar hannu na likita mai amfani idan suna kula da matafiya mara lafiya ko taɓa ruwa na jiki ko yiwuwar gurɓataccen farfajiyoyi, kuma idan matafiya mara lafiya yana da zazzabi, tari mai ɗorewa, ko wahalar numfashi, ƙila ya kamata ya sa ƙarin kayan kariya na mutum.
Dole ne a zubar da safar hannu da sauran kayan amfani a cikin jakar haɗarin halittu, kuma dole ne a tsabtace da kuma kashe ƙwayoyin cuta daga baya. Don jirgin ruwa na kasuwanci, gami da jiragen ruwa da sauran jiragen fasinja, ana buƙatar jinkirta tafiya idan sun kamu da rashin lafiya a cikin kulawar haɗari da keɓe kai da sanar da cibiyar likitancin jirgin nan da nan idan mutum ya sami zazzabi ko wasu alamomi yayin tafiya a jirgin.
Ainihin, ya kamata a bi sahun likita a cikin ɗakin wanda aka keɓe. Ga makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan gajeren lokaci don tsaftacewa ko kashe ƙwayoyin cuta idan wani mai cutar ya kasance a cikin ginin makaranta ba tare da la'akari da watsawar al'umma ba.
Lokacin da akwai watsawar al'umma mai matsakaici zuwa matsakaici, ana iya aiwatar da dabarun nisantar da jama'a, kamar ziyarar yanki, tarurruka da sauran manyan tarurruka kamar soke abinci a azuzuwan ilimin jiki ko aji ko gidajen abinci, ƙara nesa tsakanin tebur, daidaita lokutan isowa da hutu, iyakance baƙi marasa mahimmanci, da amfani da sararin ofis na kiwon lafiya daban don yara masu alamun mura.
Lokacin da akwai isasshen watsawa a cikin al'ummar yankin, ana iya yin la'akari da hutun makaranta da yawa ban da dabarun nisantar da jama'a. Ga jami'an tilasta yin doka da ke yin ayyukan yau da kullun, CDC ta ɗauki haɗarin kiwon lafiya na gaggawa da ƙasa.
Jami'an tilasta yin doka waɗanda ke da alaƙa da mutanen da aka tabbatar ko waɗanda ake zargi da COVID-19 ana ba da shawarar su bi ƙa'idodin kamar na masu fasahar likitancin gaggawa, gami da kayan kariya na sirri masu dacewa.
Idan akwai kusanci a yayin kamawa, ma'aikata su tsabtace da kashe ƙwayoyin cuta ta amfani da fesa tsabtace gida ko gogewa, kafin sake amfani da bel ɗin aiki da kayan aiki, kuma su bi ƙa'idodin aiki na yau da kullun don ƙonewa da zubar da PPE da aka yi amfani da su da kuma ƙonewa da wanke tufafi.
OSHA ta ɗauki wasu ma'aikatan kiwon lafiya da ma'aikatan gidan gawa kamar suna cikin haɗarin haɗari ko haɗari.
Ayyukan haɗarin haɗari sun haɗa da samar da kiwon lafiya, taimakawa, dakin gwaje-gwaje da ma'aikatan jigilar likita waɗanda ke fuskantar sanannun ko masu cutar COVID-19.
Waɗannan sun zama masu haɗarin haɗuwa sosai idan ma'aikata suka yi ayyukan samar da aerosol, tattara ko sarrafa samfuran daga sanannun ko marasa lafiya da ake zargi da COVID-19.
Hanyoyin da ke haifar da aerosol sun hada da shigar da bututu, hanyoyin shigar da cuff, bronchoscopy, wasu hanyoyin aikin hakori da gwaje -gwaje, ko tattara samfurin daga tsagewa.
Ayyukan gidan gawawwaki masu haɗarin haɗari sun haɗa da mutanen da ke shirya gawawwakin mutanen da aka sani ko ake zargi da cutar COVID-19 a lokacin mutuwarsu; idan sun yi gwajin gawawwakin, waɗannan sun zama masu haɗarin haɗari sosai. Ƙarin sarrafa injiniya don waɗannan rukunin haɗarin sun haɗa da ɗakunan keɓewa don mutanen da aka sani ko ake zargi da COVID-19, gami da yayin aiwatar da ayyukan da ke haifar da aerosol.
A wasu kiwon lafiya da kuma tsarin gidan gawa, sadarwa ta mummunan yanayi na iya zama dacewa.
Ya kamata a kula da samfuran tare da matakan kariya na Biosafety Level 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a ware marasa lafiya masu zuwa a yankunan jira daban-daban, dangane da ko sun kasance masu cutar COVID-19. Baya ga sauran PPE, OSHA ta ba da shawarar masu aikin numfashi ga mutanen da ke aiki a cikin ƙafa 6 na marasa lafiya da aka sani ko ake zargi da kamuwa da SARS-CoV-2, da waɗanda ke aiwatar da ayyukan da ke haifar da aerosol.
A cikin Amurka, N95 mai tace fuska mai numfashi ko mafi kyau wanda NIOSH ta amince da shi ya kamata a yi amfani da shi a cikin mahallin cikakken, rubutaccen shirin kariya na numfashi wanda ya haɗa da gwajin dacewa, horo da gwajin likita.
Sauran nau'ikan inhalers na iya samar da ƙarin kariya da haɓaka jin daɗin ma'aikaci. WHO ba ta ba da shawarar rufewa ba, saboda COVID-19 cuta ce ta numfashi maimakon watsawa ta hanyar ruwan jiki.
WHO ta ba da shawarar kawai rufe fuskar likita don ma'aikatan bincike a wurin shiga.
Ga mutanen da ke tattarawa, kulawa ko jigilar samfuran numfashi daga marasa lafiyar COVID-19 ba tare da aiwatar da hanyoyin samar da aerosol ba, WHO ta ba da shawarar abin rufe fuska, tabarau na fuska, gogewa da safar hannu.
Idan ana aiwatar da aikin samar da aerosol, ana maye gurbin abin rufe fuska da N95 ko FFP2 respirator.
Ganin cewa samar da PPE a duniya bai isa ba, WHO ta ba da shawarar rage buƙatar PPE ta hanyar telemedicine, shinge na zahiri kamar taga mai haske, ba da izinin shiga ɗaki tare da mai haƙuri na COVID-19 kawai ga waɗanda ke cikin kulawa ta kai tsaye, amfani da PPE kawai da ake buƙata don takamaiman aiki, amfani da injin numfashi ɗaya ba tare da cirewa ba yayin kula da marasa lafiya da yawa tare da ganewar asali ɗaya, dubawa da daidaita sarkar samar da PPE, da kuma hana amfani da abin rufe fuska ga mutane masu alamun cutar.
Mai aikawa: Katherine Meher, Shugaba na Wikimedia Foundation
Amfani: Dukan ma'aikatan Wikimedia Foundation
Magana: [Covid-19] Sauƙaƙa nauyi da shirya don nan gaba
Ranar aikawa: 14 ga Maris, 2020, 00:24 UTC
Lasisi: CC0: Babu haƙƙin mallaka
A wannan watan, muna fuskantar yanayi na musamman.
Cutar ta COVID-19 ta bayyana yadda dukkan mutane a duniya suke da alaƙa da juna da kuma nauyin da muke da shi ga juna.
Kalubalen da muke fuskanta ba su da iyaka, amma mun san cewa mafi kyawun amsarmu ta dogara ne da jinƙai na duniya, haɗin kai, da haɓaka al'umma, wanda shine ainihin cibiyar wannan ƙungiyar.
Irin zumuntar da muka gani tsakanin dukkan abokan aikinmu ta hanyar imel, kira da hira ta nuna cewa muna da gatan yin aiki da mutane na musamman.
Ina matukar godiya da alfahari da na samu ku duka a matsayin abokan aiki.
A makon da ya gabata, wani mutum ya yaba mini a kan aikin da muke yi.
Ya tunatar da ni yadda ma'anar duniya ta juya zuwa Wikipedia a wannan lokacin, da kuma yadda wannan alama ce mai ƙarfi ta ci gaba da kasancewa a kan layi da kuma samun wannan mahimmin kayan aiki ga kowa.
Aikinku ne ke sa wannan ya yiwu, ko kuna ci gaba da shafukan yanar gizo ko samar da albashi ga abokan aikinmu ko kiyaye al'ummominmu.
Duniya na bukatar bayanan da Wikipedia ke bayarwa, kuma yanzu fiye da kowane lokaci.
Wannan lokaci ne da aikinmu da kuma yadda muke yi zai yi tasiri a duniya.
Saboda mahimmancin wannan aikin, da kuma rawar da kuke takawa, za mu yi wasu canje -canje masu ban mamaki a yadda muke aiki tare da mu a wannan makon mai zuwa.
A lokacin da muke hidima a Bethel, muna yin amfani da littattafanmu don mu yi wa'azi.
Kamar yadda Robin ya ambata a baya, ƙungiyar C ta haɗu a daren jiya don tattauna tsarinmu da tsara jadawalin kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun tattauna yadda za mu amsa halin da muke ciki, da kuma yadda za mu ci gaba da ci gaba da kasancewa a cikin ƙungiyar.
Mun cika da damuwa kuma muna son rage damuwa da tallafawa aikinmu na dogon lokaci.
Idan kana bukatar ka rage yawan aikinka, babu laifi.
Ga dukan ma'aikata, masu kwangila, da ma'aikatan kwangila:
Muna da tsammanin aikin yau da kullum na kusan awa 4 a rana, ko awa 20 a mako, har sai da aka sanar da mu.
Ba mu sanar da hutu ba - idan kuna iya yin aiki fiye da sa'o'i na yau da kullun, aikin yana buƙatar taimakon ku.
Duk da haka, duniya ba ta da tabbas a wannan lokacin, kuma ko kuna kula da ƙaunatattunku, kawo kayan abinci, ko zuwa wurin likita, lafiyar ku ita ce fifiko.
Ba ma son mu ɓata lokacinku.
Idan kana rashin lafiya, kada ka yi aiki.
Ba mu bukatar mu faɗi hakan, amma muna faɗin haka.
Babu bukatar hutu na rashin lafiya ko PTO - kawai ka gaya wa manajanka kuma ka taimaka wa ƙungiyarka ta gyara kalandar da jadawalin don tabbatar da cewa wani ya kula da manyan wuraren aiki.
(Idan an tabbatar da cewa kana da COVID-19, da fatan za a sanar da Brian na T&amp;C Ops don T&amp;C ta iya taimaka maka kuma ta tabbatar da cewa an kula da yanayin ka ta hanyar gudanarwa.)
Ma'aikata masu aiki a kan awa ɗaya za su sami cikakken albashi.
Mun riga mun faɗi haka, kuma muna sake tabbatar da alƙawarinmu ga masu ba da sabis da abokan aikinmu na sa'a.
Kowane mutum zai sami albashi bisa ga yawan lokutan aikinsa a lokacin al'amuran al'ada.
Za ka sami albashi ko da kana rashin lafiya kuma ba za ka iya aiki ba.
Idan kana son ka yi aiki, muna tare da kai.
Mutane da yawa suna amfani da aikinsu don su kawar da damuwar da suke yi game da duniyar da ke kewaye da su.
Abin da za mu iya yi zai iya zama abin gamsarwa, musamman a irin wannan lokaci.
A nan ma, kula da kanka yana da muhimmanci.
Abin da muke cewa shi ne, ku yi magana da manajanku don mu san abin da za mu yi tsammani, sa'an nan kuma mu daidaita shi daidai.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da ba za mu iya barin su su tsaya ba.
SRE, HR Ops, Trust & Security, da kuma ƙungiyoyin tara kuɗi (da sauransu) suna da mahimman ayyuka waɗanda zasu buƙaci ƙarin haɗin gwiwa.
Za mu fara aiki tare da dukkan sassanmu don tantance manufofin da muke da su yanzu da kuma mai da hankali kan haɗa kan abubuwan da ke da mahimmanci ga aikinmu.
Dukkanmu muna da abubuwa da yawa da za mu yi, amma za mu mai da hankali ne kawai ga ayyukan da suka fi muhimmanci.
Idan muka rage gudu yanzu, za mu guji rauni daga baya.
Ba mu da wani shiri na ba da lokaci sau biyu don dawowa bayan annobar duniya ta wuce.
Ba za a bukaci ka yi aiki na tsawon sa'o'i ba don ka cika jadawalin da ya wuce iyaka.
Mun yarda cewa yanayi ya canza, kuma za mu yi aiki don saita sabbin manufofi da lokacin aiki inda ya dace.
Me zai faru da APP?
Don daidaitawa da sabon gaskiyarmu da tsammanin lokutan aiki na yau da kullun, muna son sake fasalin lokacin cikar shirinmu na shekara -shekara na 2020-2021.
Muna da niyyar gabatar da wani tsawo ga shirinmu na 2019-2020 wanda zai ba mu ƙarin lokaci don tsara kasafin kuɗi, don haka ma'aikata za su iya ba da fifiko ga mahimman ayyukansu, kula da kansu, da kula da ƙaunatattun su, kuma waɗanda ke buƙatar ko son yin aiki a kan jadawalin da aka rage a cikin makonni masu zuwa.
Wannan tsawaita lokaci zai rage yawan aikinmu na yanzu da kuma matsin lamba a cikin ƙungiyar.
Za mu gabatar da shawarwarinmu ga kwamitin a mako mai zuwa kuma da zarar mun sami tabbaci, za mu sanar da wakilai da ƙungiyoyi game da matakan da za mu bi.
Na gode wa ƙungiyar APP don jagorancinku a cikin wannan.
Matsayin Ofishin, Sadarwa, da Tsabtace
A makon da ya gabata mun gano cewa wani abokin aikinmu da ke SF na iya kamuwa da cutar COVID-19.
Koyaya, tare da taka tsantsan, mun sanya ma'aikatan tsabtace rigakafin cutar don kashe dukkan farfajiyar ofishin San Francisco.
Ta kashe kwayoyin cuta a kowane wuri, a harabar gidan, da kuma a cikin lif ɗin da ke zuwa bene da maganin rigakafin cutar.
Ana aiwatar da ladabi na kulawa da kai ta hanyar amfani da kayayyakin da ke taimakawa kare lafiyar mazaunan ginin.
Muna da tabbaci cewa za mu samu ofishin a shirye sa'ad da muka dawo.
Ofishinmu na DC yana cikin WeWork wanda ya raba ƙa'idodin COVID-19 tare da mu da duk ma'aikatan da ke DC.
A makon da ya gabata ne ofishinmu na DC ya karɓi tsarin nesa gaba ɗaya daidai da jagorar da aka raba daga San Francisco.
Kamar yadda wasu abokan aikinmu a birnin New York suka sani, ana kuma tattaunawa kan hayar wani wuri a Brooklyn.
Ana ci gaba da tattaunawar amma ana iya jinkirta hakan.
Wasu abokan aikinmu suna aiki daga gida / nesa a karon farko.
Abokan aikinmu da suka daɗe suna aiki daga gida / nesa sun san cewa wannan zai buƙaci daidaitawa, kuma suna so su ba ku wasu shawarwari:
Ka rage lokacin taron zuwa awa ɗaya ko biyu.
Idan ana bukatar ƙarin taro, ka yi la'akari da raba su cikin kwanaki da yawa.
Ka bayyana tarurruka a fili, ka shirya jadawalin taro, kuma ka aika da littattafan da za ka karanta a gaba.
Ka sa bidiyo ta zama zaɓin da ka zaɓa ta amfani da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗin kai.
Ka ɗauki mataki don sauƙaƙe kowane taro, da mutum ɗaya don saka idanu kan hira don tambayoyi da kuma lissafin masu magana, da kuma mutum ɗaya don taimakawa wajen yin rubutu (ko yin rubutu tare).
Idan kana bukatar wata lasifika mai kyau, ka aika da imel zuwa sashen tallafi.
Ka yi amfani da kuɗin da kake samu don ka ci abinci.
Shiga cikin tashar #remoties a Slack don tattaunawa da abokan aikinka game da aikin da aka rarraba.
HR Operations Team suna nazarin jagororin ingantaccen aiki na yanar gizo don tallafawa haɓaka aikin da aka rarraba a duk faɗin gidauniyar.
A makon da ya gabata mun nemi duk masu karɓar tallafin al'umma da su soke duk wani taron jama'a da Wikimedia ke tallafawa, kamar Editathon, har sai WHO ta sanar da ƙarshen annobar.
Mun sanar da su cewa mun fahimci cewa buƙatarmu ta sokewa da sauran ƙuntatawa na iya sa ba zai yiwu ba su kammala ayyukan tallafin da aka yarda da juna, kuma ba za a hukunta kowa ba saboda jinkiri ko tilasta yin canje -canje ga waɗannan manufofin.
A cikin mako mai zuwa za mu biye da ƙarin jagora game da Wikimedia da sauran taron yanki da na al'ada.
Wannan cikas yana nuna baƙin ciki a cikin al'ummar duniya baki ɗaya amma kuma yana nuna sauƙi da sauƙi daga iyawar su da kuma iyawar su na mai da hankali ga al'ummomin su, Wikimedia da sauransu.
Motsawa gaba, CRT tana aiki don shirya shafi akan Meta-Wiki, da nufin samar da wuri ga al'umma don saka idanu kan tasirin da kuma bin hanyoyin sadarwarmu da su.
Ci gaba da tuntuɓar juna game da batutuwan da suka shafi COVID-19
Za mu aika muku da gayyatar zuwa kalandarku na ranar Alhamis mai zuwa, 14:00 UTC/07:00 PT don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokacin don samar da ƙarin sabuntawa, amsa tambayoyinku, da kuma ɗan lokaci don haɗuwa da juna.
Muna tare a wannan lokaci kuma muna nan don taimakawa a duk hanyar da za mu iya.
A halin yanzu, zaku iya ci gaba da nemo bayanai daga wannan imel ɗin, da duk sauran bayanan COVID-19 da ake buƙata a kan Wiki na Office.
CRT za ta ci gaba da sabunta waɗannan shafuka kuma ta ajiye duk bayanan a wuri guda.
Muna kuma aiki don ci gaba da sadarwa tare da ma'aikatan da ke zaune a cikin ƙasashe masu fama da cutar a yanzu.
Idan kuna da tambayoyi game da tafiya, abubuwan da suka faru, babban aiki, ko ƙalubalen ɗaukar hoto, ko kuna buƙatar taimako game da wani abu, don Allah ku ji daɗin sanar da CRT kuma kuyi aiki tare da su.
Muna nan don ba da taimako da kuma taimaka wajen kulla dangantaka idan ya cancanta.
Idan batunku na sirri ne ko kuma mai mahimmanci, don Allah aika imel zuwa Brian Judden, Daraktan Ayyukan Duniya na HR International.
Babu wani daga cikin waɗannan canje -canjen da za a gani a matsayin watsi da aikinmu da alhakinmu.
Maimakon haka, sun yarda cewa a wannan lokacin, ayyukanmu da alhakinmu na iya buƙatar daidaitawa kamar yadda ba mu taɓa yi ba a baya.
Mun yi imanin cewa waɗannan matakan suna da mahimmanci don tallafawa juna, don mu ci gaba da aiki, samar da ayyukanmu tare da haɗin gwiwar da suke buƙata, da ci gaba da ba da sabis ɗin da duniya ta dogara da shi.
A lokacin da lokaci ya yi, aikin da muka shirya zai kasance a gabanmu.
A yanzu, lokaci ya yi da za mu taimaki juna, kuma mu samar da wuri don muhimman ayyukan da za su faru a makonni masu zuwa, kuma wataƙila a cikin watanni masu zuwa.
Don yin hakan, muna bukatar ku duka, kuma don haka muna son ku duka ku kula da kanku da danginku, don ku kasance cikin mafi kyawun yanayinku lokacin da kuke buƙata.
Yanzu, don Allah ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Catherine, CRT (Amanda K, Amy V, Brian J, Doreen D, Gregory V, Jamie V, Joel L, Lynette L, Ryan M, da Tony S), da sauran ƙungiyar jagoranci (Grant I, Heather W, Jamie V, Janine U, Lisa S, Robin A, Ryan M, da Toby N).
Angiotensin - converting enzyme 2 (ACE2) enzyme ne wanda ke da alaƙa da ƙwayoyin waje (ƙwayoyin sel) a cikin huhu, jijiyoyi, zuciya, koda da hanji.
ACE2 yana daidaita aikin aikin aikin aikin mai canzawa na angiotensin (ACE) ta hanyar rage adadin angiotensin-II da kuma kara angiotensin (1-7), wanda ya sa ya zama kyakkyawan maƙasudin magani don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin maɓallin shiga cikin sel don wasu coronaviruses.
Ana kiran nau'in enzyme na mutum hACE2.
Angiotensin - converting enzyme 2 shine zinc-mai dauke da metaloenzyme wanda yake a cikin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin
ACE2 sunadarai suna da N - terminal peptidase M2 yankin da C - terminal colectrain renal amino acid transporter yankin.
ACE2 shine nau'in furotin na membrane na I wanda ke wucewa sau ɗaya tare da yanki mai aiki da enzymatic wanda ba a canza shi ba a saman ƙwayoyin cuta a cikin huhu da sauran kyallen takarda.
Ana lalata yankin na waje na ACE2 daga yankin membrane ta wani enzyme da ake kira shades, kuma sakamakon ya zama furotin mai narkewa wanda aka saki cikin jini kuma daga ƙarshe ya fita cikin fitsari.
ACE2 yana cikin mafi yawan gabobin jiki: ACE2 yana da alaƙa da ƙwayoyin ƙwayoyin ƙwayoyin cuta na nau'in II na huhu, ƙananan ƙwayoyin hanji, ƙwayoyin ƙwayoyin jini da jijiyoyi, da ƙwayoyin ƙwayoyin tsoka na jini a cikin mafi yawan gabobin jiki.
Ana kuma samun bayyanar ACE2 mRNA a cikin kwakwalwar kwakwalwa, striatum, hypothalamus da kuma kwakwalwar kwakwalwa.
Babban aikin ACE2 shine aiki a matsayin mai ɗaukar nauyin ACE.
ACE yana lalata hormone angiotensin I zuwa angiotensin II mai narkewa.
ACE2 sannan ya rushe carboxyl - terminal amino acid phenylalanine daga angiotensin II (Asp - Arg - Val - Tyr - Ile - His - Pro - Phe) kuma ya rushe shi cikin ruwa mai narkewa angiotensin (1-7), (H - Asp - Arg - Val - Tyr - Ile - His - Pro - OH).
ACE2 [des-Arg9] - kuma zai iya lalata wasu peptides da yawa, gami da bradykinin, epelin, neurotensin, dinorphin A da ghrelin.
ACE2 kuma yana sarrafa jigilar membrane na mai jigilar amino acid mai mahimmanci SLC6A19 kuma an ba da labarin rawar da yake takawa a cikin cututtukan zuciya.
A matsayin furotin membrane, yana aiki a matsayin babban wurin shiga cikin sel don wasu coronaviruses, gami da ACE2, HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, haɗuwa da yankin enzymatic na ACE2 akan farfajiyar ƙwayoyin cuta na kwayar cuta S1 na SARS-CoV da SARS-CoV2 yana haifar da endocytosis da canja wuri na ƙwayoyin cuta da enzymes zuwa cikin ƙwayoyin ƙwayoyin cuta a cikin ƙwayoyin.
Wannan hanyar shigarwa tana buƙatar gina jiki na serine protease TMPRSS2 don haifar da furotin S, wanda hana shi a halin yanzu yana ƙarƙashin bincike a matsayin magani mai yiwuwa. Saboda wannan, wasu sun yi tunanin cewa rage matakan ACE2 a cikin sel na iya taimakawa wajen yaƙar kamuwa da cuta.
Koyaya, yawancin ƙungiyoyin ƙwararru da ƙungiyoyin kulawa sun ba da shawarar ci gaba da daidaitaccen maganin ACE mai hanawa da ARB.
Binciken da aka yi da tsari da kuma nazarin meta da aka buga a ranar 11 ga Yuli, 2012 ya gano cewa "amfani da masu hana ACE yana da alaƙa da raguwar haɗarin cutar nimoniya da kashi 34% idan aka kwatanta da sarrafawa".
Hakanan, "Masu haƙuri da aka bi da masu hana ACE sun sami raguwar haɗarin cutar huhu, waɗanda ke da haɗarin kamuwa da cutar huhu, musamman a cikin waɗanda ke fama da rauni da rashin ƙarfi na zuciya.
Amfani da masu hana ACE kuma an haɗa su da raguwar mutuwar da ke da alaƙa da cutar huhu, kodayake sakamakon bai fi ƙarfin haɗarin cutar huhu ba".
Ana ɗaukar sake haɗuwa da ɗan adam ACE2 (rhACE2) a matsayin sabon magani don lalacewar huhu mai tsanani, kuma ya bayyana don inganta haemodynamics na huhu da kuma oxygen saturation a cikin jariran alade tare da cutar ta acute respiratory distress syndrome.
Rabin rabin rayuwar rhACE2 a cikin ɗan adam kusan awanni 10 ne kuma farkon aikin minti 30 tare da tsarin aiki (lokaci) na awanni 24.
Yawancin binciken sun nuna cewa rhACE2 na iya zama magani mai ban sha'awa ga mutanen da ke da rashin haƙuri ga masu hana tsarin renin-angiotensin (RAS inhibitors) ko cututtukan da ke haifar da karuwar angiotensin II na wurare dabam dabam. An kimanta rhACE2 mai narkewa a cikin gwaji na asibiti don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan.
Aikace-aikacen COVID-19 aikace-aikacen software ne na wayar hannu waɗanda aka tsara don taimakawa a cikin ganowa, watau aiwatar da gano mutane ("liƙan) waɗanda ƙila sun kasance cikin hulɗa da mai cutar a cikin martani ga cutar coronavirus ta 2019-20.
An haɓaka ko kuma an ba da shawarar aikace -aikace da yawa tare da tallafin gwamnati a wasu yankuna da yankuna.
An samar da tsarin da yawa don gina aikace -aikacen gano lamba.
An tayar da damuwa game da sirri, musamman game da tsarin da ke dogara da bin diddigin yanayin masu amfani da app.
A cikin zaɓi na ɗan gajeren lokaci, yana haɗa da amfani da siginar Bluetooth don yin rajistar kusanci da mai amfani da sauran wayoyin salula.
A ranar 10 ga Afrilu, 2020, Google da Apple sun ba da sanarwar cewa za su haɗa aikin kai tsaye cikin tsarin aiki na Android da iOS don tallafawa irin waɗannan ƙa'idodin tushen Bluetooth.
A China, gwamnatin kasar Sin ta yi amfani da wata manhaja tare da Alipay, wanda zai baiwa 'yan kasa damar duba ko sun kasance tare da mutanen da ke da COVID-19.
Ana amfani da shi a birane sama da 200 na kasar Sin. A Singapore, ana amfani da wata manhaja mai suna TraceTogether.
An kirkiro manhajar ne ta hanyar al'ummar IT ta gida, an sake ta a matsayin buɗaɗɗen tushe kuma za a ba da ita ga gwamnati. Arewacin Macedonia ta ƙaddamar da wata manhajar da ke da tushen Bluetooth "StopKorona!" don gano hulɗa tare da mutanen da ke da yiwuwar kamuwa da cutar da kuma ba da saurin amsa ga hukumomin kiwon lafiya.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka kirkiro manhajar.
Har zuwa 14 ga Afrilu, 2020, wannan app ɗin yana jiran amincewa daga Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta ce manhajar gano lamba tana cikin wani mataki na ci gaba, kuma za ta kasance a shirye don tsarawa a cikin makonni. An kuma yi amfani da irin wannan manhajar ("StopCovid") a Ireland da Faransa.
Australia da New Zealand duk suna la'akari da aikace-aikacen TraceTogether na Singapore da aikace-aikacen da ke kan yarjejeniyar BlueTrace. Rasha na son gabatar da aikace-aikacen geofencing don marasa lafiya da aka gano da COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa ba sa barin gida.
Ross Anderson, Farfesa a fannin injiniyan tsaro a Jami'ar Cambridge ya lissafa matsaloli masu yawa masu amfani da tsarin tushen aikace-aikace, gami da lokuta masu kuskure da kuma yiwuwar rashin tasiri idan amfani da aikace-aikacen ya iyakance ga karamin yanki na yawan jama'a.
Da yake magance damuwa game da yaduwar aikace-aikacen "coronavirus" masu ɓatarwa ko cutarwa, Apple ya ƙayyade irin nau'ikan ƙungiyoyi da za su iya haɗa da aikace-aikacen da suka shafi coronavirus a cikin App Store, ta hanyar iyakance su ga "hukuma" ko kuma ƙungiyoyi masu daraja kawai.
Google da Amazon sun sanya irin wannan takunkumin.
Masu fafutukar kare sirrin sun nuna damuwarsu game da tasirin sa ido kan mutane ta hanyar amfani da aikace-aikacen coronavirus, musamman game da ko za a lalata kayan aikin sa ido da aka gina don magance cutar coronavirus bayan wannan barazanar ta wuce.
Amnesty International da wasu kungiyoyi sama da 100 sun fitar da wata sanarwa don takaita irin wannan sa ido.
Kungiyoyi sun bayyana sharudda takwas akan ayyukan gwamnati:
Kulawa dole ne ya zama "daidai, dole kuma mai daidaituwa";
Dole ne a sami sashe na ƙarshe don kulawa da kuma tsawo na kulawa;
Amfani da bayanai ya kamata ya zama iyakance ga dalilai na COVID-19;
Dole ne a kiyaye tsaro da rashin sani na bayanai kuma a nuna su a matsayin abin da aka kare bisa ga hujja;
Dole ne kulawar dijital ta guji haɓaka nuna bambanci da hanawa;
Duk wani rabawa na bayanai tare da wasu ɓangarorin uku dole ne a bayyana a cikin doka;
Dole ne a sami matakan kare hakkin 'yan ƙasa don magance cin zarafi da kuma amsawa;
Za a buƙaci "haɗin kai mai ma'ana" daga dukkan "masu ruwa da tsaki masu dacewa", gami da masana kiwon lafiyar jama'a da kungiyoyin marasa iko.
Manufar shirin da aka gabatar na Google / Apple shine magance matsalar sa ido akai -akai ta hanyar cire tsarin sa ido daga tsarin aiki na na'urar su lokacin da ba a buƙatarsa.
Wasu ƙasashe sun yi amfani da bin hanyar sadarwa maimakon aikace -aikace, suna kawar da buƙatar saukar da aikace -aikacen da ikon kauce wa sa ido.
A Isra'ila, an amince da bin hanyar sadarwa.
Hanyoyin sadarwa waɗanda ke da damar yin amfani da bayanan wuri na asali suna da mahimman matsalolin sirri.
Koyaya, ba duk tsarin da ke da sabar tsakiya ba yana buƙatar samun damar bayanan wurin mutum; an ƙirƙiri tsarin tsare sirri da yawa waɗanda ke amfani da sabar tsakiya don sadarwa tare kawai (duba sashe na ƙasa).
An yi amfani da tsarin da ba na aikace -aikace ba don gano lamba a Koriya ta Kudu.
Maimakon amfani da ƙa'idar sadaukarwa, tsarin ya tattara bayanan sa ido daga tushe daban -daban, gami da bayanan sa ido na na'urar hannu da bayanan ma'amala na katin, kuma ya haɗa su don samar da sanarwa ta hanyar saƙonnin rubutu ga mutanen da ke da yiwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da masu yuwuwar tuntuɓar, gwamnati ta ba da bayanin wurin a bainar jama'a saboda canje -canje masu nisa a cikin dokokin sirrin bayanai bayan barkewar MERS a wannan ƙasar.
Ana samun wannan bayanin ga jama'a ta hanyar aikace -aikace da rukunin yanar gizo da yawa. Kasashe da yawa, ciki har da Jamus, sun yi la'akari da amfani da tsarin tsakiya da tsare sirri.
Har zuwa 6 ga Afrilu, 2020, ba a fitar da wannan bayanin ba tukuna.
Bayanin tuntuɓar kariya ta sirri ya kasance ingantaccen ra'ayi tare da babban ɓangaren wallafe-wallafen bincike tun aƙalla 2013. Har zuwa 7 ga Afrilu 2020, sama da ƙwararrun ƙwararrun masana suna aiki kan hanyoyin magance sirrin sirri, kamar amfani da Bluetooth low energy (BLE) don shiga kusanci da sauran wayoyin salula na mai amfani.
Koyaya, PEPP-PT ƙoƙari ne na haɗin gwiwa wanda ya haɗa da hanyoyin da aka tsakiya da na rarraba, kuma ba wata yarjejeniya ɗaya ba. Tsarin yarjejeniya ya haɗa da rarraba sirrin sirri-kariya kusa da ganowa (DP-PPT/DP-3T), lambar tuntuɓar wucin gadi (TCN, a baya lambar taron tuntuɓar, CEN), Sirrin Sirri mai mahimmanci da kuma Tsarin don Binciken Sadarwar Sadarwa ta Wayar hannu (PACT) da sauransu.
A cikin waɗannan ladabi, bayanan sirri na mutum ba sa fita daga na'urar, kuma duk abubuwan da suka dace suna faruwa akan na'urar.
Kungiyar Sirri a MIT Media Lab tana haɓaka SafePaths, wani dandamali don amfani da fasahohin kariya na sirri yayin tattarawa da amfani da bayanan wuri ko hanyar tsallakawa don bin diddigin yaduwar COVID-19.
Wannan ya dogara ne akan binciken da aka fitar a cikin farar takarda "Aps Gone Rogue: Kula da Sirrin Keɓaɓɓen Sirri a cikin Cutar" a cikin Maris 2020. Irin wannan yunƙurin shine SafeTrace ta Enigma MPC, kamfanin haɓaka fasahar sirri, wanda aka kafa a MIT Media Lab.
SafeTrace yana amfani da fasahohin kayan aiki masu aminci, wanda ke ba masu amfani damar raba wuri mai mahimmanci da bayanan kiwon lafiya tare da sauran masu amfani da hukumomi ba tare da yin sulhu kan sirrin wannan bayanan ba.
A ranar 5 ga Afrilu, 2020, an kafa haɗin gwiwar TCN ta duniya ta ƙungiyoyi waɗanda suka haɗu bisa ga ƙa'idodi iri ɗaya da kuma ƙa'idodin ƙa'idodi iri ɗaya, tare da manufar rage rarrabuwa, da ba da damar haɗin gwiwar duniya na aikace-aikacen ganowa da faɗakarwa, wanda ya kasance muhimmin ɓangare na cimma daidaito mai yawa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta buɗe tushen yarjejeniyar BlueTrace da aka yi amfani da ita ta hanyar aikace-aikacen gwamnati na hukuma.
A ranar 10 ga Afrilu, 2020, kamfanonin da ke sarrafa Google da Apple, Android da iOS, sun sanar da wani shiri don gano lamba, wanda suka yi iƙirarin zai kare sirrin mutum bisa ga haɗin Bluetooth low-power technology da kuma ɓoyayyen ɓoyayyen ɓoyayyen ɓoye ɓoye.
Ya kuma buga ƙayyadaddun manyan fasahohin da za a yi amfani da su a cikin tsarin.
A cewar Apple da Google, ana nufin samar da wannan tsarin a matakai uku:
Samar da kayan aiki don bawa gwamnatoci damar gina aikace -aikacen gano cutar coronavirus na sirri na hukuma.
Wannan aiki ne kai tsaye a cikin iOS da Android
Sake amfani da magani (wanda aka fi sani da sake amfani da magani, sake fasalin, sake sakewa ko sauya magani), shine sake amfani da magani da aka amince dashi don magance cuta ko yanayin likita daban da wanda aka fara kirkirar sa.
Wannan tsari ne na binciken kimiyya wanda ake amfani dashi a halin yanzu don haɓaka lafiya da ingantaccen maganin COVID-19.
Sauran jagororin bincike sun hada da ci gaban allurar rigakafin COVID-19 da kuma allurar jini da ke da alaƙa da lafiyar. SARS-CoV-2 yana da kusan furotin manufa 66, kowannensu yana da wuraren ɗaure ligand da yawa.
Nazarin waɗannan wuraren ɗaurewa yana ba da kyakkyawan shiri don haɓaka maganin rigakafin cutar don kariya daga furotin na COVID-19.
Muhimman sunadaran da SARS-CoV-2 ke niyya sune papane-like proteases, RNA-dependent RNA polymerases, helicases, S proteins da ADP ribophosphate.
Hussain da sauransu sun yi nazarin mahaɗan ɗan takara da yawa, waɗanda aka sake daidaitawa da nazarin su don kamanceceniya da tsarin su tare da magungunan da aka amince da su don hanzarta haɓaka ingantaccen maganin SARS-CoV-2 a cikin binciken farko na gwaji wanda aka ba da shawarar a cikin tsarin binciken asibiti.
Chloroquine magani ne na cutar zazzabin cizon sauro wanda kuma ake amfani dashi don kare wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine masu alaƙa za su kasance cikin magunguna huɗu da za a yi nazari a matsayin ɓangare na gwajin asibiti na Solidarity.
Gwamnan New York Andrew Cuomo ya ba da sanarwar cewa gwajin jihar New York na chloroquine da hydroxychloroquine zai fara daga ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquyl phosphate a ƙarƙashin ikon Amfani da Gaggawa (EUA).
Ba a amince da maganin ta hanyar tsarin gwajin asibiti na FDA ba kuma an ba da izinin EUA ne kawai a matsayin magani na gwaji don amfani da gaggawa a cikin marasa lafiya waɗanda ke asibiti amma ba su iya samun magani a gwajin asibiti ba.
CDC ta ce "Ba a kafa amfani, sashi ko tsawon lokacin amfani da hydroxychloroquine don rigakafi ko maganin kamuwa da cutar SARS-CoV-2 ba tukuna".
Likitocin sun ce suna amfani da maganin ne kawai idan "babu wani zabi".
Wata ƙungiyar bincike ta Turkiyya a Istanbul tana yin ƙaramin bincike kan amfani da chloroquine a hade tare da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da manyan karatu a jami'ar Duke da Oxford.
Makarantar Likita ta NYU Langone tana gudanar da gwaji kan aminci da ingancin amfani da rigakafin hydroxychloroquine.
Gwaje - gwaje na asibiti na kasar Sin a Wuhan da Shenzhen sun yi iƙirarin nuna favipiravir "a bayyane yake tasiri".
A Shenzhen, marasa lafiya 35 sun gwada mummunan a matsakaita na kwanaki 4, yayin da tsawon lokacin cutar ya kasance kwanaki 11 a cikin marasa lafiya 45 da ba su samu ba.
A cikin binciken da aka yi kan marasa lafiya 240 da ke fama da cutar huhu a Wuhan, rabin marasa lafiyar sun sami favipiravir da rabi kuma omyfenvir.
Hukumar Kula da Magunguna ta Italiya ta tunatar da jama'a cewa shaidar da ke akwai a halin yanzu don tallafawa maganin ba ta da yawa kuma na farko.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi magunguna daga Japan don ajiyar ta, kuma za ta yi amfani da sojoji don isar da magunguna zuwa asibitocin jami'a, inda za a yi amfani da magungunan don kula da marasa lafiyar COVID-19.
A cewar South China Morning Post, Shinzo Abe ya aika da shawarwari ga gwamnatin Trump game da sayan maganin. Magungunan na iya zama da ƙarancin tasiri a cikin mawuyacin yanayin rashin lafiya inda kwayar cutar ta riga ta haɓaka.
Ba zai zama mai lafiya ba ga mata masu ciki ko mata masu ƙoƙarin ɗaukar ciki.
Wani binciken da aka yi na maganin cutar kwayar cutar lopinavir da rikon kwayar cutar, lopinavir/ritonavir (Calatra), ya kammala cewa "ba a ga fa'ida ba".
An tsara magungunan ne domin hana HIV yin kwafi ta hanyar ɗaure shi da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin gyara magunguna don nemo wani fili wanda zai ɗaure ga protease na SARS-CoV-2. Akwai sukar cikin ƙungiyar kimiyya game da tura albarkatu don sake amfani da magungunan da ake haɓaka musamman don HIV / AIDS.
WHO ta haɗa Lopinavir/Ritonavir a cikin gwajin haɗin kai na duniya.
An samar da remdesivir kuma an haɓaka shi ta Gilead Sciences a matsayin magani don cutar Ebola da kamuwa da cutar Marburg. Gilead Sciences daga baya ta gano cewa remdesivir yana da aikin antiviral na yanayi don kariya daga yawancin phyllo-, pneumo-, paramyxo- da coronaviruses.
Wata matsala tare da maganin rigakafin cutar ita ce ci gaban juriya ta hanyar maye gurbi wanda zai iya haifar da cututtuka da watsawa mai tsanani.
Wasu nazarin farko na gwaji sun nuna cewa remdesivir na iya samun babban katangar kwayoyin halitta don juriya. Yawancin gwaji na asibiti suna gudana, gami da gwaji biyu da Asibitin Jami'ar Cleveland ke gudanarwa; ɗaya don mutanen da ke da matsakaiciyar cuta ɗayan kuma ga waɗanda ke da ciwo mai tsanani.
Akwai gwaji uku na asibiti na intravenous bitamin C don asibiti da kuma mutanen da ke fama da rashin lafiya tare da COVID-19; biyu suna sarrafawa da wuribo (a China, Kanada) da ɗaya ba tare da sarrafawa ba (a Italiya).
Jihar New York ta fara gwaji don maganin rigakafin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya da Magunguna ta Duniya ta Japan (NCGM), tana shirin gwajin asibiti don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututut
Wani gwaji na Phase II na Angiotensin-Converting Enzyme 2 yana gudana tare da marasa lafiya 200 da ke cikin asibiti daga mawuyacin hali, asibiti a Denmark, Jamus da Austria don ƙayyade tasirin maganin.
Masu bincike a Cibiyar Zuciya ta Montreal a Kanada a halin yanzu suna nazarin rawar da colchicine ke takawa wajen rage kumburi da rikitarwa na huhu a cikin marasa lafiya da ke fama da alamun COVID-19.
A cikin binciken da ake kira COLCORONA, ana daukar manya 6000 masu shekaru 40 zuwa sama waɗanda aka gano da cutar COVID-19 kuma suna fuskantar alamun rashin lafiya waɗanda ba sa buƙatar asibiti.
Mata masu ciki ko masu shayarwa ko kuma waɗanda ba sa amfani da ingantaccen maganin hana ɗaukar ciki ba su cancanci ba.
Ana gwada magungunan anti-scan a Italiya.
Ana amfani da ƙananan nauyin kwayar halittar heparin don kula da marasa lafiya, wanda hakan ya sa Hukumar Magunguna ta Italiya ta buga jagororin kan amfani da shi.
An sanar da wani bincike mai yawa a cikin marasa lafiya 300 da ke yin bincike kan amfani da anoxaparin sodium a kan allurai masu kariya da warkewa a Italiya a ranar 14 ga Afrilu.
Tunda SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai kan sake amfani da magungunan rigakafin cutar da aka amince da su, waɗanda aka haɓaka don ɓarkewar cutar da ta gabata kamar MERS, SARS da West Nile virus.
Ribavirin: An ba da shawarar ribavirin don maganin COVID-19 bisa ga jagororin bugu na 7 na kasar Sin.
Umiphenovir: An ba da shawarar umiphenovir don maganin COVID-19 bisa ga jagororin fitowar 7 na kasar Sin.
Wasu magungunan rigakafi da aka gano a matsayin masu yuwuwar sake amfani da su azaman maganin COVID-19 sune:
Tosylisumab (mai karɓar IL-6): China ta amince da shi.
Hakanan an gwada a Italiya da China. Kuma duba Tocilizumab#COVID-19.
An yi allurar rigakafin COVID-19 don karewa daga cutar coronavirus ta 2019 (COVID-19).
Kodayake babu wani allurar rigakafi da ya kammala gwajin asibiti, amma har yanzu akwai ƙoƙari da yawa don haɓaka irin wannan allurar.
A ƙarshen Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin samun allurar rigakafi don kariya daga SARS-CoV-2, kwayar cutar da ke haifar da cutar, a cikin ƙasa da watanni 18.
A watan Afrilu, an fara gwajin lafiyar alluran rigakafi biyar.
An gano COVID-19 a watan Disamba na 2019.
A shekarar 2020 wani babban barkewar cutar ya bazu a duk duniya, wanda ya haifar da babban jari da ayyukan bincike don haɓaka allurar rigakafi.
Yawancin kungiyoyi suna amfani da bayanan da aka buga don haɓaka yiwuwar alluran rigakafi don kariya daga SARS-CoV-2.
Kamar yadda aka bayyana a watan Afrilu, abubuwan da ke da mahimmanci ga shirin CEPI don haɓaka allurar rigakafi sune saurin aiki, ƙarfin samarwa, tsarawa mai yawa da kuma ilmantarwa a duniya.
A watan Afrilu, masana kimiyya a CEPI sun ba da rahoton cewa akwai dandamali daban -daban na fasaha 10 da ke ƙarƙashin bincike da ci gaba a farkon 2020 don ƙirƙirar ingantaccen allurar rigakafi don kariya daga COVID-19.
Babban mahimman dandamali a cikin karatun tsaro na Mataki na I sun haɗa da:
Nucleic acid (DNA da RNA) (Mataki na I masu haɓakawa da masu neman allurar rigakafi: Moderna, mRNA-1273)
Kwayar cutar (Mataki na I mai haɓaka da mai neman allurar rigakafi: CanSino Biologics, adenovirus type 5 vector)
Kamar yadda masana kimiyya na CEPI suka ruwaito a watan Afrilu, jimillar alluran rigakafi 115 suna cikin matakan farko na ci gaba, daga cikinsu an tabbatar da 78 a matsayin ayyukan aiki (79 a cewar Cibiyar Milken), kuma an sanar da wasu 37, amma akwai karancin bayanan jama'a (wanda ake tsarawa ko kuma ake tsammani a cikin shirin).
A cikin gwajin Mataki na I-II ana gudanar da gwajin farko na aminci da rigakafi, ana yin sa ne a bazuwar, placebo-sarrafawa da wurare da yawa, yawanci ana ƙaddara mafi daidaito, tasiri mai tasiri.
Gwaje - gwaje na Mataki na III yawanci sun ƙunshi ƙarin mahalarta, tare da ƙungiyar kulawa da ke lura da tasirin sakamako mai illa a mafi kyawun sashi, da kuma gwada ingancin allurar rigakafin don hana cutar.
Daga cikin 'yan takarar allurar rigakafi 79 a cikin ci gaba mai aiki (wanda aka tabbatar a farkon Afrilu 2020), 74 har yanzu ba a cikin kimantawar ɗan adam ba (har yanzu suna cikin binciken "preclinical").
A kusa da ranar 24 ga Janairun 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana nazarin yiwuwar allurar rigakafin kwayar halitta, wanda zai canza kwayar cutar ta kwayar halitta don haifar da amsawar rigakafi.
A ranar 24 ga Janairun 2020 a Kanada, Cibiyar allurar rigakafin ƙasa da ƙasa a Jami'ar Saskatchewan (VIDO-InterVac) ta sanar da fara aiki kan allurar rigakafi tare da burin fara gwajin ɗan adam a cikin 2021.
An sanar da ayyukan ci gaban allurar rigakafi a Cibiyar Kula da Cututtuka ta Sin a ranar 26 ga Janairu, 2020 da kuma a Jami'ar Hong Kong a ranar 28 ga Janairu, 2020.
A ranar 29 ga Janairun 2020, kamfanin Yansen Pharmaceutical Company wanda Hanneke Schutemecker ke jagoranta ya sanar da cewa ya fara aiki kan samar da allurar rigakafi.
Yansen yana haɓaka allurar rigakafin baka tare da abokin aikinsa na fasahar kere kere Vaxart.
A ranar 18 ga Maris, 2020, Emergent Biosolutions ta sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairun 2020, Oncogen Lab a Romania ya buga wata takarda kan ƙirar allurar rigakafi mai kama da fasahar da ake amfani da ita don maganin rigakafin cutar kansa.
A ranar 25 ga Maris, shugaban cibiyar bincike ya sanar da cewa sun kammala hada magungunan rigakafi kuma suna fara gwaji.
A ranar 27 ga Fabrairun 2020, NuGenerex Immuno-Oncology, wani kamfanin haɗin gwiwar Generex, ya ba da sanarwar cewa suna ƙaddamar da aikin allurar rigakafi don ƙirƙirar allurar rigakafin peptide mai mahimmanci don kariya daga COVID-19.
Suna son samar da wani allurar rigakafin da za a iya gwadawa a cikin mutane "a cikin kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirye-shiryenta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Sojojin Amurka na Bincike da Kayan Aiki a Fort Detrick da Walter Reed Army Institute of Research a Silver Spring, Western Maryland, duk sun sanar da cewa suna aiki a kan allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa za ta taimaka wajen samar da allurar rigakafi.
Za ta yi aiki tare da Novavax Inc.
Abokan hulɗa sun sanar da tsare -tsaren gwajin gwaji da kuma gwaji na farko na gwaji ta hanyar Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta ba da sanarwar cewa suna aiki tare da masu rarrabuwa 11, kuma cewa zai ɗauki aƙalla shekaru 1.5 zuwa 2 don haɓaka allurar rigakafi, koda a kan hanya mai sauri.
A ranar 12 ga Maris, 2020, kamfanin MedicoGo, wani kamfanin fasahar kere kere a Quebec City, Quebec, ya ba da rahoton ci gaban kwayoyin kama da coronavirus a karkashin wani bangare na kudade daga Cibiyar Nazarin Lafiya ta Kanada.
An yi gwajin gwajin gwajin rigakafin a cikin dakin gwaje-gwaje, wanda aka shirya a yi gwajin ɗan adam a watan Yuli ko Agusta 2020.
A farkon wannan makon, The Guardian ta ruwaito cewa Shugaban Amurka Donald Trump ya ba Kurvak "babban kuɗi don sayan rigakafin COVID-19 na musamman", wanda gwamnatin Jamus ta yi hamayya da shi.
A ranar 17 ga Maris, 2020, kamfanin harhada magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA.
Mai neman allurar rigakafin mRNA BNT162, a halin yanzu yana cikin gwajin farko, wanda ake sa ran fara gwajin asibiti a watan Afrilu 2020.
A Italiya a ranar 17 ga Maris, 2020, kamfanin fasahar kere kere na Italiya, Tacis Biotech ya ba da sanarwar cewa za su sami sakamakon gwajin farko a watan Afrilu na 2020 kuma za su iya fara gwaji a kan takarar allurar rigakafin su ta ƙarshe a lokacin kaka.
A ranar 19 ga Maris, 2020, a Faransa, Coalition for Epidemic Preparedness Innovations (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar bincike ta allurar rigakafin COVID-19, wanda ya haɗa da Institut Pasteur, Themis Biosciences (Vienna, Austria) da Jami'ar Pittsburgh, wanda ke ba CEPI jimlar saka hannun jari na dala miliyan 29 a cikin ci gaban allurar COVID-19.
Sauran abokan saka hannun jari na CEPI don haɓaka allurar COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun ba da sanarwar cewa masana kimiyya sun fara gwajin dabbobi akan wasu takwarorin allurar rigakafi guda shida.
Masu bincike a kwalejin Imperial College London sun ba da sanarwar a ranar 20 ga Maris, 2020 cewa suna haɓaka allurar rigakafin RNA mai haɓaka kanta don COVID-19.
An samar da wannan dan takarar rigakafin ne a cikin kwanaki 14 da samun jerin sunayen daga China.
A ƙarshen watan Maris, Gwamnatin Kanada ta ba da sanarwar C$275 miliyan a cikin kudade don ayyukan bincike 96 kan hanyoyin likita don kare COVID-19, gami da kamfanoni da jami'o'in Kanada da yawa, kamar Medicago da Jami'ar Saskatchewan.
A kusan lokaci guda, gwamnatin Kanada ta sanar da dala miliyan 192 na C $ don haɓaka rigakafin COVID-19 musamman tare da shirin kafa "Bankin allurar rigakafi" na ƙasa da yawa na sabbin alluran rigakafi waɗanda za a iya amfani da su idan akwai wasu ɓarkewar coronavirus.
A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoton gwajin PittCoVacc, wata yiwuwar allurar COVID-19 a cikin beraye, suna cewa "Alurar riga kafi na SARS-CoV-2 S1 subunit da aka bayar ta MNA sun haifar da halayen antigen-takamaiman antibody [a cikin beraye], wanda ya bayyana a bayyane ya fara makonni 2 bayan allurar rigakafi".
A ranar 16 ga Afrilu, 2020, a Kanada, Jami'ar Waterloo School of Pharmacy ta sanar da ƙirar ɗan takarar allurar rigakafin DNA a matsayin yiwuwar fesa hanci.
Ta amfani da bacteriophages, za a tsara DNA don yin kwafi a cikin ƙwayoyin cuta na ɗan adam don samar da ƙwayoyin cuta marasa cutarwa, wanda zai iya motsa tsarin garkuwar jiki don samar da ƙwayoyin cuta don kariya daga cutar SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu da jami'o'i uku sun tara albarkatu don ilmantarwa daga IBM zuwa manyan kwamfutoci, tare da albarkatun sarrafa kwamfuta daga girgije daga Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da sakamako daban -daban, wanda kuma ake kira sakamako mara kyau.
Wannan yana nufin cewa suna iya samun ƙarin fa'idodi ban da cutar da suke hanawa.
Wani gwajin da aka yi a Australia yana neman ma'aikatan lafiya 4,170 su shiga.
Yana yiwuwa cewa alluran rigakafi ba za su kasance masu aminci ko tasiri ba a ci gaba.
Binciken farko da ke kimanta ingancin allurar rigakafi ta amfani da samfuran dabbobi na COVID-19 na musamman, kamar su beraye masu canzawa na ACE2, sauran dabbobin gwaji da na dabbobi marasa rai, suna nuna buƙatar matakan kariya na matakin 3 na biosegurity don magance ƙwayoyin cuta masu rai da kuma daidaitaccen haɗin gwiwar ƙasa da ƙasa don tabbatar da hanyoyin kariya.
An gwada alluran rigakafi don kariya daga SARS da MERS a cikin samfuran dabbobi marasa ɗan adam.
Har zuwa 2020, babu magani ko rigakafin kariya ga SARS wanda aka nuna yana da aminci da tasiri a cikin mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, ganowa da kuma bunkasa sabbin alluran rigakafi da magunguna don magance SARS sun kasance fifiko ga gwamnatoci da hukumomin kiwon lafiya a duniya.
Lokacin da MERS ya zama gama gari, an yi imanin cewa binciken SARS na yanzu na iya samar da kyakkyawan tsari don haɓaka alluran rigakafi da magunguna don kariya daga kamuwa da cutar MERS-CoV.
Ya zuwa watan Maris na 2020, akwai allurar MERS guda ɗaya (wanda aka kafa ta DNA) wacce ta kammala gwajin gwaji na Mataki na I a cikin mutane, kuma wasu uku suna ci gaba, duk alluran rigakafin da ke dauke da kwayar cutar, biyu adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), da MVA-vectored (MVA-MERS-S).
Sakonnin kafofin sada zumunta sun inganta wani makirci, suna ikirarin cewa an san kwayar cutar da ke da alhakin COVID-19 kuma an riga an sami allurar rigakafi.
Takaddun shaida da aka ambata ta hanyar sakonnin kafofin watsa labarun daban -daban suna nufin takaddun shaida na yanzu don jerin kwayoyin halitta da alluran rigakafi don sauran nau'ikan coronavirus kamar SARS coronavirus.
Cutar kwayar cutar Coronavirus 2019 (COVID-19) cuta ce mai saurin kamuwa da cuta wacce ke haifar da mummunan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Alamomin yau da kullun sun haɗa da zazzabi, tari, da numfashi.
Sauran alamun cututtuka na iya haɗawa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, raunin ƙamshi, da ciwon ciki.
Lokaci daga kamuwa da kwayar cutar zuwa bayyanar cututtuka yawanci kusan kwanaki biyar ne amma zai iya wucewa daga kwana biyu zuwa goma sha huɗu.
Kodayake a mafi yawan lokuta alamun suna da laushi, a wasu lokuta ana samun cutar nimoniya ta kwayar cuta da gazawar gabobin da yawa.
Ya zuwa ranar 17 ga Afrilu, 2020, an bayar da rahoton sama da mutane miliyan 2.24 a cikin kasashe da yankuna 210, wanda ya haifar da mutuwar sama da 153,000.
Fiye da mutane 568,000 sun warke. Ana yada kwayar cutar tsakanin mutane a lokacin kusanci, galibi ta hanyar ƙananan ɗigon ruwa da ke haifar da tari, hancinsa ko magana.
Ko da yake ana haifar da waɗannan ɗigon lokacin da aka fitar da numfashi, galibi suna faɗuwa ƙasa ko kan farfajiyoyi maimakon zama masu yaduwa a cikin nesa mai nisa.
Mutane na iya kamuwa da cutar ta hanyar taɓa datti da kuma taɓa idanunsu, hanci, ko bakinsu.
Kwayar cutar na iya rayuwa a saman farfajiya har tsawon awanni 72.
Yana da mafi kamuwa da cuta a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya samun yaduwa kafin bayyanar cututtuka da kuma a cikin matakan cutar. Matsayin daidaitaccen hanyar bincike shine ainihin lokacin juyawa juyawa polymerase chain reaction (rRT-PCR) daga bakin mai ciki.
Ana ba da shawarar yin amfani da abin rufe fuska ga mutanen da ake zargi da kamuwa da cutar da kuma masu kula da su.
Shawarwarin amfani da masks ga jama'a sun bambanta, wasu hukumomi suna ba da shawarar kada su yi amfani da su, wasu suna ba da shawarar amfani da su, wasu kuma suna ba da shawarar amfani da su.
A halin yanzu, babu allurar rigakafi ko takamaiman maganin rigakafin cutar COVID-19.
An samu yaduwar cutar a cikin yawancin ƙasashe a duk yankuna shida na WHO.
Mutanen da ke dauke da kwayar cutar na iya zama marasa alamun cutar ko kuma su sami alamun cutar kamar zazzabi, tari, gajiya da numfashi.
Alamomin gaggawa sun haɗa da wahalar numfashi, ci gaba da ciwo ko matsin lamba a kirji, rikicewa, wahalar farkawa da launin shuɗi a fuska ko lebe; idan waɗannan alamun sun bayyana, ana ba da shawarar neman kulawar likita nan da nan.
A mafi ƙarancin lokaci, ana iya lura da alamun sama kamar yin fitsari, hanci ko kuma ciwon makogwaro.
Alamun hanji kamar tashin zuciya, amai da gudawa an lura da su a kashi daban -daban.
A wasu lokuta a kasar Sin, a farkon lokaci kawai an lura da tsananin kirji da bugun zuciya.
A wasu lokuta, cutar na iya ci gaba zuwa cutar huhu, rashin aiki da gabobin jiki da mutuwa.
Wannan lokaci ne da ake kira lokacin haihuwa.
Lokacin bayyanar COVID-19 yawanci kwanaki biyar zuwa shida ne, amma zai iya wucewa daga kwana biyu zuwa 14.
97.5% na mutanen da suka kamu da cutar suna nuna alamun cutar a cikin kwanaki 11.5 da kamuwa da cutar. Rahotanni sun nuna cewa ba duk mutanen da ke kamuwa da cutar ba ne ke nuna alamun cutar.
Har yanzu ba a san cikakken rawar da waɗannan masu ɗaukar hoto ke takawa ba a cikin watsawa; duk da haka, shaidar farko ta nuna cewa suna iya ba da gudummawa ga yaduwar cutar.
A halin yanzu ba a san adadin mutanen da ke dauke da cutar ba kuma ana nazarin su, inda Cibiyar Kula da Cututtuka da Cututtuka ta Koriya (KCDC) ta ba da rahoton cewa kashi 20% na dukkan shari'o'in da aka tabbatar sun kasance masu alamun cutar yayin zaman su a asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada alamun cutar a cikin ayyukanta na yau da kullun a ranar 1 ga Afrilu; daga cikin kamuwa da cuta 166 a wannan ranar, 130 (78%) sun kasance alamun cutar a lokacin gwaji.
Dukansu mucous da haushi na iya samun kwayar cutar a cikin adadi mai yawa.
Yin magana da babbar murya tana sa a samu ƙarin ɗigon ruwa fiye da magana da murya mai sauƙi.
Wani bincike da aka yi a Singapore ya gano cewa tari ba tare da rufewa ba zai iya haifar da digo mai tsawon mita 4.5 (ƙafa 15).
Kodayake kwayar cutar ba ta yawan yin iska, Cibiyar Nazarin Kimiyya ta Kasa ta ba da rahoton cewa watsa kwayar halitta na iya yiwuwa kuma samfurori daga masu karɓar iska a cikin hanyoyin da ke wajen ɗakunan mutane sun sami tabbataccen RNA na kwayar.
Wasu hanyoyin kiwon lafiya kamar shigar da jijiyoyi da kuma maganin CPR na iya haifar da aerosol daga cikin numfashi kuma don haka ya zama iska.
Ko da yake akwai damuwa cewa zai iya yaduwa ta hanyar stool, ana ganin wannan haɗarin yana da ƙarancin. Kwayar cutar tana da saurin kamuwa da cuta lokacin da mutane ke nuna alamun cutar; kodayake yaduwa yana yiwuwa kafin bayyanar cututtuka, amma ba ta da haɗari.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce duk da cewa ba a san yadda cutar ke yaduwa ba, mutum daya yakan kamu da wasu mutane biyu zuwa uku. Kwayar cutar tana rayuwa a saman abubuwa na tsawon sa'o'i zuwa kwanaki.
Musamman, an gano kwayar cutar a kan kwali na kwana ɗaya, a kan filastik (polypropylene) da bakin karfe (AISI 304) har tsawon kwanaki uku, da kuma a kan jan ƙarfe 99% har tsawon awanni huɗu.
Duk da haka, ya bambanta dangane da zafi da zafin jiki.
Sabulu da kayan shafawa suna da tasiri idan aka yi amfani da su yadda ya kamata; kayayyakin sabulu suna kashe su ta hanyar lalata fat protective layer na ƙwayoyin cuta, tare da kawar da su daga fata da sauran farfajiya.
Sauran magunguna, kamar su benzalkonium chloride da chlorhexidine gluconate (mai kashe kwayoyin cututtuka na tiyata), ba su da tasiri sosai. A cikin binciken Hong Kong, an ɗauki samfurori na ƙura a matsakaita kwanaki biyu bayan an fara asibiti.
A cikin marasa lafiya biyar cikin shida, samfurin farko ya nuna mafi yawan kwayar cutar, kuma mai haƙuri na shida ya nuna mafi yawan kwayar cutar a rana ta biyu ta gwaji.
Babban Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar C
Dukkanin halaye na sabon kwayar cutar SARS-CoV-2 ana samun su a cikin kwayar cutar coronavirus a cikin yanayi.
A waje da jikin mutum, ana kashe kwayar cutar da sabulu na gida, wanda ke lalata murfin kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Fuka-fuka sune gabobin da COVID-19 ke shafar su sosai saboda ƙwayoyin cuta suna isa ga ƙwayoyin abinci mai gina jiki ta hanyar enzyme angiotensin-converting enzyme 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin ƙwayoyin cuta na huhu na nau'in II.
Kwayar cutar tana amfani da glycoprotein na musamman da ake kira "peplomer" don haɗawa da ACE2 da shiga cikin ƙwayoyin abinci mai gina jiki.
An gano cutar ta zuciya a cikin kashi 12% na mutanen da ke cikin asibiti a Wuhan, China, kuma ta fi yawa a cikin cututtuka masu tsanani.
Yawan cututtukan zuciya suna da yawa saboda rashin lafiyar jiki da cututtukan tsarin rigakafi yayin ci gaban cutar, amma lalacewar myocardial mai tsanani na iya kasancewa da alaƙa da masu karɓar ACE2 a cikin zuciya.
Ana nuna masu karɓar ACE2 sosai a cikin zuciya kuma suna da hannu cikin aikin zuciya.
An gano yawan kamuwa da cutar thrombosis (31%) da kuma venous thromboembolism (25%) a cikin marasa lafiya na ICU da ke dauke da cututtukan COVID-19. Binciken gawawwakin mutanen da suka mutu daga COVID-19 sun gano lalacewar iska mai saurin iska (DAD) da kuma ƙwayoyin lymphocyte-mai ƙonewa a cikin huhu.
Kodayake SARS-COV-2 yana da bin tsarin kwayoyin ACE2-mai bayyana epithelial na hanyoyin numfashi, marasa lafiya da ke da mummunan COVID-19 suna da alamun cutar hyperinflammatory.
Musamman, an nuna cewa kwayoyin cutar GM-CSF-secretory T-cell suna da alaƙa da zaɓar IL-6-secretory monocytes masu ba da gudummawa da kuma ciwon huhu mai tsanani a cikin marasa lafiya na COVID-19.
An kuma ba da rahoton abubuwan da ke cikin lymphocytic a cikin binciken.
WHO ta wallafa wasu ka'idojin gwaji da yawa don cutar.
Tsarin gwajin misali shine ainihin lokacin juyawa juyawa polymerase chain reaction (rRT - PCR).
Ana yin wannan gwajin ne akan samfurori na numfashi da aka samo ta bakin hanci; duk da haka, ana iya amfani da samfurin hanci ko mucous.
Sakamakon yawanci ana samun su cikin awanni da yawa zuwa kwanaki biyu.
Ana iya amfani da gwaje - gwaje na jini, amma suna buƙatar ɗaukar samfuran jini biyu a cikin makonni biyu kuma sakamakon ba shi da ƙimar nan take.
Masana kimiyya na kasar Sin sun sami damar ware wani nau'in kwayar cutar coronavirus da kuma buga jerin kwayoyin halitta don dakunan gwaje -gwaje a duniya su iya samar da gwajin polymerase chain reaction (PCR) da kansu don gano kamuwa da cutar ta hanyar kwayar cutar.
Har zuwa 4 ga Afrilu 2020, gwaje-gwajen rigakafi (waɗanda za su iya gano kamuwa da cuta mai aiki da kuma ko wani ya kamu da cutar a baya) suna cikin ci gaba, amma har yanzu ba a yi amfani da su sosai ba.
Kwarewar Sinawa tare da gwaji ya nuna cewa tsarkinsa ya kai kashi 60 zuwa 70 kawai.
A Amurka FDA ta amince da gwajin a wurin kulawa na farko a ranar 21 ga Maris, 2020 don amfani a ƙarshen wannan watan. Jagororin asibiti da asibitin Zhongnan na Jami'ar Wuhan ya bayar sun bayyana hanyoyin gano kamuwa da cuta dangane da yanayin asibiti da haɗarin annoba.
Bayyanar filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen fila
A yayin da cutar ke ci gaba, subplural rinjaye, crazy paving (ƙwanƙwasawar ganuwar da ke cike da ƙwayoyin cuta), da kuma ƙwanƙwasawa na iya bayyana.
Akwai karancin bayanai game da ƙananan raunuka da yanayin jiki na COVID-19.
Babban binciken cututtuka da aka samu daga binciken gawa shine:
Macroscopy: ƙonewa a cikin ƙwayar huhu, pericarditis, ƙwanƙwasawa na huhu da kuma ciwon huhu
Akwai nau 'ikan cutar nimoniya guda huɗu masu tsanani:
Ƙaramin ciwon huhu: ciwon huhu, ƙwayar cuta mai ƙwayar cuta, manyan ƙwayoyin cuta marasa ƙwayoyin cuta, ƙwayoyin cuta tare da ƙwayoyin lymphocytic da kuma ƙwayoyin cuta masu yawa.
Cutar huhu mai tsanani: lalacewar ƙwayar cuta ta radiation (DAD) tare da zubar da iska.
DAD shine dalilin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Maganin cutar huhu: Gudanar da leaks da kuma filayen filayen filayen filayen filayen.
jini: watsawa na ciki (DIC); amsawar leukoarythroblastic
Don rage yiwuwar kamuwa da cutar, matakan kariya sun hada da kasancewa a gida, guje wa wuraren da jama'a ke taruwa, wanke hannuwanku da sabulu da ruwa akai-akai kuma aƙalla na dakika 20, kula da tsabtace numfashi mai kyau da kuma guje wa taɓa idanu, hanci ko baki ba tare da wanke hannu ba.
CDC ta ba da shawarar rufe baki da hanci da nama lokacin da ake tari ko hancin kuma idan babu nama, ana ba da shawarar amfani da ciki na gwiwar hannu.
Ana ƙarfafa tsabtace hannu bayan tari ko hancin.
CDC ta ba da shawarar amfani da suturar rufe fuska a cikin wuraren jama'a don iyakance yaduwar ta hanyar mutane masu alamun cututtuka. Dabarun nisantar zamantakewa suna da nufin rage hulɗar mutane masu kamuwa da cuta tare da manyan ƙungiyoyi, ta hanyar rufe makarantu da wuraren aiki, ƙuntata balaguro da soke manyan taron jama'a.
Ka'idojin nisantarwa sun hada da cewa mutane su kasance aƙalla ƙafa 6 (1.8 m).
Babu wani magani da aka sani da zai yi tasiri wajen hana COVID-19. Tun da ba a sa ran samun allurar rigakafi har zuwa aƙalla 2021, wani muhimmin ɓangare na gudanar da COVID-19 shine ƙoƙarin rage ƙimar cutar, wanda ake kira "ragewa da lanƙwasawa".
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa akai-akai na aƙalla dakika 20, musamman bayan sun je bayan gida ko lokacin da hannayensu suka kasance masu datti, kafin cin abinci da bayan sun yayyafa hanci, tari ko hancin.
Bugu da kari, yana ba da shawarar yin amfani da kayan tsabtace hannu na giya da ke da aƙalla kashi 60% na giya, amma kawai idan sabulu da ruwa ba su da sauƙi. A cikin yankunan da masu tsabtace hannu na kasuwanci ba su da sauƙi, WHO tana ba da tsari biyu don samarwa na gida.
A cikin waɗannan ƙirar, aikin antimicrobial yana haifar da ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don taimakawa wajen kawar da kwayoyin cuta a cikin barasa; "ba abu ne mai aiki ba don maganin hana yaduwar jini".
Glycerol an hada shi a matsayin mai danshi.
Ana gudanar da mutane tare da kulawa mai taimako, wanda zai iya haɗawa da maganin ruwa, taimakon oxygen da kuma ba da taimako ga sauran gabobin da ke da tasiri.
CDC ta ba da shawarar cewa mutanen da ake zargi da kamuwa da cutar su sanya abin rufe fuska na yau da kullun.
An yi amfani da Extracorporeal Membrane Oxygenation (ECMO) don magance matsalar rashin ƙarfi na numfashi, amma fa'idodin sa har yanzu suna cikin tambaya.
Ana ba da shawarar tsabtace jiki da salon rayuwa mai kyau da abinci don inganta rigakafi.
Magungunan taimako na iya zama da amfani ga mutanen da ke da alamun bayyanar cututtuka a farkon lokacin kamuwa da cutar. WHO da Hukumar Lafiya ta Kasa ta China sun buga shawarwari don kula da mutanen da aka kwantar da su a asibiti tare da COVID-19.
Masu ba da shawara da masu ilimin huhu a Amurka sun tattara shawarwarin magani daga hukumomi daban -daban a cikin wata hanya kyauta, IBCC.
Har zuwa watan Afrilu na 2020, babu takamaiman magani don COVID-19.
Don bayyanar cututtuka, wasu likitocin likitanci suna ba da shawarar paracetamol (acetaminophen) maimakon ibuprofen don amfanin farko.
Dole ne a yi taka tsantsan don rage haɗarin watsa kwayar cutar, musamman a cikin tsarin kiwon lafiya, lokacin da ake aiwatar da hanyoyin samar da aerosol kamar shigar da bututu ko sadarwa ta hannu.
Ga ma'aikatan kiwon lafiya da ke kula da mutanen da ke dauke da cutar COVID-19, CDC ta ba da shawarar sanya mutumin a cikin dakin keɓewar kamuwa da cutar ta iska (AIIR) ban da amfani da ƙa'idodin kariya, kariya ta tuntuɓar, da kariya ta iska. CDC ta tsara jagororin don amfani da kayan kariya na mutum (PPE) yayin annobar.
Ana ba da shawarar kayan aiki: PPE, kayan numfashi ko abin rufe fuska, kayan kariya na ido, da safar hannu na likita. Idan akwai, ana ba da fifiko ga masu numfashi (maimakon abin rufe fuska).
An amince da na'urar N95 don tsarin masana'antu, amma FDA ta ba da izinin amfani da masks a ƙarƙashin Hukumar Amfani da Gaggawa (EUA).
An tsara su don kariya daga ƙwayoyin iska kamar ƙura, amma ba a tabbatar da inganci ga takamaiman mai maganin halitta don gwaje -gwajen da ba a yarda da su ba.
CDC ta ba da shawarar yin amfani da garkuwar fuska ko, a matsayin makomar ƙarshe, abin rufe fuska na gida idan babu abin rufe fuska.
Yawancin lokuta na COVID-19 ba su da tsanani da za su buƙaci sadarwa ta inji ko wasu zaɓuɓɓuka, amma a cikin wasu kaso kaɗan.
Nau'in taimakon numfashi ga mutanen da ke fama da rashin nasarar numfashi da ke da alaƙa da COVID-19 ana nazarin su sosai don waɗanda ke cikin asibiti, tare da wasu shaidu cewa ana iya guje wa shigar da bututun tare da shigar da hanci mai zurfi ko matsin lamba mai kyau na iska mai ƙarfi.
Ba a san ko ɗayan waɗannan yana ba da fa'idodi iri ɗaya ga mutanen da ke da rashin lafiya ba.
Wasu likitoci sun fi son yin amfani da hanyoyin sadarwa na inji idan akwai saboda wannan fasaha tana iyakance yaduwar ƙwayoyin aerosol fiye da shigarwar hanci mai gudana. Abubuwan da suka fi dacewa a cikin tsofaffi (mafi girma da shekaru 60 da musamman fiye da shekaru 80).
Yawancin ƙasashe masu tasowa ba su da isassun gadajen asibiti a kowane mutum, wanda ke iyakance ikon tsarin kiwon lafiya don ɗaukar ƙaruwar kwatsam a cikin adadin manyan cututtukan COVID-19 waɗanda ke buƙatar asibiti.
Wani bincike a China ya gano cewa kashi 5 cikin dari na masu fama da cutar sun shiga cibiyoyin kulawa mai tsanani, kashi 2.3 cikin dari na bukatar taimakon inji don sadarwa, kuma kashi 1.4 cikin dari sun mutu.
A China, kusan kashi 30% na mutanen da aka kwantar a asibiti tare da COVID-19 an kwantar da su a cikin ICU.
Sadarwar inji ta zama mafi rikitarwa yayin da COVID-19 ke haɓaka cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Ana buƙatar tsarin sarrafa matsa lamba da masu iya aiki a cikin PEEP mai ƙarfi don haɓaka isar da iskar oxygen yayin rage haɗarin lalacewar huhu da haɗarin pneumothorax da ke da alaƙa da injin.
Babban PEEP bazai iya samuwa akan tsofaffin masu numfashi ba.
Bincike kan yiwuwar maganin ya fara a watan Janairun 2020, kuma akwai magunguna masu yawa da ke cikin gwaji.
Remdesivir ya bayyana mafi alkawura.
Kodayake ana iya haɓaka sabbin magunguna har zuwa 2021, yawancin magungunan da ake gwadawa an riga an amince da su don wasu amfani ko kuma suna cikin gwaji mai ci gaba.
Za a iya gwada maganin rigakafi ga mutanen da ke da mummunan cuta.
WHO ta ba da shawarar masu sa kai su shiga cikin gwaji kan inganci da amincin magunguna masu yuwuwa. FDA ta ba da izinin ɗan lokaci don amfani da jini mai amfani da lafiya a matsayin magani na gwaji a lokuta inda rayuwar mutum ke cikin haɗari ko na gaggawa.
Ba a yi nazarin asibiti da ya dace don nuna cewa yana da aminci da tasiri ga wannan cutar ba.
A watan Fabrairun 2020, kasar Sin ta ƙaddamar da wata manhajar wayar hannu don magance cutar.
Ana tambayar masu amfani da su shigar da sunayensu da lambar ID.
Wannan app ɗin yana iya gano yiwuwar kamuwa da cutar ta hanyar gano 'kusa da kusanci' ta amfani da bayanan sa ido.
Kowane mai amfani zai iya ganin matsayin wasu masu amfani uku.
Idan an gano yiwuwar haɗari, app ɗin ba kawai yana ba da shawarar keɓe kai ba, har ma yana faɗakar da hukumomin kiwon lafiya na gida. Ana amfani da manyan bayanan bincike don bayanan wayar hannu, fasahar gano fuska, bin diddigin wayar hannu da ilimin kere kere don bin mutanen da ke fama da cutar da kuma waɗanda suka tuntuɓi a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba hukumomin tsaro damar bin diddigin bayanan wayar salula na mutanen da ake zargi da cutar coronavirus.
Wannan matakin an yi shi ne don aiwatar da keɓewa da kare mutanen da ke hulɗa da 'yan ƙasa masu kamuwa da cutar.
Bugu da kari, a watan Maris na 2020, Deutsche Telecom ta raba bayanan wurin waya tare da Cibiyar Robert Koch, wata hukumar gwamnatin tarayya ta Jamus don hana yaduwar kwayar cutar da bincike.
Rasha ta yi amfani da fasahar gano fuska don gano masu keta dokar killacewa.
Kwamishinan kiwon lafiya na yankin Italiya, Julio Galera, ya ce masu amfani da wayoyin salula sun sanar da shi cewa "kashi 40% na mutane suna motsi ta wata hanya".
Gwamnatin Jamus ta shirya taron Hackathon na tsawon awanni 48 tare da mahalarta sama da 42,000.
Bugu da kari, Shugaban Estonia, Kirsti Kaljulaid ya yi kira ga duniya da ta nemi hanyoyin samar da hanyoyin magance yaduwar cutar coronavirus.
Mutane na iya fuskantar rikici saboda tsoron keɓewa, ƙuntatawa na tafiya, tasirin magani ko kamuwa da cutar da kansu.
BBC ta nakalto Rory O'Connor yana cewa, "Ƙaruwar rashin zaman lafiya, kadaici, damuwa da lafiyar jiki, damuwa da kuma koma bayan tattalin arziki sune hadari mafi kyau ga lafiyar mutane da lafiyarsu".
Wannan cuta na iya zama mai sauƙi tare da ko ba tare da wasu alamun bayyanar cututtuka kamar sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Sauƙaƙan lokuta yawanci suna warkewa cikin makonni biyu, yayin da masu fama da cututtuka masu tsanani ko masu tsanani na iya ɗaukar makonni uku zuwa shida don warkewa.
Dangane da bayanai daga wasu ƙwayoyin cuta irin su SARS da MERS, mata masu juna biyu na iya fuskantar haɗarin kamuwa da cutar COVID-19, amma akwai ƙarancin bayanai don COVID-19. A cikin wasu mutane, COVID-19 na iya haifar da cutar huhu ta hanyar shafar huhu.
A cikin mutanen da suka fi fama da cutar, COVID-19 na iya haɓaka cikin sauri zuwa cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Matsaloli da ke tattare da COVID-19 sun haɗa da ƙonewa, ƙonewa mara kyau da lalacewar zuciya, koda da hanta.
An ba da rahoton ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙaran
Kimanin kashi 20-30% na mutanen da ke kamuwa da COVID-19 suna nuna ƙaruwa a enzymes na hanta (transaminases).
A cewar wannan rahoton, matsakaicin lokacin da ke tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki 10, tare da kwana biyar a asibiti.
Koyaya, marasa lafiya da aka sauya zuwa ICU suna da matsakaicin lokacin kwana bakwai tsakanin asibiti da mutuwa.
A cikin binciken farko na shari'o'in, matsakaicin lokacin daga nuna alamun farko zuwa mutuwa ya kasance kwanaki 14, tare da cikakken zangon kwanaki shida zuwa 41.
A wani binciken da Hukumar Lafiya ta Kasa ta kasar Sin (NHC) ta yi, mace-mace sun mutu kashi 2.8 cikin dari, yayin da mata suka mutu kashi 1.7 cikin dari.
Gwaje - gwaje na cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
An lura da canjin kwayar halitta ta hanyar kwayar cuta a cikin ƙwayoyin cuta.
Hoton huhu ya bayyana kamar ciwon bugun jini mai tsanani (ARDS).
A cikin mutuwar 11.8% da Hukumar Kiwon Lafiya ta Kasa ta kasar Sin ta ruwaito, an lura da lalacewar zuciya ta hanyar yawan matakan troponin ko bugun zuciya.
A cewar bayanan watan Maris na Amurka, kashi 89% na mutanen da aka kwantar a asibiti suna da yanayin da ke gaban su. Samun albarkatun kiwon lafiya da yanayin zamantakewar al'umma na yanki na iya shafar yawan mace - macen.
Matsayin da ake tsammani na mutuwar ya bambanta saboda waɗannan bambance -bambance na yanki da kuma matsalolin da suka shafi tsarin.
Ana iya yin hasashen yawan mutuwar saboda ƙarancin ƙididdigar ƙananan lokuta.
Koyaya, gaskiyar cewa mutuwar sakamakon abubuwan da suka faru a baya na iya nufin cewa an rage yawan mutuwar yanzu.
Masu shan sigari sun fi sau 1.4 samun alamun COVID-19 masu tsanani fiye da waɗanda ba sa shan sigari kuma sun fi kusan sau 2.4 buƙatar kulawa mai tsanani ko mutuwa. An nuna damuwa game da alamun cututtukan cutar na dogon lokaci.
Hukumar asibitin Hong Kong ta gano raguwar karfin huhu da kashi 20 zuwa 30 cikin dari a cikin wasu mutanen da suka warke daga cutar, kuma hotunan huhu sun nuna lalacewar gabobin.
Hakanan yana iya haifar da ciwo bayan warkewa.
Har zuwa Maris 2020, ba a san ko kamuwa da cutar da ta gabata tana ba da kariya mai tasiri da daɗewa a cikin mutanen da suka warke daga cutar ba.
Ana ganin cewa akwai yiwuwar rigakafi dangane da halayyar sauran cututtukan coronavirus, amma an bayar da rahoton lokuta masu gwadawa da kyau don coronavirus a kwanan wata bayan warkewa daga COVID-19.
Ana ganin waɗannan lamuran sun fi muni da cutar da ba ta warke ba maimakon sake kamuwa da ita.
Ana ganin kwayar cutar ta kasance ta halitta kuma ta hanyar kamuwa da cuta daga dabbobi zuwa mutane.
Ba a san ainihin asalin ba, amma har zuwa Disamba 2019 yaduwar kamuwa da cuta kusan ta hanyar watsawa ne daga mutum zuwa mutum.
A cikin binciken da aka buga a cikin Lancet a watan Janairun 2020, na farko 41 na tabbatar da shari'ar COVID-19, an ba da farkon farkon bayyanar cututtuka a ranar 1 ga Disamba, 2019.
Rahotanni na WHO sun nuna farkon bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Ana amfani da matakai da yawa don ƙayyade yawan mutuwa.
Waɗannan lambobin suna canzawa ta yanki da lokaci kuma suna shafar yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokacin da ya wuce tun farkon barkewar cutar da kuma halayen jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambar cutar gaggawa ta ICD-10 U07.1 don mutuwar da ke faruwa daga kamuwa da cutar SARS-CoV-2 da aka tabbatar da dakin gwaje-gwaje da lambar cutar U07.2 don mutuwar da ke faruwa daga COVID-19 ba tare da binciken asibiti ko cutar ba tare da tabbatar da SARS-CoV-2 ba.
Dangane da bayanan Jami'ar Johns Hopkins, adadin mutuwar duniya ya kai kashi 6.9% (153,822/2,240,191) har zuwa 17 ga Afrilu, 2020.
Lambobin sun bambanta ta yanki. Sauran matakan sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR) wanda ke nuna yawan mutanen da ke kamuwa da cutar da suka mutu daga cutar (wanda aka gano da wanda ba a gano ba).
Wadannan bayanan ba su da lokaci kuma suna bin wani yanki na musamman daga kamuwa da cuta zuwa warkewa.
Kodayake ba duk mutanen da ke dauke da cutar ba ne ke samun rigakafi, kasancewar rigakafin na iya ba da bayani game da mutane nawa ke dauke da cutar.
A cikin wani karamin gari mai yawan mutane 4,600, a Castelliglione d'Adea, cibiyar barkewar cutar a Italiya, 80 (1.7%) sun riga sun mutu.
A Ganglet, cutar ta yadu ne ta hanyar bukukuwan Carnival da kuma tsakanin matasa, wanda hakan ya haifar da ƙananan mutuwar, kuma ba za a iya rarraba duk mutuwar COVID-19 a hukumance ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus ba shi da tsananin.
A cikin Netherlands, kimanin kashi 3 cikin ɗari na iya samun rigakafi, kamar yadda aka kimanta daga masu ba da jini.
An tabbatar da mutuwar mutane 69 (0.004% na yawan) daga COVID-19.
Cutar da tasirinta na mace - macen mace - macen ta bambanta ga maza da mata.
Nazarin da aka yi a China da Italiya ya nuna cewa maza sun fi mutuwa.
Matsayin da ya fi dacewa ga maza shine a cikin shekarunsu na 50, kuma rata tsakanin maza da mata ya ragu ne kawai a cikin shekaru 90.
A China, yawan mace - macen maza ya kai kashi 2.8 cikin dari da mata kashi 1.7 cikin dari.
Ba a san ainihin dalilin wannan bambancin jinsi ba, amma abubuwan da ke tattare da kwayoyin halitta da halayyar mutum na iya zama sanadi.
Bambancin rigakafi na jinsi, ƙarancin shan sigari a cikin mata da haɓaka yanayin rashin lafiya a cikin maza kamar hawan jini a ƙaramin shekaru fiye da mata na iya ba da gudummawa ga yawan mutuwar maza.
A Turai, 57% na mutanen da suka kamu da cutar maza ne kuma 72% na waɗanda suka mutu daga COVID-19 maza ne.
Ya zuwa watan Afrilun 2020, gwamnatin Amurka ba ta lura da bayanan jinsi na kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Babban kaso na ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne, kuma suna iya fuskantar kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairun 2020 cewa sunan hukuma na cutar zai zama "COVID-19".
Shugaban WHO, Tedros Adhanom Ghebreyesus ya bayyana cewa CO na nufin Corona, VI yana nufin Virus, D yana nufin cuta, kuma 19 yana nufin shekarar da aka fara gano barkewar cutar, wato 31 ga Disamba, 2019.
An zaɓi wannan sunan ne don kauce wa nassoshi ga takamaiman wurin ƙasa (kamar China), nau'in dabbobi ko ƙungiyar mutane, wanda ya dace da shawarwarin ƙasa da ƙasa don sanya suna da nufin hana lalata. Ana kiran kwayar cutar da ke haifar da COVID-19 mai tsanani mai saurin kamuwa da cutar coronavirus 2 (SARS-CoV-2).
WHO ta kara amfani da "Covid-19 virus" da "virus da ke da alhakin COVID-19" a cikin sadarwar jama'a.
Dukansu cututtuka da ƙwayoyin cuta ana kiransu "coronavirus".
A lokacin barkewar cutar a Wuhan, China, an kira kwayar cutar da cutar da "coronavirus" da "Wuhan coronavirus".
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCov da 2019-nCoV a matsayin sunayen rikon kwarya don cutar da cutar, wanda ya dace da jagororin 2015 na ba da izinin amfani da sarari a cikin cututtukan cututtuka da sunayen ƙwayoyin cuta.
An fitar da sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iya aiki a cikin daidaitattun sarƙoƙin samarwa, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar su hanci da ɓangarorin masu numfashi.
A wani misali, lokacin da asibiti na Italiya ke buƙatar bawul ɗin iska na gaggawa, kuma mai ba da kaya ba zai iya samar da shi a cikin lokacin da ake buƙata ba, wani farawa na gida ya sake yin aikin injiniya kuma ya buga bawul 100 da ake buƙata cikin dare.
Bayan barkewar cutar COVID-19, jita-jita, rashin fahimta da kuma ɓatar da bayanai game da asalin cutar, sikelin, rigakafi, magani da sauran fannoni sun fito kuma sun bazu cikin sauri akan layi.
Dan Adam yana iya yada kwayar cutar zuwa wasu dabbobi.
Nazarin ya kasa gano shaidar kwayar cutar a aladu, ducks, da kaji.
Babu magani ko allurar rigakafi da aka amince da ita don magance cutar.
Ana gudanar da bincike na kasa da kasa kan alluran rigakafi da magunguna a COVID-19 ta hanyar kungiyoyin gwamnati, kungiyoyin ilimi da masu binciken masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta fara "gwadawa" don tantance tasirin maganin maganin maganin cutar guda huɗu da ke akwai tare da mafi girman begen tasiri.
Babu allurar rigakafi a halin yanzu, amma hukumomi daban -daban suna haɓaka sabbin magungunan rigakafi.
Ana amfani da aikin da ya gabata akan SARS-CoV saboda duka SARS-CoV da SARS-CoV-2 suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam.
Ana gwada dabarun rigakafi guda uku.
Da farko dai, masu binciken suna da burin samar da cikakkiyar rigakafin cutar.
Amfani da irin wannan kwayar cutar, ko tana da rai ko ta mutu, yana da nufin haifar da saurin rigakafin jikin mutum ga sabon kamuwa da cutar COVID-19.
Dabara ta biyu, allurar rigakafi, tana da nufin samar da allurar rigakafi wacce ke sa tsarin garkuwar jiki ya zama mai saukin kamuwa da wasu ƙananan ƙwayoyin cutar.
Dangane da SARS-CoV-2, irin wannan binciken yana mai da hankali ne kan furotin S-contact wanda ke taimakawa kwayar cutar shiga cikin mai karɓar enzyme ACE2.
Dabara ta uku ita ce allurar rigakafin nucleic acid (DNA ko RNA allurar rigakafi, sabuwar fasaha don yin allurar rigakafi).
Za a gwada alluran rigakafin gwaji na kowane ɗayan waɗannan dabarun don aminci da inganci. A ranar 16 ga Maris, 2020, gwajin farko na farko na allurar rigakafi tare da masu sa kai huɗu ya fara a Seattle.
Allurar rigakafi tana dauke da kwafin kwayar halitta mara lahani wanda aka kwafa daga kwayar cutar da ke haifar da cutar. An nuna karuwar dogaro da kwayar cutar a matsayin wata babbar kalubale ga ci gaban allurar rigakafi don SARS-COV-2, amma wannan abu ne mai rikitarwa.
Sama da gwaji na asibiti 300 ne ke gudana har zuwa Afrilu 2020.
Gwaje - gwaje bakwai suna kimanta maganin da aka riga aka amince da shi don zazzabin cizon sauro, gami da nazarin huɗu akan hydroxychloroquine ko chloroquine.
Yawancin binciken da ake yi a China kan magungunan rigakafin cutar da za a iya sake amfani da su, tare da gwaji tara na III akan remdesivir a ƙasashe da yawa, waɗanda aka ƙaddara za a sanar da su a ƙarshen Afrilu.
Har zuwa watan Afrilu na 2020, ana ci gaba da nazarin ci gaban asibiti don alluran rigakafi da magungunan COVID-19. Ana kimanta magungunan rigakafin cutar da ke akwai don magance COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir da interferon beta tare da lopinavir/ritonavir.
Har zuwa Maris 2020, akwai shaidar gwaji don ingancin remdesivir.
An lura da ci gaban asibiti a cikin marasa lafiya da aka kula da su tare da amfani da ba a yarda da su ba na remdesivir.
Ana gudanar da gwaji na gwaji na Mataki na III a Amurka, China da Italiya. An riga an yi nazarin chloroquine, wanda ake amfani da shi don magance zazzabin cizon sauro, tare da sakamakon farko a China a watan Fabrairun 2020.
Koyaya, an yi kira ga nazarin takwarorin bincike.
Hukumomin kiwon lafiya na Koriya da na China sun ba da shawarar amfani da chloroquine.
Koyaya, Cibiyar Nazarin Kwayoyin Cutar Wuhan ta ba da shawarar auna kashi ɗaya na gram a kowace rana, ta lura cewa sau biyu ya fi haɗari kuma yana iya zama mai haɗari.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa ga hydroxychloroquine da chloroquine a cikin hankalin likitocin da ke kula da mutanen da ke da COVID-19. Jagororin na 7 na kasar Sin sun hada da interferon, ribavirin ko umiphenovir don amfani da su don kare COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar manyan allurai na ribavirin don hana SARS-CoV-2 na yanayi.
An ba da shawarar nitasoxanide don ƙarin nazari a cikin kwayoyin bayan nuna ƙarancin ƙwayar cuta na SARS-CoV-2. Nazarin ya nuna cewa farkon furotin mai lamba ta hanyar serine 2 (TMPRSS2) mai ɗauke da ƙwayar cuta yana da mahimmanci ga shigar SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2.
Nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba suna da manyan iyakoki waɗanda suka hana ƙungiyar likitoci karɓar waɗannan magungunan ba tare da ƙarin bincike ba. Oseltamivir ba ya hana SARS-CoV-2 na yanayi na wucin gadi kuma ba shi da wani sanannen rawa a cikin maganin COVID-19.
Ƙara yawan adadin cytokines na iya zama matsala a cikin matakai na ƙarshe na COVID-19 mai tsanani.
Akwai shaidar cewa hydroxychloroquine na iya samun kaddarorin hana karuwar adadin cytokines. Hukumar Lafiya ta Kasa ta kasar Sin ta hada tokilizumab a cikin jagororin magani bayan kammala karamin bincike.
Yana cikin gwaji na kasa na 2 wanda ba a yi ba a Italiya bayan ya nuna sakamako mai kyau a cikin mutanen da ke da mummunan cuta.
A hade tare da gwajin jini na serum ferritin don gano karuwar adadin cytokines, ana nufin magance irin wannan karuwa, wanda ake tsammanin yana haifar da mutuwa a wasu mutanen da ke fama da cutar.
An amince da mai hana karɓar interleukin-6 ta FDA a cikin 2017, bisa ga nazarin shari'ar da aka yi a baya don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Har zuwa yau, babu wata hujja ta bazuwar, tabbatacciyar hujja cewa tosalizumab magani ne mai tasiri don CRS.
Ana binciken canja wurin tsarkakakkun da ke tattare da rigakafin da tsarin garkuwar jiki na mutanen da suka warke daga COVID-19 ke samarwa ga waɗanda ke buƙatar su a matsayin hanyar ba da allurar rigakafi ba.
An yi amfani da wannan dabarar don SARS tare da sakamako mara kyau.
Yanayin rashin lafiyar kwayar cuta shine tsarin aikin da ake tsammani wanda maganin rigakafin rigakafi zai iya daidaitawa don karewa daga SARS-CoV-2.
Duk da haka wasu hanyoyin aiki, kamar su kwayar halitta mai ƙarancin ƙwayar cuta da / ko phagocytosis na iya yiwuwa.
Sauran nau'ikan maganin rigakafin rigakafi, misali amfani da rigakafin monoclonal da aka kera, suna cikin ci gaba.
Za a iya kara samar da maganin cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar ta cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar ta cutar cutar cutar cutar cutar cutar.
Cutar coronavirus, rukuni ne na cututtukan da suka shafi kusanci
Li Wenliang, wani likita a asibitin tsakiya na Wuhan, wanda ya kamu da COVID-19 kuma ya mutu bayan ya wayar da kan jama'a game da yaduwar kwayar cutar.
